Evaluation of microreactor technology for multicomponent reactions by Acke, D
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Printed by: DCL Print & Sign 
Zelzate | Belgium | www.dclsigns.be 
 
 
 
 
 A practitioner is a person that knows how, but not why, 
 A theoretician is a person that knows why, but not how, 
 I have combined the two: 
 I can’t make it work and I don’t know why. 
(after P. Harremoes - Heineken Prize for Environmental Sciences, September 2000) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Members of the Jury: 
  Prof. dr. ir. W. Steurbaut (Chairman) 
  Prof. dr. ir. R. Orru 
  Dr. W. Van Brussel 
  Prof. dr. E. Van der Eycken 
  Prof. dr. ir. P. Van der Meeren 
  Prof. dr. ir. J. Dewulf 
  Prof. dr. ir. R. Verhé 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Promoter: 
  Prof. dr. ir. C. Stevens 
  Research Group SynBioC, Department of Organic Chemistry 
  Faculty of Bioscience Engineering, Ghent University 
Dean: 
  Prof. dr. ir. H. Van Langenhove 
Rector: 
   Prof. dr. P. Van Cauwenberghe  
 
 
 
 
 
 
 
 
ir. Davy ACKE 
 
 
 
 
EVALUATION OF MICROREACTOR TECHNOLOGY 
FOR MULTICOMPONENT REACTIONS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thesis submitted in fulfilment of the requirements 
For the degree of Doctor (PhD) in Applied Biological Sciences: 
Chemistry 
Dutch translation of the title: 
Evaluatie van microreactortechnologie voor multicomponentreacties 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ISBN-number: 
  978-90-5989-202-6 
 
 
The author and the promoter give the authorisation to consult and to copy 
parts of this work for personal use only. Every other use is subject to the 
copyright laws. Permission to reproduce any material contained in this work 
should be obtained from the author. 
 
 
 
 Ghent, November 2007 
 
 
The author: The promoter: 
 
 
 
 
 
ir. Davy Acke Prof. dr. ir. C. Stevens 
 - i - 
Woord Vooraf 
 
Waarom heb ik, ondertussen zoveel jaar geleden, voor bio-ingenieur gekozen? 
Wel, hoofdzakelijk voor het ruime gamma aan wetenschappen die ons 
aangeboden werd. Dat ik die brede basis altijd geapprecieerd heb, getuigt mijn 
curriculum: een masterthesis in de voeding, een doctoraat in de organische 
scheikunde gecombineerd met technologie en sinds kort terug de stap naar de 
voedingsindustrie. De zijstap naar dit doctoraat heeft me enorm gesmaakt. Na 
4 jaar wordt het dan ook tijd om een aantal mensen te bedanken. 
 
Het afleggen van een doctoraat gaat niet alleen om de resultaten, want de 
boog kan niet altijd gespannen staan. Ik denk hierbij aan bbq’s, fuiven, 
snooker, minivoetbal, atletiek, film, de afsluitende party in Spa, ... Op die 
manier leer je je collega’s, waarvan sommigen ondertussen vrienden geworden 
zijn, ook op een andere manier kennen. Kortom, An A., Eva, Dominick, 
Guido, Sven C., Sven M., Matthias, Jan, Marijke, Kurt, Vera, Sarah, Erika, 
Pascal, Ann DB, Bart R., Karel, Stijn, Mudiganti, Filip, Riccardo, Viviana, Ana, 
Camelia, Mirjana, Thomas, Fien, Nicola, Nicolai, Griet, David, Bert, Yves, 
Tina, Inge, Bart V., Berten, Willem, Bram, Kristof, Ellen, Diederica, Pieter, 
Aziz, Tamer, Viviane en Sandra. Bedankt voor de leuke sfeer in en buiten het 
labo! Ik kom zeker nog eens af voor een babbel, een matchke minivoetbal of 
voor het zoveelste rondje rond de Watersportbaan. 
 
Enkele mensen wil ik hierbij extra bedanken. Om praktische redenen (zijnde 
een blauwgeschilderde constructie) werd ik 4 jaar geleden ‘verbannen’ naar 
het vierde verdiep en mocht ik dus constant pendelen tussen het vierde en het 
vijfde. Die verbanning vond ik alles behalve negatief, want ze heeft me de 
kans gegeven om met een aantal fantastische mensen samen te werken, zoals 
David, Bert, Yves, Griet, Camelia en Mirjana. En uiteraard zal ik me de leuke 
babbels met Vera zeker blijven herinneren. Ellen en Kristof wil ik speciaal 
bedanken voor de leuke samenwerking. Samen hebben we een stukje ‘mooie 
chemie’ verwerkt tot een boeiend artikel. En Dominick, mijn bureaumakker, 
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samen uit, samen thuis: Proficiat ook met je doctoraat! Bedankt voor de leuke 
momenten op het werk. Samen met Eva en An heb je het schrijven een heel 
stuk aangenamer gemaakt. 
 
Bij een doctoraat hoort vanzelfsprekend ook een promotor. Ik had daarbij de 
eer om professor Chris Stevens als mijn promotor te mogen hebben. Bedankt 
dat ik zomaar kon binnenlopen als er eens iets niet goed lukte om dan samen 
tot een oplossing te komen. Ik hoop dat dit werk een aanzet mag zijn tot 
verdere studies met microreactoren. 
 
Verder zou ik de leden van de examencommissie van harte willen bedanken 
voor het kritisch nalezen en becommentariëren van mijn werk. I also want to 
thank Wojciech Piotr Bula and professor Han Gardeniers from the MESA+ 
Institute for Nanotechnology, University of Twente, Enschede, The 
Netherlands for the comparative study with the 1-line chip. 
 
Ik ben ervan overtuigd dat je dit enkel maar kunt verwezenlijken als je een 
aantal mensen achter je staan hebt. Daarom zou ik mijn vrienden en 
vriendinnen willen bedanken. Een extra dank naar PJ en Sam om mijn Engels 
wat begrijpelijk te maken. Joke, jij bent eigenlijk onlosmakelijk verbonden met 
mijn doctoraat. Ik wil je bedanken voor de aangename tijd die we samen 
gehad hebben. En voor het boeiend luisteren als ik voor de zoveelste keer 
over die pompen en verstoppingen aan het zagen was: hét bewijs dat alfa en 
beta samen gaan. 
 
En ten slotte zou ik ook graag mijn ouders en mijn broer willen bedanken. 
Het was jullie heel waarschijnlijk nooit echt duidelijk waar ik precies mee 
bezig was. Ik hoop dat dit nu wat duidelijker is geworden. Bedankt moe’tje, pa 
en Andy (aka kleine broer) voor de steun en de motivatie die jullie mij gaven 
om dit tot een goed einde te brengen. 
 
 Davy Acke 
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τ residence time 
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Chapter 1 - Introduction and Goal 
 
1.1 INTRODUCTION 
 
Chemists have been using almost the same equipment for many hundreds of 
years now. Even though batch methods are mostly slow and inefficient, they 
are still performed mainly on expensive products, such as e.g. perfumes, 
wines or pure maple syrups. The process of extracting oils from flowers by 
means of distillation, which is the procedure that is most commonly used 
nowadays to produce perfumes, was already developed in the 10th century by 
Avicenna, an Arabian doctor who was also a chemist. The round-bottom 
flask in the organic lab and the conventional large-scale batch reactor in the 
pharmaceutical and chemical industry were and still are inherent facilities in 
synthetic chemistry.[1] In this way, chemists have been able to synthesise a 
broad range of molecules, and to provide large quantities of potentially 
biological active molecules. Although the access through classical synthetic 
chemistry is quite successful, there is also another side of the coin. Very often, 
these syntheses are accompanied with insufficient conversions, production of 
by-products and a lot of waste, mainly due to insufficient mixing or heat 
removal.  
 
Having in mind the fast decreasing petroleum feedstock, one must constantly 
search for new methods to cope with these disadvantages. Therefore, during 
the last decennia, several attempts have been made to increase the synthetic 
efficiency. These efforts can roughly be divided in two groups, namely 
synthetic and technological improvements, which both have the goal to 
improve the reaction efficiency.  
Important synthetic improvements include the development and use of solid 
phase reactions,[2-4] combinatorial chemistry,[5-7] homogeneous[8] or 
heterogeneous[9,10] catalysis and library syntheses via multicomponent 
reactions (MCRs)[11,12]. 
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Technical improvements that are studied most intensively are process 
intensification methods. This includes the optimisation of reaction 
engineering by changing the instrumentation to reduce waste, energy usage 
and equipment, including the search for new analytical tools for online 
monitoring and the change of equipment such as packed bed reactors and 
microreactors.  
 
Next to the decreasing petroleum feedstock, a second incentive exists to 
develop and study microreactor technology, mainly from a pharmaceutical 
point of view. Nowadays, it takes on average 10 to 15 years for an active 
substance to travel from being an experimental drug in the lab to a 
medicine.[13] The procedure to develop a new drug can be divided in three 
different steps. Firstly, a variety of potentially biological active compounds are 
developed in the laboratory producing several milligrams to grams of the 
product. After incorporating these compounds in preliminary activity tests, 
the lead compounds are selected for further intensive clinical testing in a 
second step. The approval of the medicine is the final phase in the drug 
development. Only five in 5,000 compounds that enter preclinical testing 
make it to human testing, according to the Pharmaceutical Research and 
Manufacturers of America.[14] One of these five tested in people is approved 
for medical use.[13,14] According to a recent study, the total cost involved with 
this process is estimated at 800 million USD.[15] An important issue in this 
context to reduce the time-to-market, and thus the total cost, during the drug 
design is the fast supply of several kilograms of the active product for the 
preclinical and clinical studies. Unfortunately, here lies often the bottleneck 
due to an incompatibility of the laboratory procedure with pilot scale or large 
scale production. The scale up of mixing tanks from laboratory to plant size is 
indeed a crucial issue in the design of industrial processes to find optimal 
configurations and operating conditions. Depending on the physical process 
limiting the performance of the mixing vessel, it is commonly suggested that 
at least one of the mixing characteristics such as power input per unit volume, 
impeller discharge flow, impeller tip speed, Weber number, and Reynolds 
number, should be maintained constant. The most significant problem in 
scale up occurs when different physical processes become limiting at different 
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scales. Industrial scale reactors must perform several functions simultaneously 
(dispersion, reaction, and heat transfer) which do not scale up in the same 
manner.[16] The main scale up problems of organic reactions are associated 
with heat and mass transport, and can result in increased formation of by-
products and lower yields. In the worst cases, shortcomings can lead to 
thermal runaway and other hazardous situations such as the release of large 
amounts of toxic reagents.[17] Approximately 20 to 30 runaways occur each 
year.[18] As a consequence, a lot of time needs to be spent to optimise the 
large scale production. Microreactors could lead to a solution for this problem 
by using the principle of numbering up (vide infra, § 2.4.5).    
 
Microreactor technology is a rather new type of technology which has gained 
a high interest during the last 2 decennia. The first literature about chemistry 
related microstructures appeared in 1986 as a German patent that describes 
how a microreactor should be built.[19] In 1989, the Forschungszentrum 
Karlsruhe (Germany) already built the first micro-heat exchanger and stated 
its application for chemical engineering.[20] Especially since 1997, a lot of 
literature has appeared on microreactors as such, which is probably closely 
related to the first International Conference on Microreaction Technology 
(IMRET 1). Organic synthesis in microreactors is only a very small part of it 
because the technology is used in a much broader concept than organic 
synthesis alone. In 2001, a specific journal for microreactor and microfluidic 
technology, Lab on a Chip, was founded. The increasing interest in 
microreactor technology since the end of the ‘90s is illustrated in Figure 1.1. 
 
1.2 GOAL OF THE CURRENT RESEARCH 
 
Microreactors are especially suitable for fast reactions with a large heat 
effect,[21] since it is possible to maintain isothermal conditions, even at high 
concentrations. Several experiments were performed as a proof-of-concept 
for this technology. Most of these studies however were performed on easy, 
well known reactions. 
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Figure 1.1: Appearance of articles about microreactor subjects (source: 
SciFinder Scholar 2006). 
 
Despite the large interest in MCRs during the last decennia,[11,12,22-26] due to 
their potential to produce large libraries in combinatorial chemistry, no 
studies were performed yet on the use of microreactors for the production of 
compounds via this promising entry. Our goal will be to enlarge the scope of 
the technology and investigate what the possibilities are towards the use of 
MCRs in microreactor technology, both concepts to improve the efficiency in 
organic synthesis. Starting from a commercially available microreactor setup, 
several MCRs will be evaluated.  
 
To test the applicability of microreactor technology for the production of 
chemical compounds via multicomponent reactions, 5 types of reactions are 
chosen. Firstly, the Baylis-Hillman, which is known to be a very slow 
reaction,[27,28] is selected, expecting that microreactor technology could cope 
with this disadvantage. A second reaction that will be evaluated is the 
production of imidazoles via a 4-CR. This reaction is currently optimised 
using microwaves.[29,30] However, because of the problems of the scalability of 
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microwave technology, microreactor technology might be more suitable. 
Since the type of microreactor used in this doctoral study is specially designed 
for the production of larger quantities of products, it is also interesting to test 
the production of chemical compounds on a larger scale. Therefore, a 
multicomponent reaction producing α-aminophosphonates will be thoroughly 
studied. A penultimate interest in this study is the ability to work with toxic 
products in a safe way. For this study, the multicomponent reaction to 
produce 3-amino-4-(arylamino)-1H-isochromen-1-ones is chosen as an 
interesting example. This last compound will be converted to 1H-
isochromeno[3,4-d]imidazol-5-ones in a final study.   
 
In a first research project, the applicability of microreactor technology to the 
interesting Baylis-Hillman reaction will be evaluated. This reaction is known 
to be very slow in particular cases.[27,28] To optimise the procedure, different 
conditions will be evaluated such as the order of mixing, the temperature, the 
solvent and the residence time. After evaluating the optimised reaction 
conditions for the Baylis-Hillman reaction between 4-nitrobenzaldehyde 1a 
and methyl acrylate 2a (Scheme 1.1), a comparison between a conventional 
batch setup and this microreactor setup will be given. The optimisation study 
will be followed by a generality test of this procedure. To allow slow reacting 
compounds to go to completion in the optimised procedure, a technique 
called stopped-flow will be tested. The aza-Baylis-Hillman reaction, which 
starts from the imino compound 6 instead of the aldehyde 1a, will also be 
investigated (Scheme 1.1). 
 
In a second part of the Baylis-Hillman study, a comparison will be made 
between 2 types of microreactors. Therefore, the commercially available 
CYTOS® College System, mainly used in this doctoral study, is compared 
with a microfluidic chip prepared by the MESA+ Institute for 
Nanotechnology of the University of Twente in order to evaluate differences 
in performance or reaction rate due to the difference in microstructure. Next 
to this, the influence of performing reactions in the microreactor unit with or 
without the use of the residence time unit (RTU) will be evaluated. 
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Scheme 1.1: (Aza)-Baylis-Hillman reaction. 
 
Imidazoles are an important class of compounds, which are widely available 
in nature and by organic synthesis.[31] An interesting way to produce 
imidazoles is the four-component reaction starting from a modified 
Radziszewski reaction (Scheme 1.2).[32] The performance of this reaction will 
be evaluated using the microreactor approach. An optimisation study towards 
these tri- and tetrasubstituted imidazoles also includes the order of mixing, 
the temperature and the solvent. Furthermore, in the case of the 
tetrasubstituted imidazoles, efforts will be made to increase the selectivity to 
avoid producing the trisubstituted compounds. Finally, a small library of 
imidazoles will be prepared to test the generality. 
 
O
O
H
O
N
N
NH4OAc
++ NH2
solvent, HOAc
8a 9a 1g
10
11f  
Scheme 1.2: Imidazole synthesis via the modified Radziszewski method. 
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α-Aminophosphonates, with glyphosate as a well-known total herbicide,[33,34] 
are structures with important biological activities.[35-37] In a preliminary 
research performed by the Research Group SynBioC at the Department of 
Organic Chemistry, Faculty of Bioscience Engineering at Ghent University, a 
procedure was optimised to produce these compounds in a simple, high 
yielding way starting from a neat reaction between an imine and a dialkyl 
phosphite.[38] In a first stage, this two-component addition reaction of 
phosphite 13 to an imine 12a (Scheme 1.3) will be evaluated and optimised to 
be performed under microreactor conditions. Attention will be paid to 
conserve high yields, but the optimisation will be performed towards high 
throughput synthesis. The general applicability will also be evaluated. After 
this approach, a shift towards the three-component reaction, starting from the 
aldehyde and the amine, will be studied. The selectivity towards the α-
aminophosphonates 14 instead of the α-hydroxyphosphonates will be studied 
in detail. 
 
H
N
HP(O)(OMe)2
P(OMe)2
HN
O
12a 14a
13
 
Scheme 1.3: Formation of α-aminophosphonates starting from imines. 
 
In a penultimate research topic, the production of 3-amino-4-(arylamino)-1H-
isochromen-1-ones 17 under microreactor conditions will be evaluated 
(Scheme 1.4). During this reaction, the hazardous hydrogen cyanide is 
produced in situ. An evaluation (qualitatively and quantitatively) between the 
batch and microreactor setup will be made to study the safety of both setups 
during hazardous reactions. In the batch procedure, reaction completion is 
induced via crystallisation of the end product.[39] During optimisation in the 
microreactor however, this crystallisation must be avoided to prevent 
blockage of the microchannels. Furthermore, the optimised procedure will be 
tested for a small library of compounds to obtain a high throughput.  
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Finally, in order to further explore these 3-amino-4-(arylamino)-1H-
isochromen-1-ones, a ring closure of the vicinal amino groups will be studied 
to obtain a new scaffold, namely 1H-isochromeno[3,4-d]imidazol-5-ones 19, 
containing an imidazole ring (Scheme 1.4). Therefore, several ring closing 
procedures will be evaluated and the optimum method will be transformed to 
a microreactor setup to produce a small library after an optimisation study. 
 
H
O
O
KCN 16, HOAc
NH
O
O
NH2+
NH2
O
O
N
N
OH
HC(OMe)3
15 9b 17a 19a
18a
 
Scheme 1.4: Production of 3-amino-4-(arylamino)-1H-isochromen-1-ones 
and subsequent ring closure to 1H-isochromeno[3,4-d]imidazol-5-ones.
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Chapter 2 - Literature Overview 
 
2.1 INTRODUCTION 
 
This literature overview gives a general introduction about the concept 
‘microreactor’, followed by a short overview of the different applications. 
Because of the wide applicability of this technology and in the context of this 
doctoral thesis, the review will focus on the use of microreactors in organic 
synthesis. Special attention will be given to the possible advantages and 
disadvantages of the use of microreactor technology in close relation to the 
applications in organic synthesis.   
 
2.2 DEFINITION 
 
Microreactors, as part of the wide group of microsystems, were generally 
defined as ‘miniaturised reaction systems fabricated by using, at least partially, 
methods of microtechnology and precision engineering’.[40] This rather old-
fashioned definition is recently revised.[41] Nowadays the broader definition 
also contains down-scaled designs of existing reactors and modern reactor 
concepts such as falling-film reactors,[42] packed-bed reactors,[43] structured 
catalysts e.g. foams,[44] and capillary-in-tube reactors.[45] During the last 
decades, a wide variety of different microreactors has been developed.[46,47] 
 
2.3 APPLICATIONS 
 
As mentioned in the introduction, organic synthesis in microreactors has 
gained attention during the last decade. Meanwhile, a lot of review articles 
about this issue appeared in literature.[48-55] Next to this application, a wide 
variety of other applications is known, most of which are situated in the field 
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of the analysis, especially for the development of micro total analysis systems 
(µ-TAS),[17,56] and the study of basic biology[57] such as the interaction between 
different cell types[58]. Generally, a µ-TAS includes the miniaturisation of an 
overall analytical process from sample preparation through reaction and 
separation to detection.[59] 
Important issues herein are the study towards DNA polymerase chain 
reaction (PCR) microchips[60-62] and the subsequent separation of different 
DNA strains[63]. Recently, researchers were able to purify DNA on-chip via 
the merging, mixing and splitting of droplets.[64] For the study of kinetic 
interactions between DNA and dyes, fluorescence lifetime imaging (FLIM) 
was tested in microfluidic systems. The authors state that this technique is 
applicable to resolve and quantify several multistate chemical and biological 
systems.[65] The development of microchips that evaluate the activity of 
enzymes,[66,67] or the use of enzymes, immobilised or not, for analytical 
methods is also well known[68,69]. Furthermore in the context of enzymatic 
activity, both research of protein digestion by enzymes[70] and protein 
synthesis by using microbial extracts[71] were successfully accomplished using 
microstructures. Recently, some microfluidic reactors were developed with 
on-chip analysis. The performance is comparable with a bench scale reaction 
followed by HPLC[72] or MS analysis[73,74]. Another on-chip analysis system 
used a microcoil NMR to evaluate the conversion towards an imine 
synthesis.[75] 
Detection and separation of proteins was successfully performed by the 
production of self-assembled monolayers on a microchip. Separation of the 
low concentration protein in a 1:1000 mixture of 2 proteins was possible.[76] 
Another chip that was developed contained an integrated optical Young 
interferometer sensor for ultrasensitive, real-time, direct detection of viruses. 
The herpes simplex virus type 1 (HSV-1) was detectable in clinically relevant 
concentrations.[77] Various studies were able to detect and eventually quantify 
single[78-80] or more[81] cells by using different analysis techniques on 
microchips. This gave the opportunity to monitor growth curves.[78] Wang et 
al. developed a µ-TAS for metabolic analysis of a mixture of metabolites 
including glucose, uric acid, ascorbic acid and acetaminophen. Enzymatic 
oxidation of glucose was carried out in a microchannel, followed by the 
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separation and electrochemical detection of the end products. The chip-based 
protocol integrated a miniaturised bioassay, separation and amperometric 
detection in a single device.[82] In a second example of a µ-TAS, a Duchenne 
muscular dystrophy diagnosis microdevice was developed. An extraction of 
genomic DNA from whole blood using a novel sol-gel matrix, followed by 
IR-mediated PCR amplification of a β-globin fragment of the genomic DNA 
and electrophoretic analysis was thereby integrated on a single microdevice.[83] 
In the same context, Mitchell et al. developed a µ-SYNTAS system, which 
combines a chemical microreactor and a total analysis system. This 
microdevice was used to study a sub-reaction of the Ugi-MCR.[74] 
 
2.4 ADVANTAGES 
 
Generally, a lot of advantages for organic synthesis are suggested by 
developers and manufacturers of microreactor systems of which a better mass 
and heat transfer, a safer handling of reactions and a higher selectivity are the 
most important.[40,84-86] A wide variety of organic syntheses were already 
performed in microreactor systems to prove these concepts.[87-89] Some of 
these reactions are discussed below. From an economical point of view, 
studies conclude that approximately 50 % of today’s chemical reactions could 
benefit from continuous processes which are mainly based on microreaction 
technology.[1] Recently, a life cycle assessment (LCA) investigated the 
microreactor technology potential. As a model reaction, the production of 3-
anisaldehyde 22 via an exothermic 2-step synthesis starting from 3-
bromoanisole 20 was evaluated (Scheme 2.1). 
 
BrMeO LiMeO MeO
H
O
BuLi, THF 1. DMF, THF
2. H2O
20 21 22  
Scheme 2.1: Model reaction for the LCA. 
 
A study was made between a conventional batch reactor and 2 CYTOS® Lab 
System modules in serial. Both laboratory and industrial scale productions 
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were evaluated. The research clearly pointed out that the application of 
microreactors can lead to significant reductions in the environmental impact 
of chemical processes. On the laboratory scale, a reduction of 20 to 60 % was 
observed. The main reasons for this reduction were found in the increased 
yield, the reduction of solvents and energy consumption savings. The use of 
microreactor technology on the industrial scale was advantageous due to the 
avoidance of a cryogenic system for temperature control, which led to 
reductions of approximately 20 to 30 %. In order to get long term advantages, 
special attention has to be paid to the longevity of the microstructured system. 
However, it must also be emphasised that this study was specifically for this 
particular reaction and conclusions could not be generalised.[90]  
 
2.4.1 Mass transfer 
 
In conventional chemistry, mixing is usually performed by convection 
because a diffusion controlled reaction would mean a very slow mixing in 
conventional batch reactors. The main reason being the diffusion time, that is 
proportional with the square of the distance: 
 
D
d2
 
d
t =  (2.1) 
 
with td = diffusion time (s) 
 d = distance of diffusion (m) 
 D = diffusion coefficient (m²/s) 
 
Indeed, a molecule with a diffusion coefficient of 10-9 m²/s needs 
approximately 15 min to travel only a distance of 1 mm.[17,56] Therefore, 
turbulence is introduced in conventional batch reactors. To obtain this 
turbulent mixing, different techniques such as baffles and stirrers were 
developed. However, a problem which mostly occurs is the existence of 
concentration gradients in the system. 
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Compared with the conventional batch system, a better mass transfer is 
possible in microreactors. Due to the very small channels (mostly between 50 
and 500 µm) in microreactors, it is not possible to obtain turbulence in 
microchannels and therefore a laminar flow regime is observed.[91] Because 
the Reynolds number is proportional to the characteristic length, a small value 
will be obtained for miniaturised systems, indicating laminar flow (vide infra, § 
3.2.5).[17] So mixing of compounds will happen via diffusion between the 
parallel flowing layers.[91] This occurs very fast, because the chemicals do not 
need to travel a large distance due to these small channels. As an example, the 
same molecule needs only 10 s and 100 ms to travel 100 µm respectively 10 
µm.[17,56]  This gives the possibility to mix to homogeneity within milliseconds 
to seconds.  
 
Although the better mass transfer is often given as a main reason for the 
better conversion and yields of a chemical reaction using microreactor 
technology, to date no real in-depth study of the influence of the mixing 
characteristics of microreactors on the performance of chemical reactions is 
performed. The literature that is found related to this topic, are experimental 
data concerning the mixing performance[92,93] or theoretical calculations of the 
mixing effect on chemical reactions[94,95]. 
 
Calculations of the mixing behaviour, together with an experimental 
validation, proved the statement that a size reduction of a T-shaped 
micromixer, leads to faster chemical reactions and a better heat transfer, as 
long as the geometry stays similar. Given below is the theoretical study of the 
mixing behaviour in a T-shaped micromixer.[96] 
 
The transport of mass and momentum is described by the non-dimensional 
Navier-Stokes equations. For incompressible Newtonian fluids, with a 
constant density, these equations are: 
 
0u =⋅∇  (2.2) 
u
Re
1'puu
dt
u Δ⋅+−∇=∇⋅+∂  (2.3) 
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ν
⋅= HdURe  (2.4) 
 
with u = non-dimensional velocity field (-) 
 p’ = modified pressure (-) 
 Re = Reynolds number (-) 
 U = reference velocity (m/s) 
 dH = hydraulic diameter (m) 
 ν = kinematic viscosity (m²/s) 
 
This means that, in the case of geometrical similarity and if the inlet and 
outlet conditions are scaled correspondingly, the flow behaviour is only 
determined by the Reynolds number. Therefore, microsystems have no 
advantage if the flow behaviour is considered alone, considering the 
mentioned assumptions. In this fluid flow, the transport of an ideally diluted 
non-reactive species is given by: 
 
c
ScRe
1cu
dt
c Δ⋅=∇⋅+
∂  (2.5) 
D
Sc ν=  (2.6) 
 
with c = non-dimensional concentration (-) 
 Sc = Schmidt number (-) 
 D = diffusion coefficient (m²/s) 
 
For reaction flows, an additional kinetic term has to be included. For a first 
order reaction, the transport equation becomes: 
 
cDa
l
dc
ScRe
1cu
dt
c
I
H−Δ⋅=∇⋅+
∂  (2.7) 
U
lkDaI
⋅=  (2.8) 
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with l = length (m) 
 DaI = Damköhler(I) number (-) 
 k = kinetic constant (1/s) 
 
The Reynolds number depends on the product UdH, while the Damköhler(I) 
number depends on the quotient l/U. For a fixed ratio dH/l, both numbers 
cannot be kept fixed while changing the size. This means that physico-
chemical and hydrodynamical similarity cannot be achieved for reactors of 
different size. To quantify the scale effect, a geometrical scaling factor λ is 
introduced, with λ << 1. By introducing l' = λl, d'H = λdH and U' = U/λ to 
obtain the same flow conditions, the dimensionless numbers for the micro- 
and macroscale system become: 
 
II Da²'Da
Sc'Sc
ReRe'
λ=
=
=
 (2.9) 
 
This means that the apparent rate constant (dH/λ)DaI of the chemical reaction 
decreases massively if the geometric dimensions are reduced by a factor λ << 
1 at fixed Re and Sc. 
 
Because of the laminar flow regime, a lot of research is done towards the 
improvement of the mixing zone.[97-99] A concept that is used in several 
designs of microreactors to improve mixing is the multilamination 
structure.[100] To obtain a faster mixing, the microchannel of one input is 
divided in several parallel smaller channels. Each small channel is then united 
with the same parallel channels from the other input (Figure 2.1). This gives 
faster mixing compared to joining the 2 starting channels because of the 
smaller diffusion distances.[97] Based on computational studies, it is proven 
that the lamination width greatly affects the yield for the desired product.[94] 
Consider following reaction type: 
 
BA11 CCkrRBA ⋅⋅=→+  
RB22 CCkrSRB ⋅⋅=→+  
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with A, B = reactants 
 R = desired product 
 S = by-product 
 ri = reaction rate of step i (mol/m³.s) 
 ki = rate constant of step i (m³/mol.s) 
 Cj = molar concentration of product j (mol/m³) 
 
Using computational flow dynamics (CFD), the relation between the mass 
average conversion of reactant A at the reactor exit (xA) and the yield of the 
desired product R (YR) was calculated for different rate constants k (= k1 = k2) 
and lamination widths W.  An important factor in this context was the 
dimensionless number Φi, which represents the ratio between the reaction 
rate and the diffusion rate. 
 
D
WCk 21nBi
i
0
⋅⋅=Φ
−
 (2.10) 
 
with 1nB0C
− = initial concentration of reactant B (in this case: 27.7 kmol/m³) 
 n = order of the reaction 
 R = desired product 
 W = lamination width (m) 
 D = diffusion coefficient (~ 10-9 m²/s) 
 
This number gives a criterion to determine the controlling step of reactions. 
The reaction is the controlling step when Φi < 1 and the diffusion is the 
controlling step when Φi > 104. So, at high rate constants, a smaller 
lamination width is necessary because otherwise the diffusion limits the 
reaction rate to the desired product. For a rate constant k of 0.01 m³/kmol.s, 
Φi is 2.8 when W = 100 µm and 0.17 when W = 25 µm. Calculations showed 
that in these cases the yield YR approached the yield obtained in ideally mixed 
situations. In the case the reaction rate k is 100 m³/kmol.s, Φi is 2.8 x 104 
when W = 100 µm and 1.7 x 103 when W = 25 µm. In this case, diffusion 
becomes the limiting factor, especially at high lamination widths. This 
strongly affects the conversion to the desired product R, since the diffusion 
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length between A and B is longer than between B and R, which means the 
side-product S is more easily formed. Using different CFD simulations, the 
authors stated that the mixing conditions in the reactor can be controlled by 
the design.[94] 
 
 
Figure 2.1: Example of multilaminar mixing. 
 
2.4.2 Heat transfer 
 
In addition to the better mass transfer, the heat transfer is also ameliorated 
due to the geometry of the devices. Small channels give higher surface-to-
volume ratios. Typical values are in the range of 10,000 to 100,000 m²/m³.[40] 
These values range from 10 to 100 m²/m³ in conventional batch reactors. So, 
heat or cold is transferred faster through the microreactor walls. A similar 
approach as for the mass transfer calculations shows that better thermal 
control is achieved in microsystems.[96] A combination of the previously 
mentioned fast mixing and the fast heat transfer, avoids the formation of hot 
spots. 
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As an example, Swern oxidations with a high selectivity were possible at room 
temperature in a sequential micromixer device, while in batch reactions the 
temperature had to be kept below -50 °C to avoid side-product formation. 
This meant a lower energy expenditure together with a higher yield.[101]   
 
2.4.3 Safety 
 
Another advantage of microreactors is the safety. Due to the small inner 
volume (typically less than 5 mL), dangerous reactions, such as Grignard 
reactions,[102] methyl carbamate formations[102] and nitrations,[103,104] are better 
controlled. All reaction products are continuously present in low amounts. 
Moreover, in contrast with the batch reactions, only small amounts of the end 
product are released at the end of the process. 
 
A risk in conventional reactors is thermal runaway, a process by which an 
exothermic reaction goes out of control, often resulting in an explosion. This 
is mostly caused by failure of the reactor vessel's cooling system. Failure of 
the mixer can result in localised heating, which initiates thermal runaway. 
Exothermic side reactions and combustion begins at higher temperatures, 
accelerating this process. It has contributed to industrial chemical accidents, 
most notably the 1984 explosion of a Union Carbide plant that produced 
methyl isocyanate in Bhopal, India. This accident resulted in the direct death 
of 3,000 people, while another 15,000 died because of related illnesses. A 
second example is the catastrophe in Seveso, Italy in 1976. The clogging of 
one of the reactors, which produced 2,4,5-trichlorophenol (a herbicide), 
caused thermal runaway. Thereby, a large amount of 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD) was exposed to the environment and 
tens of thousands of farm animals and pets died. This gave rise to numerous 
scientific studies and standardised industrial safety regulations, known as the 
Seveso II Directive. 
 
Due to the high level of control in microreactors, it is easier to avoid the 
occurrence of thermal runaway. One example of a dangerous reaction that is 
performed safely in a microreactor unit is the formation of the highly reactive 
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diazomethane. This compound is very interesting for incorporation of a one-
carbon unit in a molecule. However, a major problem is the explosive 
character of diazomethane. A lot of care has to be taken during the 
production in the laboratory and contact of diazomethane with sharp parts of 
laboratory glassware has to be prevented. Using a microreactor setup, Ferstl et 
al. were able to produce diazomethane in high concentrations within seconds 
with a conversion of 82 ± 2 %. There was no need for special safety 
precautions.[105] 
 
An interesting way to incorporate cyanides in chemical molecules or to 
produce cyanohydrins is by in situ production of hydrogen cyanide. Because 
of the high toxicity of this gas (acute lethal oral dose: 50-90 mg), the use in 
large scale production is avoided as much as possible. Nevertheless, due to 
the interesting applications in organic synthesis, HCN gas is industrially 
produced via the Andrussov process in which methane and ammonia react in 
the presence of oxygen (Scheme 2.2). In the past, specialised microreactor 
systems were already assembled to synthesise HCN via this highly exothermic 
process. Therefore, some modifications of the original process were necessary: 
the distance between the hot reaction zone and the cold heat exchanger were 
minimised and the catalyst structure was modified. Comparison with the 
industrial process showed a lower, but safer, conversion in the microreactor: 
60 % versus 31 % respectively.[40]   
 
CH4 NH3 1.5 O2 HCN
Pt catalysis
+++ 3 H2O 
Scheme 2.2: The industrial Andrussov process. 
 
Several epoxidations and the Baeyer-Villiger lactonisation were successfully 
performed in a similar microreactor (CYTOS® Lab System) as the one used in 
this doctoral research. For these reactions the dangerous peracetic acid 24 was 
used as one of the reagents. It is known that batch reactions mostly need long 
reaction times, because peracetic acid is explosive at reaction temperatures 
exceeding 60 °C.1 Moreover, because of the formation of acetic acid a lot of 
                                        
1 due to an explosion point of 110 °C, this temperature buffer is applied in many chemical companies, especially with 
exothermic reactions. 
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degradation reactions can occur, which decreases the final yield. Therefore, in 
labscale synthesis the safer and cleaner m-chloroperbenzoic acid is mostly 
used. In the microreactor procedure however, it was even possible to perform 
the epoxidation of allyl acetate 23, which is known for its low reactivity 
towards epoxidation, at temperatures up to 90 °C, in reasonable yields and 
without safety risks. The lactonisation of bicyclo[3.2.0]hept-2-en-6-one 26 
could be performed at elevated temperatures to reduce the reaction time from 
several hours in batch to approximately 4 min in the microreactor (Scheme 
2.3).[106] 
 
O
O
2 equiv CH3CO3H 24
70 °C, 1 mL/min
τ = 92 min
O
O
O
34 %, 1.2 g/h
3 equiv CH3CO3H 24
58 °C, 4 mL/min
τ = 4.3 min
90 %, 13.6 g/h
O
H
H
H
H
O
O
23 25
26 27
 
Scheme 2.3: Safe epoxidation and Baeyer-Villiger oxidation with peracetic 
acid using a microreactor. 
 
2.4.4 Selectivity 
 
Another important advantage linked to microsystems is the improved 
selectivity of chemical reactions.[104,107] This is strongly related to the 
aforementioned advantages, especially the better heat transfer. An explanation 
of this improved selectivity is given in Figure 2.2. Consider a product A which 
can form 2 different products, B and C. Assume that the activation energy to 
form product B is much smaller than to form the undesired side-product C. 
Then, the smaller temperature range obtained in the microreactor system -due 
to a better heat control in the small channels- provides that the activation 
energy to form product C is never reached. To the contrary, a wider 
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temperature range is obtained in a batch reactor due to less sufficient mixing. 
This can give rise to the formation of product C.[92] 
 
An interesting example herein is the selective monoiodination of aromatics. 
First the iodine was converted to the active species via electrochemical 
oxidation. This active I+ compound 29 was then mixed in a micromixer with 
different aromatic compounds, such as 1,3-dimethoxybenzene 30, to obtain a 
mixture of monoiodinated an diiodinated aromatics (Scheme 2.4). 
Comparison with batch reactions showed a higher selectivity in all the 
iodinations performed in the microsystem.   
 
 
Figure 2.2: Correlation between temperature range and selectivity in organic 
synthesis, using conventional or microreactor synthesis. 
 
An important effect that was observed was the dependence of the selectivity 
on the flow rate. The higher the flow rate, the better the selectivity. This was 
related to the better mixing performance of this type of micromixer at larger 
volume flow rates.[108] CFD simulations also showed the importance in mixing 
efficiency to obtain a high mono/dialkylation selectivity in the Friedel-Crafts 
aminoalkylation of (hetero)aromatics.[109] A larger flow rate seemed also to 
have an influence on the conversion rate, as proved in the Claisen-Schmidt 
reaction.[110] 
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The improved selectivity in the microsystems was also proven in the Pd-
catalysed carbonylative Sonogashira coupling of aryl iodides 33 and 
phenylacetylene 35 (Scheme 2.5). While in the batch reaction a mixture of the 
acetylenic ketone 36 and the expected by-product 37 occurred, the reaction 
under microreactor conditions provided solely the ketone 36, even at reduced 
CO pressure. In addition, the yield was also markedly improved. This increase 
in selectivity was attributed to the occurrence of a plug flow in the 
microreactor system. The substrate dissolved in the ionic liquid phase and 
diffusion of CO in the ionic liquid plug was facilitated due to the large 
specific interfacial area. Such a high specific interfacial area-to-volume ratio, 
which is necessary for the efficient CO diffusion, does not occur in a batch 
reactor because of the inefficiency of mechanical stirring.[111]    
 
I2 + 2 CH3CN 2 CH3CN-I+
- 2 e-
"I+" +
OMe
OMe
OMe
OMe
OMe
OMe
I I
I
+
batch reactor
microsystem
45 % 18 %
78 % 4 %
28 29
29 30 31 32
 
Scheme 2.4: Selective monoiodination of aromatics using an IMM (Institut 
für Mikrotechnik Mainz) single mixer. 
 
Ar-I +
33 34
CO + HPh Ar
O
Ph
Ar
Ph
+
Pd-catalyst (1 mol%)
[BMIm]PF6, Et3N
120 °C35 36 37  
Scheme 2.5: Pd-catalysed carbonylative Sonogashira coupling. 
 
The selectivity issue of microreactor technology was also clearly demonstrated 
by some aminocarbonylation reactions (Scheme 2.6).[112-115] In most batch 
procedures, no or minimal formation of the α-ketoamides 40 and 43 is 
observed, because the reaction is mostly performed at near atmospheric 
pressure.[112] Using microreactor systems, higher yields of the amides 39 and 
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42 were obtained and also significant amounts of the side-products were 
formed.[113] By adjusting the process parameters, it was possible to increase 
the selectivity towards one of the end products. An increased temperature 
selected for the amide, while increasing the CO pressure yielded more α-
ketoamide.[112] Using the optimised procedure for amide 39, radiolabeling 
experiments with 11CO were successful and thus microfluidics offers an entry 
to positron emission tomography.[114,115]  
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X = Br, I  
Scheme 2.6: Aminocarbonylation of halogenated aromatics. 
 
Using a multichannel continuous flow modular microreactor, it was possible 
to fluorinate 1,4- and highly deactivated 1,3-disubstituted aromatics. Although 
the conversions were quite low in the latter case, the reaction proved to be 
highly selective towards the monofluorinated compound. Using a recycling 
system, in which the crude reaction mixture was passed several times through 
the microreactor device, higher conversions were obtained without loss of 
selectivity.[116] 
 
2.4.5 Scaling up of chemical reactions 
 
The major advantage for this kind of technology is the scalability. If a 
conventional labscale process has to be scaled up, the normal method is to 
work in several steps. First the process is scaled up to the litre or several litres 
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scale. The next step is the pilot plant and finally the process is scaled up to 
production scale. Every step needs careful control of different process 
parameters like temperature, pressure, rate of addition of reagents and 
removal of products in order to keep the process under control. Especially 
for exothermic and endothermic reactions or reactions using toxic reagents, 
the differences between labscale and production scale parameters can be 
extreme. Scale up is therefore a time-consuming and expensive process in 
industry. By contrast, once a process is optimised under microreactor 
conditions, there is no need anymore to scale up the reactor. Instead of 
scaling up a microreactor, numbering up is the expression that is used in this 
technology. This principle means that several microreactors are placed in 
parallel to produce higher quantities. Using this method, no modifications of 
the labscale conditions are necessary anymore. This means that a lot of time 
and money can be gained during process development and to further improve 
a process.[117] As a proof-of-concept, Schenk et al. developed a liquid-flow 
splitting unit, that was connected to 6 parallel micromixers. To test the 
performance of this device, a fast organic reaction between acetyl chloride 44 
and n-butylamine 45, with formation of the corresponding amide 46 was 
evaluated (Scheme 2.7). The yield in a single micromixer device varied 
between 87 and 100 %. Using the parallel micromixers, an overall yield of 
88 % was achieved, with a standard deviation of 16 % between the parallel 
micromixers. The relative high standard deviation had two main reasons. 
Firstly, in one of micromixers clogging occurred, which gave a lower product 
outcome. Excluding this device gave a standard deviation of 8 %. Secondly, 
salt formation occurs during the reaction, which resulted in higher variations 
in the flow distributions between the micromixers.[118] Another concept that is 
recently introduced in microreactor technology, next to the numbering up, is 
equalling up.[119] The concept is more or less the same, but instead of having 
several microreactors in parallel, there is one reactor in which several 
microreactors are built in. In fact, this is a kind of internal numbering up. 
 
Et3N
44 46
Cl
O
+ NH2 N
H
O
45  
Scheme 2.7: Synthesis of n-butyl acetamide 46. 
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Although this advantage is mentioned in several scientific papers, only few 
researches have applied this in practice. One of them is the large scale 
synthesis of pristane 46, an important adjuvant for monoclonal antibody 
production. The overall synthesis is given in Scheme 2.8.     
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Scheme 2.8: Synthesis of pristane 52. 
 
The batch synthesis of the key step, which is the dehydratation of the allylic 
alcohol 50, yielded 55 % on a 100 mg scale and less than 20 % (due to 
inseparable by-products) on a 100 g scale. Optimisation of this step using a 
micromixer gave an overall yield starting from farnisol 47 to pristane 52 of 
80 %. For the large scale production, a Comet X-01 microreactor, containing 
10 micromixers in parallel, was used for producing 8 kg dehydration product 
within 3 to 4 days. An overall yield of 50-55 % of 52 was obtained with > 
99 % purity.[120] 
The easy scale up procedure was also proven in the cathodic coupling of 
activated olefins with benzyl bromide to produce for example dimethyl 2-
benzylsuccinate 55 in a micro flow reactor (Scheme 2.9). Two microreactors 
in parallel gave twice the output of a single reactor.[121]    
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Scheme 2.9: Synthesis of dimethyl 2-benzylsuccinate 55. 
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2.5 DRAWBACKS 
 
The introduction of a new technology not only brings several advantages, but 
also involves some disadvantages. These slow down the introduction of 
industrial applications. During the last decennium different research groups 
have tried to overcome several of these issues.  
 
2.5.1 Clogging of the system 
 
The small dimensions of the microdevices make them prone to clogging. 
Especially when highly viscous products or crystalline compounds are formed, 
high risks of clogging of the system occurs. This necessitates a regular 
flushing of the system to avoid pressure from building up, which is a major 
drawback in continuous processing. Another important problem that can 
occur during the processes is the limitation of start product concentration (in 
the case of solids), the formation of precipitates, crystallisation or 
polymerisation in the system. 
 
During the last years, some research has been done to work with solid 
particles or high viscous compounds, despite the risk of clogging the 
microsystem. For example, Ismagilov and coworkers did some fundamental 
research about the crystallisation of proteins in microchannels. They 
developed a setup to avoid crystallisation by using a two phase system to give 
the crystals no opportunity to adsorb to the surface.[122,123] Moreover, they 
were able to crystallise the proteins inside the microchannels in a controlled 
way to obtain X-ray pure crystals.[124-126] Another microreactor design to 
perform reactions in droplets was based on a tube reactor in which carrier 
fluid was pumped. The tube was pierced with syringes containing the disperse 
phase. It was possible to create bubbles containing solid reaction products, 
such as indigo, N,N’-dicyclohexylethylenediimine and 4-chloro-N-
methylbenzamide, in the microtubular reactor.[127] Performing reactions in 
droplets is also an efficient way to screen for optimised reaction parameters, 
since many droplets per time unit can be created. Some possible methods for 
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fast screening are the use of cartridges and the variation of the reagent 
concentration. The cartridge technique can be used for screening a large 
number of reaction conditions against one target sample. Therefore, an array 
of plugs, which contain different reagents or reaction conditions, is stored in a 
preformed cartridge. The target sample is than introduced in the plugs by a T-
junction microchannel. In the other method, the variation of reagent 
concentrations is accomplished by varying the relative flow rates of the 
different reagents.[128] 
 
By combination of a micromixer and a microwave irradiated capillary tube, 
several nucleophilic aromatic substitutions (Scheme 2.10) were performed 
successfully without clogging, although crystallisation was detected. The 
substitution of the fluorine of 1-fluoro-2-nitrobenzene 56 to products 58, 60 
and 62 gave 72, 66-100 and 68-80 % conversion respectively.[129,130] In some 
previous work, this was already done using a continuous flow system under 
microwave conditions. Clogging of the system occurred after a while, 
although no microcapillar was involved in this case.[131] The reason of the 
success in the first case was assigned to the reactor design which was a short 
and straight tube instead of a spiral one. Further optimisation provided a 
multireactor assembly with a continuous flow, sequential, parallel synthesis.[129] 
Recently, the researchers also performed some MCRs in this microwave-
assisted microreactor.[132] In an attempt to use a combination of micromixers 
and tubular reactors for the industrial phenyl boronic acid process, also some 
fouling occurred in the system. By tuning the internal dimensions, it was 
possible to avoid this clogging phenomenon in the system.[133]  
 
Although the clogging is a hot issue in the microreactor technology, also 
experiments are performed in which the (solid-supported) catalyst is 
incorporated into the microchannels as a packed-bed. Care has to be taken 
that in this case, the resin or silica package does not swell in the system 
because this would create pressure and consequently won’t give a 
reproducible output. Successful results were obtained in the Knoevenagel 
condensation using 1,5,7-triazabicyclo[4.4.0]undec-3-ene (TBD) on a 
methacrylate-based Amberzyme Oxirane resin (AO). By using the packed-bed 
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microreactor setup, an increase in conversion from 69 to 90 % was achieved 
without loss of catalyst activity after 30 trials (Scheme 2.11). Moreover, there 
was, in contrast to the batch procedure, no need for catalyst recovery from 
the reaction mixture.[43] 
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Scheme 2.10: Examples of nucleophilic aromatic substitutions performed in a 
microreactor-microwave system with formation of crystalline end products. 
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Scheme 2.11: Knoevenagel condensation. 
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2.5.2 Particles 
 
Although it is generally accepted that the formation of particles in 
microreactor equipment is not possible, some examples of particle handling in 
microreactors were already reported.  
The coupling step for the production of azo-pigments is already performed in 
a CYTOS® type microreactor. Firstly, the diazotation takes place in a batch-
wise manner. The next step, the exothermic electrophilic substitution of the 
diazonium compound 65 with a coupling compound 66, was performed in a 
microreactor (Scheme 2.12). Final pigmenting also took place in a batch 
reactor. The diazonium salt was used in a suspension and resulted in a better 
particle formation, i.e. smaller particles with a smaller particle distribution. 
The process was scaled up to a pilot plant without any problems.[134,135] Only a 
regular cleaning was necessary to avoid pressure loss due to fouling or coating 
of the system.[136] 
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Scheme 2.12: Example of a coupling step in the formation of pigments.[135] 
 
Others use microfluidics to study the effect of mixing on the nucleation of 
protein crystals. A plug-based flow initiates the formation and transportation 
of crystals without clogging of the system.[137] As an example, diffraction-
quality proteins of oligoendopeptidase F from Bacillus stearothermophilus and the 
N-terminal domain of the SARS nucleocapsid (the “SARS protein”) were 
obtained in this manner.[126] The concept of using plugs for the transportation 
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of particles in microstructured reactors was also applied to form CdS and 
CdS/CdSe nanoparticles.[123] 
 
2.5.3 Polymerisations 
 
Although polymerisation of reagents was already stated as a major drawback 
because of the possibility of clogging the microreactor channels, several 
examples were published which show that polymerisation in microchannels 
might occur under special conditions.[138]  
 
One research group studied the formation of polymeric microdroplet 
capsules. An oily phase containing sebacoyl and trimesoyl chloride, is injected 
via a needle in a PVC tubing containing a continuously flowing aqueous phase 
in which polyethyleneimine is present. As a result oil-filled capsules are 
formed, surrounded by a polyamide shell due to interfacial polymerisation.[139]  
 
Another research group developed a polyurethane microfluidic reactor with a 
microfluidic flow-focusing device (MFFD).[140] This system was used to 
produce droplets surrounded by a polymer shell. A conventional MFFD starts 
with three parallel channels. The central channel contains a fluid (e.g. oil 
phase) that is immiscible with the fluid in the outer channels (e.g. water 
phase). The three flows come together in a small orifice after which the 
channel broadens again. Due to shear effects, small droplets of the inner 
phase are sheared off by the two outer flows. This type of microdroplet 
formation system is used in different setups.[80,141-143]  
First, a ternary phase diagram was developed, because of the different 
outcome of the droplet size and core-shell in relation to the flow rates of 
monomer, water and oil phase. By tuning one flow rate (while the other 2 
were constant), a precise control of droplet size, core diameter and shell 
thickness was possible, which is an example of the previous mentioned 
reaction optimisation by the adjustment of the reagent concentrations (§ 
2.5.1). At certain flow rates of the 3 fluids, it was even possible to produce 
core-shell droplets with more cores inside. Using this technology, polymeric 
microbeads with a variety of shapes were produced without clogging the 
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system. The polymerisation itself was an in situ photopolymerisation of the 
monomer ethylene glycol dimethacrylate (EGDMA) or tripropylene glycol 
diacrylate (TPGDA) in the core-shell droplets.[144]  
 
Previous examples of polymerisation were all based on the formation of 
beads or droplets in a microreactor system. Next to these droplet based 
results, also solution based polymerisations are evaluated using microreactor 
technology.  
 
For the industrial radical acrylate polymerisation, a tube reactor in 
combination with static mixers was used. The mixers were used to form a 
homogeneous solution of initiator and monomer directly after mixing. 
However, due to imperfect mixing of this premixer, precipitation of the 
polymers and subsequent fouling occurred. Gel permeation chromatography 
(GPC) analysis showed that a high molecular weight fraction of polymers 
(range 105-106 g/mol) was formed, leading to this precipitation. As a solution, 
the tubular reactor was preceded by 32 interdigital micromixers. Interdigital 
micromixers are mixers that make parallel lamination. First many parallel 
flows are generated and then all these flows are set side by side ('interdigital'). 
In one step the final lamellae width is reached and then diffusion is the only 
mixing mechanism. Using this setup, a better mixing of initiator and 
monomer was achieved, so that no high molecular weight fraction was 
formed anymore. Via this optimised process, an output of 2000 ton per year 
was achieved.[40] It must be emphasised that in this case no actual 
polymerisation occurs in the microreactors, but they serve as premixing 
controlling units for better polymerisation afterwards. In the following 
examples the polymerisation actually occurs in the microreactors. 
 
The batch cationic homopolymerisation of vinyl ethers was compared with 
the polymerisation in a T-shaped micromixer in combination with a 
microtube reactor. In the batch reaction, the polymerisation was difficult to 
control. Even at -25 °C, the reaction occurred too fast with molecular weight 
distributions of 2.73-4.71. When applying the microsystem, living polymers 
were obtained with a high level of molecular weight control. A polydispersity 
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index (PDI) of 1.19-2.34 was obtained, depending on the residence time and 
thus the flow rate. Subsequently, a second serial microsystem was built to 
provide block copolymers of vinyl ethers. Also here, narrow polydispersity 
ranges were obtained (1.41-1.55). Importantly, no clogging was observed 
during the experiments because the produced polymers serve as lubricating 
oils and conditions were tuned for low molecular weights.[145,146] 
 
Serra et al. studied both the free radical polymerisation of styrene and n-
butylacrylate. By using the less reactive monomer (styrene), comparable PDIs 
were obtained with the batch reaction when low molecular weights were 
desired. For high molecular weights targeted, the microsystem proved to be 
superior. In the case of highly reactive monomers (n-butylacrylate), controlled 
polymerisations were only possible in the microreactor, with a PDI lower 
than 1.5.[147] Similar results were obtained in another study with substrate 
dependent effects on the PDI.[148] 
The copolymerisation was tested via a continuous two-stage process. In the 
copolymerisation procedures, two types of micromixers were compared for 
mixing the second monomer with the first homopolymer block. The 
interdigital multilamination micromixer allowed higher incorporations of the 
second monomer and also a lower overall PDI was obtained, compared to a 
T-junction micromixer (bilamination). To move the polymers through the 
microreactor system, very harsh conditions were necessary. The viscous 
solutions were pumped via HPLC pumps with use of pressure relief valves 
(PRVs) controlled at 50 bar.[147] 
  
2.5.4 Bulk production 
 
Due to the very small dimensions, microreactors are not suitable for use in 
the bulk industry since it would take too many devices to produce an annual 
amount comparable to conventional systems. Besides, these conventional 
systems are mostly sufficiently optimised. Important intermediates, such as 
products in the pharmaceutical industry, are more economical producible 
under microreactor conditions. Given below are some examples of semi bulk 
productions. 
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A comparative study on the production of phenyl boronic acid 73 was 
performed (Scheme 2.13). Phenyl boronic acid is a start product of the 
intensively studied Suzuki(-Miyauri) coupling reaction in microreactor 
technology.[129,149-152] A pilot scale microreactor produced the end product in 
89 % yield, exceeding the industrial continuous stirred tank reactor (CSTR) 
process with 25 %. Another advantage was the lower energy expenditure. The 
success of the study was dependent on the microreactor type.[133] 
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Scheme 2.13: Production of phenyl boronic acid 73. 
 
Xi’an Huian Chemical Industrial Group in China was able to build a 
microreactor plant to produce nitroglycerine to use as a treatment for heart 
disease.[153] The microstructured reactor consists of three main parts: the part 
where mixing of highly concentrated sulphuric acid and nitric acid occurs, the 
reactor itself where the mixing of the acid and the glycerine occurs and finally 
the phase separation, washing and purification device. An output of 15 kg/h 
of highly pure nitroglycerine was achieved.[154] Recently, a Starlam 3000 
microreactor, fabricated by the IMM (Germany), was incorporated as the first 
step of a (not specified) 2-step batch process in an existing plant with the aim 
to double the production capacity. An improvement in production rate from 
1.8 ton/h to 3.6 ton/h was achieved. Moreover, additional energy savings 
were obtained because no cooling of the first step was necessary anymore.[155] 
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2.5.5 Material of construction 
 
An important issue in the construction of microreactor devices for organic 
synthesis purposes is the choice of the material. Nowadays, microreactors are 
fabricated from a wide variety of materials of which the most important are 
silicon (e.g. polydimethylsiloxane or PDMS), glass, quartz, metals (e.g. 
stainless steel) and polymers.[87] However, once the material is chosen, it can 
limit the applications. In stainless steel microreactors, for example, it is not 
possible to work with hydrochloric acid or any other compound containing 
bromine, chlorine or fluorine ions because of corrosion risks. Using PDMS 
on the other hand, limits the solvent use because PDMS swells in most 
organic solvents.[156] 
 
2.5.6 Pumping mechanism 
 
Also the transportation method of the products and solvents in the 
microreactor is an important factor, because once a mechanism is chosen, this 
limits the possible applications. Two important types are known: electro-
osmotic flow (EOF) and hydrodynamic (or pressure-driven) pumping. The 
main disadvantage in the case of EOF is the need for a polar solvent such as 
water, methanol or acetonitrile and EOF is restricted to microreactors 
constructed from silicon, glass and treated PDMS. An important advantage in 
this system is the nearly equal velocity across the channels, which means low 
dispersions and thus very strict residence times. Hydrodynamic pumping on 
the other hand has the advantage that it can be used in almost every device 
and with almost every solvent. The main drawback is the parabolic flow 
profile inside the channels. This leads to dispersion in the flow rate direction 
and subsequent distribution in residence times, which can decrease yield and 
selectivities. Moreover, these pumps apply a pulsed flow, which can be 
disadvantageous at low flow rates.[48] 
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2.5.7 Solvent changes 
 
In multistep organic synthesis, one of the bottlenecks that frequently occurs is 
that different reaction steps in a synthesis require different solvents. This 
means that between the two steps, a solvent switch is needed. Between 
different batch production steps, this is more easily incorporated as an 
intermediate purification step. With a continuous procedure, such as in 
microreactor technology, this solvent switch is much harder to realise. 
Therefore, this is an important drawback for the application of multistep 
syntheses in a continuous microreactor mode.[153] One of the procedures 
developed in this doctoral thesis suffered from this drawback (vide infra, § 
3.6.3). 
 
An illustrative example of this solvent related drawback is the multi-step 
synthesis of the alkaloid natural product oxomariditine 74 (Figure 2.3) via flow 
synthesis.[157] The whole synthesis was continuous, except for one step in 
which a solvent switch from THF to dichloromethane was necessary. The 
advantage of this batch step was a preconcentration of the intermediate. 
Starting from the commercially available products 4-(2-bromoethyl)phenol 
and 3,4-dimethoxybenzyl alcohol, the oxomariditine 74 was formed in 7 steps 
with an overall yield of 40 %. During the whole synthesis, 2 types of 
microreactors were used: a Syrris AFRICA® system and a microfluidic chip.      
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N
MeO
MeO
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H
 
Figure 2.3: The natural product (±)-oxomaritidine 74. 
 
If no solvent switch is necessary, microreactor technology is well suited for 
continuous multistep synthesis. This is shown by enolate formation and 
subsequent 1,4-addition to α,β-unsaturated carbonyl compounds. In all the 
investigated examples, higher conversions than the batch procedure were 
obtained, although sometimes a stopped-flow technique was necessary (vide 
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infra, § 3.2.4). However, even in this latter procedure, the reaction time was 
considerably shorter (20 min) compared to the batch process (24 h).[158] 
 
2.5.8 Work up 
 
A major drawback mostly found in literature is the lack of an efficient work 
up procedure, compatible with the continuous process. In many cases, the 
advantage created by using a microreactor is lost, due to the need of a 
batchwise reaction work up. 
 
One of the exceptions is the formation of butyl cinnamate 78 described by 
Liu and coworkers (Scheme 2.14). They were able to combine a CYTOS® Lab 
System with a continuous microextraction and catalyst recycling system, using 
a low-viscosity ionic liquid. To achieve this continuous work up, the 
ammonium salt and the end product were extracted via T-shaped micromixers. 
The CYTOS® Lab System ionic liquid outlet mixture was mixed in a first 
micromixer with a 0.5 M aqueous NaOH solution to remove the ammonium 
salt. The residual mixture was then introduced in a second micromixer where 
hexane was used to extract the product. As a result, the final outcome 
separated in three phases: a hexane layer containing tripropylamine and the 
end product, an aqueous layer containing the inorganic salt and the ionic 
liquid layer containing the Pd catalyst. This last layer was pumped back to one 
of the microreactor inlets to maintain continuous recycling, while the end 
product was continuously extracted. It was possible to produce 10 g/h of the 
end product in 80 % yield.[159] In case the design consists of reaction bubbles, 
it is possible to extract the solid reaction product by using a suitable carrier 
phase. This was demonstrated for the continuous production of N,N’-
dicyclohexylethylenediimine.[127] Using an on-column purification step directly 
after the mixing and reaction of the reagents, highly pure 4,5-disubstituted 
oxazoles were obtained in a mesofluidic flow reactor.[160] Microfuidic solvent 
extraction has been studied as well.[161] 
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Scheme 2.14: Production of butyl cinnamate 78. 
 
2.6 MULTICOMPONENT REACTIONS 
2.6.1 Introduction 
 
A very efficient way to access complex structures, such as heterocycles, using 
simple starting materials is the use of MCRs.[162-164] In this type of reactions 
three or more easily accessible components are reacted in a one-pot process 
to form ideally one product which incorporates essentially all the atoms 
present in the initial reactants. Generally, MCRs contain a very large chemical 
space, due to the variability possible in the different components of one 
reaction.[11] Important characteristics of MCRs are their convergency, atom 
efficiency and flexibility.[162] Starting from the Strecker reaction, discovered in 
1850, a wide range of different types of MCRs has been designed.[12] Some 
important examples (Scheme 2.15) are the Biginelli reaction (1891),[165,166] the 
Mannich reaction (1912),[167-169] the Passerini reaction (1921),[12] and the Ugi 
reaction (1959).[170] 
 
2.6.2 Application of microreactor technology in multicomponent 
reactions 
 
Until now, only one real microreactor procedure is applied in the production 
of MCRs.  
 
Literature Overview 
- 38 - 
+
R1 OH
O
R2 R3
O
R N C R5NH2+ +
Passerini 3-CR
Ugi 4-CR
R1
O
O
R2 R3
O
H
N
R4
R1
O
N
R2 R3
O
H
N
R4
R5
R5NH2 + R6 H
O
R7
O
+ R8
Mannich 3-CR
N
H
NH2
X
R9
R6 H
O
+ +
R10
O
EWG
Biginelli 3-CR
R7
O HN
R5
R6
N
NH
X
EWG
R10
R6
R9
R8
79 80 81 9
9 1 82
831 84
85
86
87
88  
Scheme 2.15: Some important MCRs. 
 
One research group focuses on the library synthesis of 4,6-diaryl-1,3-
dihydropyrimidin-2(1H)-ones 89 in a nanochip system based on 3 
microstructured silicon wafers, using the Biginelli reaction on single beads 
(Scheme 2.16). The chip needed to be pressurised to avoid evaporation of the 
solvent and cross-contamination between the different microwells. 
Comparison with macroscopic batch beads showed that this technology 
seemed to be promising for high throughput production of compounds on a 
solid-phase support. It must be emphasised that this was a batch 
procedure.[171] 
 
Literature Overview 
- 39 - 
H2N NH2
S
R2 H
O
+ + R1
O
N
NH
SHR2
R1
83a1 84a 89
N
H
Pol
O
N
H
O
Pol
 
Scheme 2.16: Formation of 4,6-diaryl-1,3-dihydropyrimidin-2(1H)-ones 89. 
 
Another recent paper describes the use of a micromixer-microwave 
combination for the formation of tetrahydropyrazolo[3,4-b]quinolin-5(6H)-
ones 92 (Scheme 2.17) and tetrasubstituted furans via MCRs. However, the 
enhanced conversion and yield were attributed to the microwave irradiation 
and not to the micro-channels.[132] 
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Scheme 2.17: Formation of tetrahydropyrazolo[3,4-b]quinolin-5(6H)-ones 92. 
 
The Grieco 3-CR reaction (Scheme 2.18) was performed using a droplet 
microfluidic system based on an ionic liquid (IL) solvent system. 
Optimisation was performed towards the IL and the problem of slow mixing 
in microdroplets was overcome by heating the droplet to decrease viscosity. 
Comparable reaction rates as the macroscale system were obtained.[172,173] 
 
A manufacturer of microreactor modules recently published some results 
about the reaction optimisation of a Passerini 3-CR in an AFRICA® flow 
reactor system.[174] AFRICA stands for Automated Flow Reaction, Incubation 
and Control Apparatus and is a complete flow chemistry system. The system 
contains a glass microreactor chip. High-accuracy pumps and temperature 
control systems are used to control the chemical process via integrated 
sensors. Samples are collected in a fraction collector.[174,175] In the Passerini 3-
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CR, a shift from 62 % yield in a 60 h batch reaction to 91 % yield in a 1 h 
residence time microreactor system was obtained.[174] 
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Scheme 2.18: The Grieco 3-CR.
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Chapter 3 - Results and Discussion 
 
3.1 INTRODUCTION 
3.1.1 Description of the microreactor device 
 
Unless otherwise stated, the microreactor that is used in this doctoral research 
is the commercially available CYTOS® College System, produced by CPC - 
Cellular Process Chemistry Systems GmbH.[176] Figure 3.1 shows the entire 
device, consisting of 2 piston pumps, the microreactor itself, and a residence 
time unit (RTU). The different parts of the CYTOS® College System were 
connected via PTFE tubes. 
 
 
Figure 3.1: Setup of the CYTOS® College System. 
 
The microreactor itself consists of 16 plates, which are fabricated using 
stainless steel (type 1.4571 according to the German standard). Each plate has 
at least one opening. The advantage of such a design is the ease of 
manufacturing. Machining or stamping openings in a flat surface is less 
complicated than producing grooves or channels that not fully penetrate the 
plate. The design of the different plates is in such a way that, when stacking 
the plates together, 2 physically separated fluid pathways are formed: one for 
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the chemicals and also one for the heating or cooling medium. To obtain an 
excellent heat exchange between the heating or cooling medium and the 
reactant flow, the plates between both media have a thickness of maximum 
300 µm. The different plates can be held together by exerting pressure on the 
outer plates or they can be permanently joined together via vacuum soldering 
or diffusion welding, as is the case of the device that was used in this doctoral 
study. The advantage of the latter setup is that there is no danger of leakages, 
while the disadvantage is the loss of modularity. This microreactor is designed 
for the mixing of two chemical solutions, containing only liquid and/or 
completely dissolved compounds (i.e. a liquid/liquid phase reaction). The 
fluid pathway of the chemicals is given in Figure 3.2, and consists of 3 zones: 
the entrance zone of both chemical solutions (plate 1-5), the mixing zone 
(plate 6 and 7) and the reaction zone (plate 8-16). The mixing in this 
microreactor is based on the interdigital principle (vide supra, § 2.5.3), which is 
constructed by plates 3 to 5. These plates separate and align both reactant 
flows into a plurality of individual fluid paths. All individual fluid paths (of 
both reactants) are then joined in a laminar flow pathway, constructed by 
plates 4 to 7, to provide a stacked laminar flow of the first and second 
reactant (Figure 3.3). The fluid channel geometries are in the range of 100 to 
500 µm, depending on the location in the microreactor. Another important 
part of the mixer design is that both reactant flows enter from the same side 
to provide the preferred stacked laminar flow and no side-by-side flow. This 
is shown in Figure 3.4. In the upper design, both reactants enter from 
opposite sides on plate 4. Via the holes in plate 5 (see Figure 3.2), these flows 
enter the mixing zone of plate 6 and 7. The direction of each fluid path is 
thereby changing by approximately 90 degrees. As a consequence, the fluid 
path has the tendency to propagate faster along the inside of that corner, 
because the distance is shorter. This behaviour favours an unwanted side-by-
side flow. Therefore, the design is adjusted in such a way that both reactants 
enter the mixing zone from the same side (see lower design in Figure 3.4). 
This design eliminates the velocity difference between both reactants and 
provides the desired stacked flow shown in Figure 3.3.  
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Figure 3.2: Flow pattern of the reactant flows through the microreactor unit. 
Upper left: reagent A entrance zone; Lower left: reagent B entrance zone; 
Right: mixing and reaction zone of both reagents. 
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After the mixing, the reaction mixture is allowed to react (plates 8-14). Finally, 
all individual flows are merged again on plate 15 to leave the microreactor via 
plate 16. The fluid path of the heating or cooling medium will not be 
discussed in detail, but follows a similar profile. 
 
The pumps that were used were valveless rotary piston dispensing pumps, a 
type of positive displacement pumps. The advantage of these pumps is the 
conservation of a constant flow, whenever the maximal differential pressure 
of 6.9 bar is not exceeded. This is of great importance to maintain a well-
defined residence time. The piston itself is of ceramic material. The speed of 
the piston can be set between 40 and 1800 rpm, which means a flow rate of 
0.04 to 90 mL/min. 
 
The RTU consists of a stainless steel tube which is surrounded by another 
tube wherein the heating or cooling medium flows (for dimensions and 
typical Reynolds numbers, vide infra, § 3.2.5). The combination of these 
different types of materials in the pumps and microreactor makes it necessary 
to study the chemical resistance intensively before using a certain chemical 
compound. The use of e.g. AlCl3 is not allowed because of the corrosion risk 
of the stainless steel, while the use of toluene is limited due to the possible 
reaction with certain parts of the pumps. 
 
3.1.2 General procedure 
 
In all the experiments described in this doctoral thesis, some standard 
operations were necessary to obtain reliable results. Every time a new MCR 
was evaluated, it was necessary to check the batch procedure since not all 
reactions are suitable in a microreactor.[1] If it was feasible to perform the 
reaction in a microreactor, the next step in the procedure was the flushing of 
the system with the solvent that will be used in the reaction. Meanwhile, the 
reaction solutions were prepared. According to the flow rate, the residence 
time was calculated and sample collection was started after at least 1.6 times 
the residence time was passed to be sure that steady state conditions were 
reached. After collection of the sample(s), the microreactor and the RTU 
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were again thoroughly flushed to remove any residual products. During the 
whole experiment, the input and output volumes were constantly measured 
and the corresponding flow rates were calculated to control for clogging or 
leakage problems. 
 
 
Figure 3.3: Construction of the stacked laminar flow pattern. 
 
 
Figure 3.4: Different mixer designs. Upper left: plate 4 on top of plate 6. 
Upper right: detailed view of the reactant fluid paths providing a side-by-side 
flow pattern. Lower left: plate 4 on top of plate 6. Lower right: detailed view 
of the reactant fluid paths providing a stacked flow pattern. (plate 5 is not 
shown in both designs). 
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3.2 BAYLIS-HILLMAN REACTION 
3.2.1 Introduction 
 
The (Morita-)Baylis-Hillman reaction was first described in a patent by Morita 
et al. in 1968.[177,178] They described a carbon-carbon bond formation between 
an aldehyde and an acrylate with the aid of a phosphine catalyst, yielding 
highly functionalised β-hydroxy-α-methylene esters. In 1972, Baylis and 
Hillman reinvestigated the reaction and found a threefold higher yield if 1,4-
diazabicyclo[2.2.2]octane (DABCO) was used as a catalyst.[179] Ever since, the 
Baylis-Hillman reaction has gained a lot of importance in organic 
synthesis.[27,28] Generally, the Baylis-Hillman reaction is a three-component 
reaction in which an activated alkene 97 couples to a carbon electrophile 98 
with the aid of a tertiary amine 3 (mostly DABCO) as a catalyst. A carbon-
carbon bond is formed at the α-position of the alkene (Scheme 3.1). When 
phosphines are used as a catalyst, the reaction is mostly called Morita-Baylis-
Hillman. In the case imines are used as electrophilic reagents, with the final 
formation of a β-amino-α-methylene compound, an aza-Baylis-Hillman 
reaction is performed (vide infra, § 3.2.7). 
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R2+
tertiary amine
97
3
98 99
EWG = COR, CN, CHO, COOR, PO(OEt)2, SO2Ph, SO3Ph, SOPh
R1 = aryl, alkyl, heteroaryl
R2 = H, COOR, alkyl
X = O, NCOOR, NTs, NSO2Ph  
Scheme 3.1: General Baylis-Hillman reaction. 
 
The wide variety of the different building blocks made this reaction of high 
synthetic interest because of the possibility of creating highly functionalised 
building blocks in a one-pot reaction. In the context of industrial applications, 
in which the microreactor technology could play an important role, it should 
be mentioned that this reaction is a 100 % atom efficient conversion which is 
an important characteristic in the green chemistry concept. Unfortunately, the 
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Baylis-Hillman reaction is a slow reaction, often requiring days or weeks to go 
to completion.[180] This depends mostly on the reactivity of the reagents, i.e. 
the activated alkene and the electrophile. Nowadays, literature about the 
Baylis-Hillman reaction can be divided into 4 main topics: 
 
1. Finding new procedures or reaction conditions to improve reaction rate 
 and yield.[181-196]  
 
Ever since the discovery of the Baylis-Hillman reaction, a wide variety of 
different reaction conditions are already tested to obtain better yields and 
reaction rates. A general classification can be made. 
 
-  the use of different catalysts, such as quinuclidine, 3-hydroxyquinuclidine 
 and DABCO,[181] or diethylaluminum iodide.[182]  
-  the importance of the solvent use e.g. aqueous solutions,[183-185] 
 sulfolane,[186,187] N-methylpyrrolidinon (NMP),[186] N-methylmorpholine[186] 
 or poly(ethyleneglycol).[188]  
-  the study of physical effects such as temperature,[189] pressure[190,191] and 
 ultrasound[180,189]. 
-  the influence of Lewis acids e.g. lithium perchlorate[192] and titanium(IV) 
 chloride[193]. 
-  other effects such as the co-catalysis between DABCO and phosphonium 
 salts[194] or between L-proline and imidazole,[195] or the use of 
 cyclodextrin complexes[196]. 
 
2.  Mechanistic studies of the reaction.[197-204] 
 
A lot of research has already been done to unravel the mechanism of the 
Baylis-Hillman reaction. Recently, this mechanism has been revised, under 
aprotic, protic, polar and nonpolar conditions.[201,202] It was found that the 
Baylis-Hillman reaction appeared to be a first order reaction in the tertiary 
amine and the activated alkene and a second order reaction in the aldehyde 
moiety, although this latter was believed to be first order until then. The 
Baylis-Hillman reaction consists of an addition-elimination sequence which 
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involves the tertiary amine. Scheme 3.2 illustrates the mechanism of the 
reaction between an aldehyde, methyl acrylate, and DABCO as the catalyst. 
The tertiary amine 3 attacks the double bond of the activated alkene 2a with 
the formation of a zwitterion 100, which then reacts with the aldehyde 1. 
According to the revised mechanism, the intermediate 101 then attacks a 
second equivalent of the aldehyde, with formation of an intermediary 
hemiacetal, before the final proton transfer. This last step, in which the 
catalyst is eliminated, is also considered as the rate-determining step (RDS). 
Another research group obtained similar results, showing that the catalyst 
elimination was the RDS. However, their data suggest also that, in the 
absence of protic solvents, there is a switch of the RDS from the catalyst 
elimination step to the aldehyde addition step (which is believed to be the 
RDS in the former mechanism) once there is built up enough end product.[203] 
 
3.  Study towards an increase in enantioselectivity.[205-214] 
 
The generation of a chiral centre in the Baylis-Hillman reaction has been the 
subject of several investigations towards enantiopure adducts. Chirality is 
induced via the use of chiral aldehydes,[205,206] chiral activated alkenes,[205] chiral 
solvents[205,207] or chiral catalysts. Most of these chiral inducing catalysts are 
derived from quinidine,[208-211] binaphthol[212,213] or camphor[214]. 
 
4.  Developing new compounds starting from Baylis-Hillman 
 adducts.[27,28,215-230]  
 
Due to the creation of several functionalities in one molecule, the Baylis-
Hillman adduct is an interesting starting material for the further development 
of other compounds. A wide variety of interesting compounds are already 
synthesised of which antibiotics,[217,218] isoxazoles,[219,220] β- and γ-
lactams,[206,215,216,231] isobenzofurans,[232] [1,4]oxazepine-7-ones,[233] coumarin 
and chromene derivatives[234,235] are only a few examples. 
In literature, it is stated that the use of microreactor technology for organic 
synthesis is advantageous because the reaction rate is often increased. Indeed, 
several examples are known in which this is the case.[102,149,150] Since the 
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Baylis-Hillman reaction is known as a very slow multicomponent reaction,[180] 
it was interesting to investigate if this technology would be advantageous for 
solving this major drawback of the reaction. 
 
3.2.2 Optimisation study using microreactor technology 
3.2.2.1 Choosing an appropriate test reaction 
 
As the maximal possible residence time in the microreactor (plus RTU) is 
calculated and experimentally validated to approximately 2 h, a rather fast 
Baylis-Hillman reaction was evaluated first. It is possible to have longer 
residence times by using lower flow rates. However, this is not feasible, due to 
reproducibility problems of the pumps.2 The research was initiated therefore 
using starting materials of which the reaction time for the Baylis-Hillman 
reaction was comparable to the maximum residence time of the microreactor 
used in this study. 
 
The reaction between 4-nitrobenzaldehyde 1a and methyl acrylate 2a with 
DABCO 3 as catalyst (Scheme 3.3) seemed suitable, because of the short 
reaction time and the good yields of this particular Baylis-Hillman reaction 
under batch conditions.[180,185,236] Interestingly, compound 4a has a high in vitro 
antiproliferative activity against a variety of human tumor cell lines.[237] Since 
the goal was to study the impact of a switch from a batch process to the 
microreactor system, the same catalyst was used in both systems. It has to be 
mentioned that, next to DABCO, a lot of catalysts or co-catalysts are studied 
for this type of reaction.[192,194,195,221-230,238-244] Several of these catalysts give 
similar or better results, but DABCO was chosen from an economic as well 
as an industrial point of view.3 
 
                                        
2 The piston pumps are pumping at a speed of 40 to 1800 rpm while the volume pumped per pump cycle (i.e. stroke 
volume) is between 1 and 50 µL. This means the flow rate range of the piston pumps is between 0.040 and 90 
mL/min. However, to maintain accuracy, the manufacturers recommend not to work below 10 % of the maximal 
stroke volume i.e. 5 µL. This means the minimal recommended flow rate is 0.2 mL/min. At lower stroke volumes, 
the relative variation of the stroke volume is too high (there is a tendency for pulsation at lower flow rates). 
3 Prices: 22.10 € per 100 g of DABCO versus 80.60 € per 1 g of quinuclidine. 
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Scheme 3.2: Revised mechanism of the Baylis-Hillman reaction. 
 
3.2.2.2 Defining the critical concentration 
 
Initially, a suitable solvent for the microreactor setup was needed. According 
to literature, the best results were obtained using a mixture of water and 1,4-
dioxane (v/v 1:1).[236] Some initial experiments in a batch setup showed a 
considerable concentration effect with a higher concentration of the reagents 
leading to better conversions (Table 3.1, entries 1, 4, and 6). However, a 
concentration limit needs to be determined when solid reagents (such as in 
this case DABCO and 4-nitrobenzaldehyde) are used, because of the risk of 
clogging the capillaries of the microreactor (width approximately 100 µm) 
when reagents or the product precipitates from the reaction medium. 
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Moreover, the supply medium of the reactor needs to be double concentrated 
for each storage solution compared to the reactive concentration inside the 
reaction cell, provided that both pumps are operating at the same flow rate.  
 
Table 3.1: Baylis-Hillman reaction of 4-nitrobenzaldehyde and methyl acrylate 
in batch mode using DABCO as a catalyst in water/1,4-dioxane (v/v 1:1) as 
solvent.a 
Entry 
4-nitro-
benzaldehyde (M) 
DABCO 
(M) 
Methyl 
acrylate (M)
Degree of conversion 
(mol %)b 
Yield 
(%)c 
1 0.1 0.1 0.3 81 74 
2d 0.1 0.1 0.3 -- 83 
3e 0.1 0.1 0.3 75 69 
4 0.05 0.05 0.15 51 43 
5f 0.05 0.05 0.15 49 44 
6 0.033 0.033 0.1 21 22 
--: Not determined. a Reaction time: 3 h; a solution of 1 equiv 4-nitrobenzaldehyde and 3 
equiv methyl acrylate in 10 mL of water/1,4-dioxane (v/v 1:1) was stirred at room 
temperature in the presence of 100 mol % DABCO.[236] b Based on the integration signals 
in the 1H-NMR spectrum. c Based on total mass of end product collected in the crude 
mixture and degree of conversion. d Reference [236]. e Reaction time: 2 h. f Without 
stirring the mixture. 
 
Therefore, the maximum concentration that could be investigated in the 
microreactor was 0.1 M of 4-nitrobenzaldehyde, since concentrations higher 
than 0.2 M became insoluble in the case that water/1,4-dioxane (v/v 1:1) was 
used. Dissolving 0.2 M of 4-nitrobenzaldehyde in the water/1,4-dioxane (v/v 
1:1) mixture was not possible, even with gentle heating of the mixture. First 
dissolving the 4-nitrobenzaldehyde in 1,4-dioxane worked well. When the 
water was added then (in which the DABCO was dissolved), at a critical 
concentration, the 4-nitrobenzaldehyde started to precipitate. This was more 
or less when a v/v 1:1 mixture of the solvents was reached. Gentle warming 
of the medium up to 35 °C at the inlet was required to prevent precipitation 
in the supply medium. So, a concentration of approximately 0.2 M of 4-
nitrobenzaldehyde was the critical concentration. It must be emphasised that 
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this concentration is in the presence of DABCO in the mixture, so normally 
the critical concentration is somewhat higher.  
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Scheme 3.3: Investigated Baylis-Hillman reaction. 
 
To optimise the reaction in the microreactor, several conditions were tested 
by altering the residence time, the initial concentration of the substrates, the 
ratio between the substrates, the temperature, and the mixing of the 
substrates. Table 3.2 summarises these results.  
 
3.2.2.3 Mixing order 
 
First, the order of mixing of the substrates was investigated. Considering the 
mechanism (vide supra, § 3.2.1), the mixing of methyl acrylate and the catalyst 
prior to the entrance of the microreactor seemed advantageous. However, 
compared to the use of a mixture of the aldehyde and the catalyst, this 
resulted in lower conversions and yields (entries 2, 3, 4 and 5). This is in 
accordance with the results obtained by Yu et al., who stated that 
preincubation of 100 mol% DABCO with 3 equivalents of methyl acrylate in 
a water/1,4-dioxane (v/v 1:1) mixture before the addition of aldehyde 
resulted in a ninefold decrease of the product yield due to a side reaction.[236] 
In this side reaction the hydrolysis of the Michael adduct leads to a stable 
betaine 106 which consumes both the catalyst and the methyl acrylate 
(Scheme 3.4). This was also seen by a light yellow colouration of the mixture, 
while the separate solutions were transparent. Although the difference in 
conversion and yield was not as big as in the batch case, mixing 4-
nitrobenzaldehyde and DABCO indeed proved to be the best option for the 
continuous reaction.  
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Table 3.2: Baylis-Hillman reaction of 4-nitrobenzaldehyde and methyl acrylate 
in continuous mode using DABCO as a catalyst in water/1,4-dioxane (v/v 
1:1) as solvent.a 
Entry 
4-Nitrobenzaldehyde 
(M) 
DABCO 
(M) 
Methyl 
acrylate (M)
T 
(°C)
Degree of 
conversion 
(mol %)b 
Yield 
(%)c 
1 0.1 0.1 0.3 RT 83 64 
2 0.05 0.05 0.15 RT 57 48 
3 0.05 0.05 0.15 RT 38 40 
4 0.05 0.05 0.05 RT 17 17 
5 0.05 0.05 0.05 RT 11 11 
6 0.05 0.1 0.05 RT 26 40 
7 0.05 0.1 0.1 RT 48 69 
8 0.05 0.025 0.025 RT 10 7 
9 0.05 0.05 0.15 40 33 31 
10 0.033 0.033 0.1 RT 29 27 
11 0.033 0.067 0.1 RT 46 66 
12 0.017 0.017 0.05 RT 7 11 
13 0.05 0.05d 0.15 RT 64 34 
14e 0.2 0.2 0.6 RT 93 82 
a Residence time: 1 h 58 min; products in bold are mixed together before they enter the 
microreactor system; concentration of the reagents as in the reactor; reaction quenched 
with HCl (1 N). b Based on the integration signals in the 1H-NMR spectrum. c Based on 
total mass of end product collected in the crude mixture and degree of conversion. d 
Quinuclidine as catalyst instead of DABCO. e 4-Nitrobenzaldehyde and DABCO 
dissolved into a 3:7 (v/v) water/1,4-dioxane mixture; methyl acrylate stirred into a 7:3 
(v/v) water/1,4-dioxane mixture. 
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Scheme 3.4: Side reaction of the Baylis-Hillman reaction with formation of 
betaine 106. 
 
3.2.2.4 Concentration optimisation  
 
In a second step, different concentrations were tested. As can be seen from 
entries 1, 2, 10, and 12 the same concentration effect appears as in a batch 
setup. Moreover, the conversions and yields in the batch reaction after 3 h 
appear to be more or less the same as these in the microreactor with a 
residence time of 2 h (Table 3.1, entry 1 and Table 3.2, entry 1). Since the 
reaction profile under batch conditions at the highest concentration (for the 
continuous reaction i.e. 0.1 M aldehyde in the microreactor) proved that the 
reaction is still not completed after 2 h (Figure 3.5), it can be concluded that 
this Baylis-Hillman reaction is faster under microreactor conditions. Table 3.1, 
entry 3, also shows the conversion after 2 h, which is lower compared to the 
microreactor reaction at the same time (Table 3.2, entry 1). Although better 
results were expected using this technology, in analogy to other 
reactions,[102,149,150,245-247] no important improvement was achieved. However, 
in this particular case a rate enhancement of approximately 30 % was 
observed. A possible explanation for this rather small enhancement, 
compared to some classical examples of rate enhancement in microreactors, is 
shown in Table 3.1, entries 4 and 5. These results show that the intensity of 
mixing of the reagents is not important in achieving higher conversions and 
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yields. This means that the mass transfer advantage of the microreactor 
technology is minimalised for the Baylis-Hillman reaction. 
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Figure 3.5: Course of the batch reaction of 4-nitrobenzaldehyde and methyl 
acrylate in the presence of DABCO. 
 
Another important issue is that since the reagents also react upon standing at 
room temperature (without stirring), the reaction mixture had to be quenched 
immediately with an equal amount of hydrochloric acid (1 N) so that further 
conversion was prevented after leaving the RTU of the microreactor. This 
was tested to prove the effect. Indeed, immediately quenching the mixture led 
to a conversion of 33 % (entry 9), while waiting until the sample was collected 
(which took about 25 min) gave a conversion of 69 %. 
 
Since the conversion was not complete at the highest possible concentration 
of the substrates, no higher flow rates (resulting in smaller residence times) 
were tested. Also no higher residence times were tested with continuous flow 
because the applied flow rate was the lowest reproducible one the piston 
pumps could handle. To increase the residence time, the stopped-flow 
technique was evaluated (vide infra, § 3.2.4). Since the initial concentration of 
the reagents was of great importance (Table 3.2), attempts were made to 
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further increase the concentrations. It is already stated that 4-
nitrobenzaldehyde is very well soluble in 1,4-dioxane. So it was possible to 
make a 0.4 M solution of 4-nitrobenzaldehyde and 0.4 M of DABCO if the 
solvent mixture was changed to 3:7 (v/v) water/1,4-dioxane. Because a 1:1 
(v/v) mixture proved to give the highest yields,[236] the methyl acrylate was 
dissolved in a 7:3 (v/v) mixture of water and 1,4-dioxane to have a 1:1 (v/v) 
mixture in the microreactor. Table 3.2, entry 14 shows that the conversion 
and yield were further improved. Importantly, it was necessary to 
continuously stir the starting solution with the high methyl acrylate 
concentration, in order to keep the solution homogeneous.  
 
3.2.2.5 Reaction temperature 
 
A third aspect was the evaluation of the optimal reaction temperature. Due to 
the small capillaries (width approximately 100 µm), the microreactor provides 
a narrower temperature profile than that in batch systems (vide supra, § 2.4.4). 
At higher temperatures no improvement was noticed (Table 3.2, entry 9), 
although sometimes this is the case.[248] Since in some cases lower 
temperatures have a positive effect on the reaction rate of the Baylis-Hillman 
reaction,[249] attempts were made to improve the rate by decreasing the 
reaction temperature beneath room temperature. However, in the case of the 
1:1 (v/v) mixture of 1,4-dioxane and water, lower temperatures (significantly 
below room temperature) could not be investigated due to the melting point 
of 1,4-dioxane.4 Although no solidification occurred at 5 to 15 °C in the batch 
reaction due to the dissolved compounds, partial to complete clogging already 
occurred at these temperatures in the microreactor, probably due to the 
capillaries, the high concentration of the substrates in a low temperature 
environment and the considerably low flow rate. In the batch system, a high 
turbulence prevents solidification. So, the optimal reaction temperature under 
microreactor conditions was set at room temperature, which was standardised 
to 22 °C. 
 
                                        
4 1,4-dioxane has a melting point of 12 °C. 
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3.2.2.6 Final optimisation 
 
A further investigation consisted of varying the ratio of the substrates. Table 
3.2, entry 4 shows that lowering the concentration of the methyl acrylate to 1 
equivalent gave less favourable results compared to the excess of 3 
equivalents. This was expected since in most procedures an excess of the 
activated alkene is used.[243,250-252] An excess of catalyst (Table 3.2, entry 6) 
instead of an excess of methyl acrylate also increased the yield. However, 
because of the low enhancement it was not a breakthrough in the 
optimisation process. Since the Baylis-Hillman reaction proved to be a 
second-order reaction in the aldehyde,[201,202] an experiment with an excess of 
aldehyde was also evaluated. Entry 8 shows the very low conversion and yield 
in this case. It was also found in the literature that quinuclidine was more 
active than DABCO in this particular Baylis-Hillman reaction,[181] so an 
experiment was performed under the same conditions. The degree of 
conversion was somewhat higher than in the case of DABCO. Further 
optimisation with quinuclidine was not done since DABCO is a much 
cheaper catalyst.5  
 
Also other solvents were evaluated to obtain better results. In one study, 
sulfolane was used as the solvent in combination with DABCO as a base. 
According to the authors, this gave better results than the aqueous 1,4-
dioxane mixture.[187] A major disadvantage seemed to be the high melting 
point of the sulfolane,6 which makes it less suitable for industrial purposes. 
Nevertheless, several reaction conditions were evaluated to test the 
performance under microreactor conditions. Table 3.3 summarises the results. 
The first reaction that was performed was at 40 °C at a relative high flow rate, 
to prevent clogging of the microreactor. Although there were no problems in 
performance, the conversions were rather disappointing (Table 3.3, entry 5). 
Since it was noticed that the aldehyde/catalyst did not solidify in sulfolane, 
when standing at room temperature, a second trial was performed at room 
temperature conditions at the highest possible residence time. Entry 3 shows 
                                        
5 See remark 3 on page 48. 
6 The melting point of sulfolane 99+% is 27.4 - 27.8 °C (Acros). 
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that the result was very promising, since better results were obtained 
compared to the reaction in water/1,4-dioxane (v/v 1:1) (Table 3.2, entry 2). 
Increasing or decreasing the reaction temperature did not give better results 
(entries 2 and 6). A temperature of 70 °C was tested because of the good 
results obtained at the reflux temperature of methyl acrylate (76 °C) with 
DABCO as a catalyst.[248] As mentioned, the mixture of aldehyde and 
DABCO in sulfolane did not solidify at room temperature. When the 
temperature was further decreased to 4 °C, there was still no solidification, 
even after standing for 2 days. However, performing the reaction at 10 °C in 
the microreactor (according to literature, lower temperatures are beneficial for 
the Baylis-Hillman reaction[249,250]), almost immediately led to clogging of the 
microchannels (entry 2). A similar explanation as for the aqueous 1,4-dioxane 
mixture is suggested (vide supra, § 3.2.2.5). Combining methyl acrylate and 
DABCO also led to solidification however, but now it already occurred in the 
mixture. Taking all these results into account, a final experiment in sulfolane 
was done at a higher concentration in order to increase the output. 
Surprisingly, the conversion and yield of the reaction dropped significantly 
(entry 1). No decent explanation for this behaviour was found. Although the 
higher conversion obtained with sulfolane at a 0.05 M concentration of 
aldehyde, this route was abandoned, since in the case of water/1,4-dioxane 
(v/v 1:1), a higher output was possible without the extra problems of 
solidification. 
 
Further attempts to work at decreased temperatures were made by using 
dichloromethane as a solvent,[182,253] since no solubility problems occurred in 
this solvent. Unfortunately, the use of dichloromethane showed a severe drop 
in the actual flow rate during processing.7 As a consequence, the residence 
time was not reproducible. When evaluating the reaction mixture, also no 
Baylis-Hillman adduct was formed, although the residence time was increased 
due to the lowered flow rates. For these reasons, this route was abandoned. 
In attempts to work with neat methyl acrylate as a solvent, which proved to 
                                        
7 According to the chemical resistance chart of the CYTOS® College System, provided by CPC - Cellular Process 
Chemistry Systems GmbH, dichloromethane can be used in a limited way because of the low compatibility with 
some parts of the piston pumps. In this particular case, even after half an hour problems occurred to maintain the 
flow rate. Therefore, no further experiments were done with dichloromethane.  
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be advantageous in some cases,[248,254] problems with the pump stability were 
also observed,8 so no further experiments were performed.  
 
Table 3.3: Baylis-Hillman reaction of 4-nitrobenzaldehyde and methyl acrylate 
in continuous mode using DABCO as a catalyst in sulfolane as solvent.a 
Entry 
4-Nitrobenzaldehyde 
(M) 
DABCO 
(M) 
Methyl 
acrylate (M)
T 
(°C)
Degree of 
conversion 
(mol %)b 
Yield 
(%)c 
1 0.1 0.1 0.3 RT 23 19 
2 0.05 0.05 0.15 10 -- -- 
3d 0.05 0.05 0.15 RT 82 (8) 73 (7)
4 0.05 0.05 0.15 RT -- -- 
5e 0.05 0.05 0.15 40 5 5 
6 0.05 0.05 0.15 70 7 6 
--: Clogging of the microreactor. a Residence time: 1 h 58 min; products in bold are mixed 
together before they enter the microreactor system; concentration of the reagents as in 
the reactor; reaction quenched with HCl (1 N). b Based on the integration signals in the 
1H-NMR spectrum. c Based on total mass of end product collected in the crude mixture 
and degree of conversion. d In brackets: results collected after the microreactor alone i.e. 
with a residence time of 3 min. e Residence time: 23.5 min. 
 
3.2.3 Generality 
 
The aforementioned optimisation study was used to check the generality of 
the Baylis-Hillman procedure under microreactor conditions. Several aromatic 
and aliphatic aldehydes were subjected to these conditions, together with 
different activated alkenes. The results are presented in Table 3.4. In case of 
the aldehyde, moderate to good conversions were obtained without any 
problems. Even the aliphatic propionaldehyde gave a good conversion to the 
Baylis-Hillman adduct. No side-products were detected in the spectrum with 
one exception. In the 1H-NMR spectrum of the Baylis-Hillman reaction with 
furaldehyde 1d, formation of a side-product was detected. A ratio of Baylis-
                                        
8 No compatibility issues were known about methyl acrylate, according to the chemical resistance chart of the 
CYTOS® College System. 
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Hillman adduct 4d versus side-product of 86:14 was calculated. When the 
reaction time was prolonged, as in the stopped-flow procedure (vide infra, § 
3.2.4), a further shift towards the side-product was seen (ratio = 58:42), which 
meant that the Baylis-Hillman adduct was converted to this side-product. 
Purification by column chromatography and analysis of the different spectra 
proved that this side-product was methyl (2E)-3-furan-2-yl-2-hydroxymethyl 
acrylate 107 (Figure 3.6). Considering the E- or Z-isomer the following 
rationale was followed. First of all, it was expected that the E-isomer was 
formed based on literature data since for Baylis-Hillman esters, mostly the E-
isomer was formed in a SN2’ reaction, while this was mostly the Z-isomer in 
the case of nitrile adducts.[255-257] Secondly, the proton on the double bond has 
a value of 7.45 ppm. Calculations predict the value of this proton in the E-
configuration to be around 7.62 ppm, while the Z-configuration has a far 
more upfield value of around 7.08 ppm. Moreover, a carbon value of 57 ppm 
is expected for the methylene protons in the E-configuration, while this is 63 
ppm in the other case. The real value (58.2 ppm) is closer to the E-isomer. 
Finally, some NOE experiments were performed. No Nuclear Overhauser 
Effect was observed between the methylene protons and the vinylic proton. 
These facts led to the conclusion that the side-product is the E-isomer. The 
reason why only in the case of the furaldehyde a side reaction to the SN2’ 
product was observed, is not clear. 
 
OMe
O
107
O
OH
 
Figure 3.6: Methyl (2E)-3-(furan-2-yl)-2-hydroxymethyl acrylate 107 as a side-
product of the Baylis-Hillman reaction between furaldehyde 1d and methyl 
acrylate 2a. 
 
Generally, it was possible to achieve throughputs of several g/day. In some 
particular cases, a production rate up to 17 g Baylis-Hillman adduct/day was 
possible.  
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Table 3.4: Continuous Baylis-Hillman reaction for different aldehydes and activated alkenes.a 
R H
O N
N
R
OH
EWG
+
1a-f
3
microreactor
4a-j2a-e
EWG
 
Entry Aldehyde 1 Alkene 2 Product Concentration (M) 
Degree of conversion 
(mol %)b 
Yield 
(%)c
Throughput 
(g/day) 
1 4-nitrobenzaldehyde methyl acrylate 4a 0.2d 93 82 22.4 
2 3-nitrobenzaldehyde methyl acrylate 4b 0.2d 76 66 18.0 
3 2-pyridinecarboxaldehyde methyl acrylate 4c 0.1 97 47 5.2 
4 2-furaldehyde methyl acrylate 4d 0.1 52 -- -- 
5e 5-nitro-2-furaldehyde methyl acrylate 4e 0.05 90 52 3.4 
6 propionaldehyde methyl acrylate 4f 0.1 68 20 1.7 
7 4-nitrobenzaldehyde acrylonitrile 4g 0.2d 100 74 17.4 
8 4-nitrobenzaldehyde methyl vinyl ketone 4h 0.2d -- 13f 3.3 
9 4-nitrobenzaldehyde 2-cyclohexen-1-one 4i 0.2d No reaction -- 
10 4-nitrobenzaldehyde acrylamide 4j 0.2d Clogging -- 
--: No determination possible. a Reaction conditions: ratio aldehyde/DABCO/alkene is 1:1:3; residence time is 1 h 58 min; reaction 
quenched with HCl (1 N). b Based on the integration signals in the 1H-NMR spectrum. c Based on total mass of end product collected in 
the crude mixture and degree of conversion. d Aldehyde and DABCO dissolved into a 3:7 (v/v) water/1,4-dioxane mixture; alkene stirred 
into a 7:3 (v/v) water/1,4-dioxane mixture. e Residence time is 26 min. f Isolated yield. 
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Varying the activated alkenes showed a higher variability. In the case of 
acrylonitrile, a complete conversion was observed and the adduct was 
obtained without need for further purification. Using methyl vinyl ketone, the 
end product was detected in the spectra, but due to the presence of various 
side-products, it was not possible to determine the conversion. After 
purification by flash chromatography, 13 % of the Baylis-Hillman compound 
was obtained. With 2-cyclohexen-1-one, no end product was detected at all. 
Finally, when the reaction was conducted with acrylamide, clogging of the 
microreactor channels was observed. The reason for this clogging remained 
unclear. So this procedure is more or less general for a variety of aldehydes, 
but variation of the alkene was less successful. 
 
3.2.4 Stopped-flow technique 
 
Since the reaction was not completed after the maximal residence time of the 
microreactor and the reaction profile of the batch process shows that the 
conversion still increases after 3 h (Figure 3.5), the residence time of the 
microreactor was increased using the stopped-flow technique. The rationale 
of this process is to increase the residence time and thus the reaction time, by 
pausing the pumping at regular time intervals. Recently, other research groups 
have also successfully applied this technique.[151,158,245,247] To make a decent 
comparison without making the experiment unnecessarily long, a fivefold 
increase of the residence time was chosen, so that the ratio of pumping time 
to pause time had to be 1:4. Also, the pumping interval had to be long 
enough to ensure a reproducible residence time since the pump does not 
reach the maximum flow rate immediately. By using a pumping interval of 1 s 
the influence of the start up of the pump was too big, and a longer residence 
time occurred due to the lower flow rates (Figure 3.7, upper part). On the 
other hand, long pause times are disadvantageous because of more diffusion 
in the longitudinal direction. As a compromise, a pumping interval of 1 min 
was chosen, to minimise the effect of the startup and to minimise the pause 
time which was 4 min in this case. Since problems with the reactivity of the 
methyl acrylate (lower conversions were obtained after 9 h 50 min residence 
time compared to 1 h 58 min residence time) occurred when the methyl 
Results and Discussion 
- 63 - 
acrylate-solvent mixture was standing too long before reaction, the mixture 
was refreshed on a regular basis. Also for previous experiments, the methyl 
acrylate-solvent mixture needed to be refreshed on a daily basis to avoid 
lower conversions.  
 
 
Figure 3.7: Effect of time interval of stop and flow period on the pumping 
regime (A: suboptimal conditions; B: optimal conditions). 
 
The results of the stopped-flow study are shown in Table 3.5. These data 
prove that the reactions are still not completed after 2 h of reaction time, 
since considerable enhancement of conversion and yield can still be achieved. 
In the case of 3-nitrobenzaldehyde 1b (entry 2), the conversion to the Baylis-
Hillman adduct is doubled at a concentration of 0.05 M. If 2-
pyridinecarboxaldehyde 1c is used (entry 3), even a complete conversion is 
achieved, although it is obvious that in this case it is not necessary to increase 
the residence time 5 times since already 97 % conversion is achieved in the 
normal procedure. Moreover, almost complete conversion is obtained after 
passing the microreactor alone. The lower conversion in the case of 
furaldehyde after the stopped-flow is due to the formation of the side-
product 107 mentioned in § 3.2.3. When this is taken into account, 
conversions without or with stopped-flow are respectively 61 and 67 %, 
which meant only a slight increase. 
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Thus, by regulating the residence time using the stopped-flow technique, it is 
possible to drive the Baylis-Hillman reaction to completion in a continuous 
way. The lower yields are associated with a more difficult work up of the 
reaction. It must be emphasised that, in this case, this is only a proof-of-
concept. Applying these conditions in an industrial scale will not be 
economically feasible due to the long start up procedure and the lower yield 
of the experiments. It takes approximately 16 h to reach steady state 
conditions. A probable solution to the second problem is the use of a 5-way 
valve and 5 parallel RTUs after the microreactor in order to get a continuous 
flow instead of a stopped-flow in 80 % of the time (Figure 3.8). Similar 
solutions are already found in literature.[258] 
 
Table 3.5: Comparison between continuous Baylis-Hillman reaction without 
or with stopped-flow for different aldehydes.a 
Entry Product 
Concentration 
(M) 
Without stopped-flow With stopped-flow 
Degree of 
conversion 
(mol %)b 
Yield 
(%)c 
Degree of 
conversion 
(mol %)b 
Yield 
(%)c 
1 4a 
0.2d 93 82 99 94 
0.05 57 48 83 87 
2 4b 
0.2d 76 66 80 76 
0.05 23 21 45 35 
3e 4c 0.1 97 (66) 47 (30) 100 (89) 51 (50) 
4 4d 0.1 52 -- 39 -- 
--: Not determined. a Reaction conditions: ratio aldehyde/DABCO/methyl acrylate is 
1:1:3; residence time is 1 h 58 min without stopped-flow and 9 h 50 min stopped-flow; 
reaction quenched with HCl (1 N). b Based on the integration signals in the 1H-NMR 
spectrum. c Based on total mass of end product collected in the crude mixture and degree 
of conversion. d Aldehyde and DABCO dissolved into a 3:7 (v/v) water/1,4-dioxane 
mixture; methyl acrylate stirred into a 7:3 (v/v) water/1,4-dioxane mixture. e In brackets: 
results at the microreactor outlet i.e. with a residence time of 3 min (without stopped-
flow) or 15 min (with stopped-flow). 
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Figure 3.8: Possible setup solution to work with a stopped-flow technique in a 
continuous way. A = input reagents, B = microreactor, C = 5-way valve, D = 
parallel RTUs. 
 
3.2.5 Effect of RTU 
 
In many articles it is stated that the high mass transfer in the capillary system 
is one of the major reasons for the higher reaction rates under microreactor 
conditions. The question rose if there would be a difference in reaction 
conversion/output if the system was used as a micromixer instead of as a 
microreactor. Indeed, if the flow is high enough and the rate small enough, 
only a small part of the reagents is converted into the end product before 
leaving the microreactor in the case of a slow reaction. So at higher flow rates, 
the microreactor only acts as a micromixer while the residence time unit is the 
real reaction zone of the system. On the contrary, if the flow rate is small 
enough, mixing and reaction takes place in the microreactor. To check this, it 
was necessary to select a very fast Baylis-Hillman reaction, because this still 
takes several minutes to complete. Because the minimum reproducible flow 
rate of the piston pumps is 0.2 mL/min.pump, the maximum residence time 
in the microreactor is 3 min. So a reaction which has the biggest increase in 
conversion between 1 and 5 min was necessary, in order to see the effects. 
Based on the conditions that were used in the previous chapter, it was found 
in literature that 5-nitro-2-furaldehyde 1e reacted very fast with methyl 
acrylate.[236] To check if this was an appropriate compound to use in this study, 
a conversion curve was determined. Figure 3.9 shows the result of this 
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experiment. As shown, complete conversion to the Baylis-Hillman adduct 
was obtained within 10 min, which made it a suitable reaction to use. 
The idea of the experiment was to compare the conversions to the end 
product with a certain residence time in the microreactor on the one hand 
and the same residence time in the microreactor and the RTU on the other 
hand. This meant a flow rate ratio ([microreactor + RTU]/microreactor) of 
38.5 was necessary. The results of this study are shown in Figure 3.10. 
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Figure 3.9: Conversion curve of the Baylis-Hillman reaction between 5-nitro-
2-furaldehyde 1e and methyl acrylate 2a under batch conditions. 
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Figure 3.10: Comparison of the conversion to the Baylis-Hillman adduct 4e 
with or without the use of the RTU. 
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In the experiment where the RTU is included, residence times shorter than 
1.25 min were not tested because of the high flow rates that are necessary. In 
the experiments, it is not evident to work accurately at high flow rates and 
this is seen in the results: higher fluctuations occur in the conversion (see 
error bars). Furthermore, the results show that there is a difference in 
conversion between the 2 setups. It was expected that the effect of the 
microreactor unit would be advantageous, or in the worst case equal, because 
of two reasons. Firstly, because of the lower flow rate when the experiment 
was only performed in the microreactor, the reagents stay longer in the 
microreactor mixing chamber. Secondly, although the flow rate is much 
higher in the experiment where the RTU is included, there is no expected 
turbulence (see calculations below). So it was presumed that there will be no 
extra positive mixing effect and the RTU will only serve to increase the 
reaction time. However, in the conversion to the Baylis-Hillman adduct, the 
graph shows opposite results. Indeed, if the RTU is included, the conversion 
is somewhat higher. Some possible explanations of the opposite phenomenon 
were suggested, but no decent explanation was found. 
 
1. Effect of turbulence in the RTU. 
 
As already mentioned, there was no expected turbulence in the RTU. As an 
example, the Reynolds number in the RTU for water as the liquid is calculated 
(at a temperature of 22 °C, the dynamic viscosity µwater is 0.000955 kg/m.s and 
the density ρwater is 997.86 kg/m³). The characteristic properties of 1,4-
dioxane are quite close to these of water (at T = 25 °C, µ1,4-dioxane = 0.0011795 
kg/m.s and ρ1,4-dioxane = 1027.97 kg/m³), so it can be assumed that the 
characteristics of a water/1,4-dioxane (v/v 1:1) mixture are of the same order 
of magnitude.[259] The RTU consists of a stainless steel tube which is 
surrounded by another tube wherein the heating or cooling medium flows. 
Measurement of the tubing gives a total length of approximately 3.14 m. It is 
known that the inner volume of the RTU is 45 mL. This gives a flow cross-
section of approximately 1.43 x 10-5 m². The characteristic length Lchar of a 
tube is known as the inner diameter of that tube. This gives a Lchar of 4.27 x 
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10-3 m. The Reynolds numbers at some flow rates are calculated in Table 3.6 
according to the following formula: 
 
μ
Lvρ chars Re ⋅⋅=  (3.1) 
 
with Re = Reynolds number (-) 
 ρ = fluid density (kg/m³) 
 vs = mean fluid velocity (m/s) 
 Lchar = characteristic length (m) 
 µ = dynamic fluid viscosity (kg/m.s) 
 
Calculations of the Reynolds number gave a value of around 50 in the case 
the residence time was around 5 min in the microreactor + RTU (flow rate of 
4.7 mL/min.pump). This is far from the turbulence region which starts 
approximately at a value of 3500 for Re. Moreover, the mixing seems not to 
be of importance for the Baylis-Hillman reaction (vide supra, § 3.2.2.4).  
 
Table 3.6: Estimated Reynolds numbers in the RTU at different flow rates. 
Flow rate (mL/min.pump) Mean fluid velocity (m/s)a Re (-) 
0.2 4.7 x 10-4 2 
0.4 9.3 x 10-4 4 
1.0 2.3 x 10-3 10 
4.7 1.1 x 10-2 49 
9.4 2.2 x 10-2 98 
18.8 4.4 x 10-2 196 
a To calculate the mean fluid velocity, the flow rate has to be doubled, since the 
microreactor has 2 inlets. 
 
2. Clogging of a part of the microreactor. 
 
It was suggested that if a part of the microreactor was clogged (e.g. 1 of the 4 
channels), the pumped volume has to flow through 75 % of the reactor, 
which means a decrease in residence time by 25 %. In the case of the 
Results and Discussion 
- 69 - 
microreactor, this means a significant reduction in residence time, while in the 
case the reaction is flown through both the microreactor and the RTU, there 
will be only a small difference. According to literature, a difference in channel 
diameter has only little influence on microreactor performance in a 
homogeneous reaction.[260] In these calculations however, the assumption was 
made that the number of channels was large (i.e. more than 30) which is not 
the case here. Therefore, a similar experiment was performed using the 
optimised α-aminophosphonate synthesis (vide infra, § 3.4.2). No differences 
occurred here, which proved that this was not a microreactor defect. 
Interestingly, this also meant that the effect was reaction dependent. 
 
3. Negative surface effect. 
 
Because of the reaction dependence, a surface effect was also considered, 
conform a positive surface effect already mentioned in the literature. In an 
acid-catalysed esterification reaction (Scheme 3.5), it was proven that the 
interaction of the silanol groups of the glass microchip were the reason for 
the higher and faster conversion observed. The acid was responsible for the 
activation of the glass surface hydroxyl groups.[261] 
 
108 109
OH
O
OEt
OEtOH, H+
 
Scheme 3.5: Acid-catalysed esterification of 9-pyrenebutyric acid 108. 
 
In our specific case, the contact area with the surface in the RTU is lower 
(due to a lower surface-to-volume ratio). Moreover, the conversions in the 
experiment where the RTU is included are higher. Combining these findings 
means that if there is a surface effect on the reaction, this should be a 
negative one. However, intense study of the literature concerning possible 
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negative effects of the stainless steel inner structure9 did not bring a possible 
explanation.  
 
4. Effect of the flow rate.  
 
A final hypothesis included an increase in conversion due to the higher flow 
rate. However, this is normally due to a better mixing performance.[107,110] The 
main difference between both setups was the high difference in flow rate. It 
was suggested that there was a positive influence of the flow rate on the 
conversion of the Baylis-Hillman reaction, conform positive effects on the 
selectivity observed by some researchers[108,109]. Unfortunately, this could not 
be tested due to the static setup of the system. 
 
3.2.6 Comparison of 2 types of microreactor setup 
 
During the last 2 decennia, many different types of microreactors are 
developed for organic chemistry.[40,46,48,54,107] They all have different properties 
and some of them are developed for specific purposes like research of 
microfluidics, optimisation studies or industrial applications to name a few. 
An overview of some providers of microreactor systems is given in Table 3.7. 
 
Comparisons between microreactors were already made concerning mixing 
performance[100,262,263] or for selection in a pilot plant[136]. In this chapter, a 
comparison was made between 2 types of microreactor in their use for the 
Baylis-Hillman reaction. The first microreactor was the commercially available 
CYTOS® College System. The second microreactor was a 1-line chip 
produced at the MESA+ Institute for Nanotechnology at the University of 
Enschede, Twente, The Netherlands. Some properties of both microreactors 
are given in Table 3.8. 
 
                                        
9 The stainless steel is from the type 1.4571 (German standard) which has the following composition:  0.08 wt% C, 
17 wt% Cr, 12 wt% Ni, 2 wt% Mo, 0.6 wt% Ti. 
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Table 3.7: Commercially available microreactors.a 
Supplier Material Microreactor types 
Synthacon and Micro-Reactor Systems Provider, 
Inc. (in collaboration with CPC-Cellular Process 
Chemistry Systems GmbH) 
Stainless steel CYTOS® Lab System, SEQUOS®, OPTIMOSTM 
Microinnova Engineering GmbH (in 
collaboration with IMM) 
Stainless steel 
Slit Interdigital Mixer, Caterpillar Mixer, Star 
Laminator 
Syrris Glass FRXTM system, AFRICA® system 
Ehrfeld Mikrotechnik BTS Stainless steel Modular microreaction systems 
Micronit Microfluidics BV Glass Microreactor chips (standard or design) 
Dolomite Centre Glass Design of devices 
INI Power SystemsTM Polymer Laminar Flow Fuel Cell (LFFC®) 
ThalesNano, Inc. Stainless steel CatCartTM, H-CubeTM, X-CubeTM 
Siemens Stainless steel SIPROCESS 
Systanix, Inc.TM Unknown SysFlo 
Uniqsis Ltd.b Unknown Unknown 
a A wide variety of other microreactors is available. Only commercial manufacturers are mentioned in this table. Other research groups 
specialised in the design of microreactors are e.g. the Forschungszentrum Karlsruhe (FZK), the Department of Chemistry at the University 
of Hull and the Department of Chemical Engineering at the Massachusetts Institute of Technology. b Uniqsis Ltd. was formed in January 
2007 by Asynt Ltd. and Grant Instruments Ltd. to develop innovative microreaction technology products for customers in both the 
research and biopharmaceutical sector. Specific information is not available yet. 
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Table 3.8: Properties of the 2 microreactors used in this study. 
Property CYTOS® 1-line chip 
Material Stainless steel Silicon-glass 
Channel width (µm) 200-500 50 
Internal volume (mL) 1.2 2.18-2.26 x 10-³ 
Mixing Interdigital Modified Tesla-mixer 
Quenching External Internal 
 
The same starting reagents were used as in § 3.2.5. Since the experiments in 
the second type of microreactor were done with an output of 10 µL samples, 
because otherwise the sampling time was too long, it was necessary to find an 
appropriate analytical method in order to compare the results. A very 
convenient method for the reaction follow up is UV spectrometry. 
Unfortunately, because the absorption maxima of the 2 products were too 
close to each other (5-nitro-2-furaldehyde 1e: 301 nm; Baylis-Hillman adduct 
4e: 313 nm), this was not an option. Another method was the use of GC-
analysis. Because the reaction was done in a solvent mixture containing water, 
a preliminary extraction was needed, before analysing the sample. 
 
Some initial experiments using the 1-line chip showed problems of bubble 
formation in the microchannels. This was not allowed, since no reproducible 
residence time could be achieved. A procedure to prevent this consists in 
sonicating the reaction mixture prior to use in the microreactor setup. In 
literature, some rate enhancement is observed when ultrasound is used while 
performing the Baylis-Hillman reaction.[180,189] However, this was on the 
complete reaction mixture instead of the separated reagent mixtures. 
Although the bubble formation was never observed in the CYTOS® College 
System10, it was decided to test if the sonication had an effect. According to 
the results presented in Figure 3.11, there was an effect noticed in the initial 
stage of the reaction and at high conversions. Between 60 and 70 % 
conversion, the ultrasound effect was minimal.  
                                        
10 It must be mentioned that in the CYTOS® College System no observation of the inner part of the microreactor is 
possible. However, there were never bubbles observed in the PTFE tubes at the outlet of the system. 
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Figure 3.11: Effect of sonication of the reagent solutions on the conversion 
to the Baylis-Hillman adduct 4e (CYTOS® College System). 
 
In this and further experiments, 5-nitro-2-furaldehyde 1e was mixed with 
methyl acrylate 2a instead of with the catalyst, as in previous experiments. 
There were 2 reasons for doing this. Mixing 5-nitro-2-furaldehyde and 
DABCO provided a dark brownish to black mixture, which made it 
impossible to see if, in the case of the microreactor chip, clogging occurred or 
not. Secondly, using ultrasound on the mixture showed already 85 % 
conversion within 30 seconds in the case DABCO was mixed with 5-nitro-2-
furaldehyde and then reacted with methyl acrylate in the microreactor (Figure 
3.12), which makes it difficult to compare between the microreactors in 
further stages, because of the high rates. As previously seen in § 3.2.2.3, 
mixing methyl acrylate and DABCO was not an option due to the betaine 
formation and consequently the very low conversion. The only option left 
was mixing 5-nitro-2-furaldehyde and methyl acrylate. Comparing both 
figures shows the significant effect of the order of mixing of the reagents, 
prior to addition to the microreactor, on the conversion. In the case the 
experiment was repeated, the error bars are added. Calculation of the relative 
standard deviations showed that, with a few exceptions, this value stayed 
below 5 %. In the few exceptions, the relative standard deviations also stayed 
below 10 %. Due to this good reproducibility when performing the same 
experiment, it was not necessary to repeat every experiment. 
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Using these reaction conditions, a comparison of the conversion towards the 
Baylis-Hillman adduct was made between the 1-line chip, the CYTOS® 
microreactor and the round bottom flask. Some remarkable results were 
observed (Figure 3.13). The highest reaction rate was observed in the batch 
procedure. After 15 seconds, already 70 % of the end product was detected. 
In the microreactors it took between 1 min and 1.25 min to achieve 70 % 
conversion, with a better performance in the CYTOS® microreactor. 
Moreover, both microreactors reach a plateau around 70-75 % conversion, 
while the conversion in the batch procedure further increases. 
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Figure 3.12: Conversion to the Baylis-Hillman adduct 4e after mixing 5-nitro-
2-furaldehyde 1e with DABCO 3 and using different pre-treatments 
(CYTOS® College System). 
 
Conversion curves using different reagent ratios in the 1-line chip were also 
determined (Figure 3.14). As previously seen, the same trends were visible. 
Without an excess of methyl acrylate, the conversion was significantly low. 
The switch towards a catalytic amount of DABCO however had an even 
more pronounced negative effect on the conversion. Interesting to note is the 
rate enhancement between 0.8 and 1.3 min residence time in the 2 upper 
curves. This can be seen by the steeper curve. All the experiments have more 
or less the same initial reaction rate. In the case of the experiment with the 
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catalytic amount of DABCO, there is a higher probability to form the stable 
betaine after some time, which leads to a stagnation of the conversion. 
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Figure 3.13: Comparison of a conventional batch procedure with 2 different 
microreactor setups to form Baylis-Hillman adduct 4e. 
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Figure 3.14: Conversion to the Baylis-Hillman adduct 4e under different 
reaction conditions using the 1-line microreactor chip. 
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Thus, after some modifications it was possible to compare 2 types of 
microreactors with the batch procedure. Although otherwise expected, the 
reaction performed better under batch conditions. Probably, a similar 
explanation as in § 3.2.2.4 lies at the basis of these results: the intensity of 
mixing of the reagents seems not to be important in achieving higher 
conversions and yields. 
 
3.2.7 Investigation of the aza-Baylis-Hillman reaction 
 
The aza-Baylis-Hillman reaction is even more interesting due to the formation 
of β-amino-α-methylene functionalised compounds.[207,264-266] This allows the 
formation of e.g. β-amino acids.[267,268] β-Amino acids occur in nature both in 
free form and in peptides. The corresponding β-peptides have been 
thoroughly investigated due to there specific properties, of which the most 
important ones are the stability of β-peptides towards cleavage by peptidases 
and to metabolic transformations, their specific folding to form secondary 
structures in solution with short chain lengths and their possibility to mimic 
α-peptides in peptide-protein and protein-protein interactions.[269]  
 
In this doctoral thesis, several attempts were made to optimise a procedure to 
produce aza-Baylis-Hillman adducts in a continuous manner. Some initial 
batch experiments were started from a known procedure, which used 2-
propanol as the solvent.[268] These initial experiments showed already that 2-
propanol could not be used in the microreactor, because of the insolubility of 
the 4-nitrobenzaldehyde in it, even at very low concentrations. Moreover, the 
selectivity appeared to be low in the batch reactions, although otherwise 
mentioned in the literature[269]. 11  The selectivity to the aza-Baylis-Hillman 
adduct versus the Baylis-Hillman adduct was around 40-45 % in our 
experiments. Therefore, further attempts to produce the aza-Baylis-Hillman 
adducts used the imine compound 4-methyl-N-(4-nitrobenzylidene) 
benzenesulfonamide 6, made via a known procedure.[270] Several solvents, 
                                        
11 Correspondence with the authors learned that in the literature procedure, the aldehyde and the amine were stirred 
in advance to form the imine. Then the methyl acrylate was added to react to the aza-Baylis-Hillman adduct. This 
explained the high selectivities of 78 to >99 %. 
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such as methanol, dichloromethane and DMF, were tested in batch to use in 
the microreactor procedure. DMF was the solvent of choice since all the 
reagents were easily dissolved in this solvent and complete conversion 
occurred after 2 hours of reaction, while in the other solvents there was still 
20-30 % of imine left.  
 
Table 3.9 shows the outcome of the aza-Baylis-Hillman adduct formation 
under microreactor conditions. Several attempts were made and the different 
tested reaction conditions gave more or less the same result. In the case that 
the imine 6 was mixed with DABCO before adding to the microreactor (entry 
1), a low conversion of 35 % was realised. The unreacted imine was further 
hydrolysed during the quenching and the work up and both the aldehyde and 
the amine were detected in the 1H NMR spectrum. In order to increase the 
conversion to the aza-Baylis-Hillman product, other reaction conditions were 
tested. Unexpectedly,[249,250] decreasing the temperature to -15 °C had no 
advantageous effect on the conversion (entry 2). Interesting to note is the fact 
that there is no decrease in conversion when DABCO is mixed with methyl 
acrylate (entry 3), although this was expected according to the results obtained 
in the previous studied Baylis-Hillman reaction (vide supra, § 3.2.2.3). In view 
of the formation of the betaine (Scheme 3.4), which acts as a competing 
factor for the formation of the Baylis-Hillman adduct, water is needed for the 
hydrolysis of the ester. In this case however, dry reaction conditions are used, 
so probably no formation of the stable betaine is possible which could explain 
why there is no negative effect on the conversion to the aza-Baylis-Hillman 
adduct. In a final experiment, the highest possible imine concentration in 
DMF was used (entry 4). This afforded an increase in conversion, but after 
work up, the yield stayed approximately the same. In all the reactions 
performed, no Baylis-Hillman product was detected in the reaction mixture 
using the microreactor procedure, which meant that no hydrolysis of the 
imine occurred during the reaction. On the contrary, in the batch procedure, 
performed under the same conditions as entry 1, 5 % Baylis-Hillman adduct 
was detected. 
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Table 3.9: Aza-Baylis-Hillman reaction of imine 6 and methyl acrylate in 
continuous mode using DABCO as a catalyst in dry DMF as solvent.a 
H
N
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O
OMe
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N
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6
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microreactor
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Entry 
Imine 6 
(M) 
DABCO 
(M) 
Methyl 
acrylate 
(M) 
T 
(°C)
Degree of conversion 
(mol %)b 
Yield 
(%)c 
1 0.05 0.05 0.15 RT 35 29 
2 0.05 0.05 0.15 -15 31 27 
3 0.05 0.05 0.15 RT 33 30 
4 0.075 0.075 0.225 RT 46 30 
a Residence time: 1 h 58 min; products in bold are mixed together before they enter the 
microreactor system; concentration of the reagents as in the reactor; reaction quenched 
with HCl (1 N). b Based on the integration signals in the 1H-NMR spectrum. c Based on 
total mass of end product collected in the crude mixture and degree of conversion. 
 
3.2.8 Conclusions 
 
It was possible to produce comparable results under continuous conditions 
with those from batch procedures after optimisation. In the specific Baylis-
Hillman reaction studied, a reduction of the reaction time by approximately 
30 % was accomplished. The best conditions were obtained using water/1,4-
dioxane (v/v 1:1) as a solvent at room temperature using a 1:1:3 ratio of 
aldehyde, DABCO, and methyl acrylate and a concentration of 0.2 M of 4-
nitrobenzaldehyde in the microreactor. To work with these high 
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concentrations, the solvent mixture had to be adjusted properly. In this 
optimised procedure, a throughput of 22 g/day Baylis-Hillman product was 
achieved. 
Using a stopped-flow regime, the Baylis-Hillman reaction can be forced to 
completion, although this had as a consequence a significant decrease in 
output. Further study of this reaction showed that there was an effect of the 
microreactor setup, which was probably due to a flow rate effect on the 
Baylis-Hillman reaction. A final comparison between 2 different 
microreactors and the batch procedure showed that the batch procedure 
performed best, followed by the CYTOS® College System.  
The study of the aza-Baylis-Hillman reaction yielded some disappointing 
results. Preforming the imine was necessary to avoid competition with the 
Baylis-Hillman adduct formation and only a maximal conversion of 46 % was 
achieved. 
 
Results and Discussion 
- 80 - 
3.3 IMIDAZOLE SYNTHESIS 
3.3.1 Introduction 
 
The imidazole core is an important unit in heterocyclic chemistry.[31] It occurs 
in different natural products and in a variety of synthetic compounds. Some 
examples of imidazole-containing compounds in living organisms are the 
essential amino acid histidine 110 and histamine 111 (Figure 3.15). Different 
imidazoles show biological activities such as anti-inflammatory activity 
inhibiting cytokine release or inhibiting the p38 MAP kinase,[271-278] anti-
allergic activity[279] and analgesic activity[280]. They are also sensitisers of multi-
drug-resistant cancer cells,[281] pesticides,[282-284] antibiotics[285] or sodium-
channel modulators[286,287]. Recently, neurodazine 112, an imidazole that is able 
to induce neuro-specific activity in mouse myoblasts and in human muscle 
tissue, was discovered.[288]  
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Figure 3.15: Some natural and synthetic imidazole containing compounds. 
 
Known imidazole based drugs are ketoconazole 113, which has antifungal 
properties, and losartan 114, a drug against hypertension (Figure 3.15). More 
recently, interest in imidazoles is increasing due to applications as green 
solvents by means of ionic liquids[289,290] and in organometallic chemistry as 
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N-heterocyclic carbenes[291-295]. Imidazole was firstly prepared in 1858 from 
glyoxal and ammonia,[296] and the scope was broadened in 1974[297]. Ever since, 
many procedures have been developed to generate a broad range of 
differently substituted imidazoles.[298-302] 
 
Although there is a wide variety of synthetic routes towards imidazoles, only a 
few studies exist for the synthesis of 1,2,4,5-tetrasubstituted imidazoles which 
are mostly obtained via multistep routes[274,276,277,303-308] or via a trisubstituted 
1H-imidazole in which the nitrogen is substituted in the final step[280,309]. 
Several MCRs have been developed towards the efficient construction of 
imidazole scaffolds.[281,310-314] However, the reported MCRs often make use of 
solid-supported reactants which make these procedures not suitable for 
continuous multigram-scale production under microreactor conditions. 
Recently, a solution-phase MCR procedure based on a modified[29,30] 
Radziszewski[32] reaction under microwave conditions has been developed, in 
which an α-diketone 8, an amine 9 and an aldehyde 1 react with ammonia to 
form a tetrasubstituted imidazole 11 (Scheme 3.6). Although a promising 
approach, scale up of this four-component condensation under microwave 
conditions is not trivial and multigram production of the desired imidazoles is 
not straightforward. The similar batch reaction to form tri- or tetrasubstituted 
imidazoles without microwave heating was very slow,[315] although starting 
from benzoin, good results were obtained.[316] This led us to study the 
potential of the microreactor concept towards a continuous production of 
tetrasubstituted imidazoles. 
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Scheme 3.6: The modified Radziszewski reaction. 
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3.3.2 Optimisation study using microreactor technology 
 
The one-pot reaction of benzil 8a, benzylamine 9a, isobutyraldehyde 1g and 
ammonium acetate under acidic conditions to give imidazole 11f was used to 
optimise the four-component condensation in the microreactor environment 
(Scheme 3.7). Similar compounds appeared to have antinociceptive and anti-
inflammatory properties.[317] Although the exact reaction mechanism is not yet 
fully understood, it is believed that the reaction proceeds via initial imine 
formation followed by cyclocondensation-aromatisation with the concomitant 
loss of two molecules of water (Scheme 3.8).[29] The main side-product 
produced proved to be the trisubstituted imidazole 11’d (Figure 3.16), formed 
by the incorporation of two moles of NH4OAc (as a source of NH3) instead 
of benzylamine. 
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Scheme 3.7: The modified Radziszewski reaction, used for the optimisation 
study. 
 
N
H
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11'd  
Figure 3.16: The main side-product of the tetrasubstituted imidazole 
formation. 
 
First, different solvents or solvent mixtures were evaluated, since handling of 
solids in this type of microreactor is disfavoured. Thus, the maximal 
concentration of the reagents was dictated by the solubility of NH4OAc in the 
reaction solvents, since this was in general the least soluble reactant. The 
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relative ratios of the reactants were based on the reaction procedure described 
for the microwave-assisted modified Radziszewski imidazole formation.[29] 
Since only two inlets are available in the microreactor system, reactants were 
pre-mixed pair-wise before entering the microreactor. In order to avoid imine 
formation in advance, which seems essential to the reaction mechanisms, 
benzil 8a and isobutyraldehyde 1g were supplied simultaneously via one inlet, 
while benzylamine 9a and ammonium acetate were added simultaneously via 
the other inlet. 
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Scheme 3.8: A proposed mechanism of the 4-CR imidazole synthesis. 
 
Table 3.9 shows the results of this first screening. It must be emphasised that 
the maximum reaction temperature in a given solvent needs to be 10 °C 
below the boiling point of the reaction mixture. Otherwise, gas-bubble 
formation in the system occurs, resulting in unequal residence times. Based 
on the literature methods,[30,313,318] first acetic acid was chosen as the solvent. 
Entry 1 shows little conversion and mainly the starting products benzil 8a and 
benzylamine 9a were recuperated. Only an experiment at 50 °C was evaluated 
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since corrosive effects of HOAc to the stainless steel material of the 
microreactor could not be fully excluded.12 
 
Table 3.9: Distribution of the end products during the screening for the 
appropriate solvent.a 
Entry Solvent T (°C) 
Starting material 
8a (%)b 
11f 
(%)b 
11’d 
(%)b 
Selectivity 
(%) Other (%)
b 
1 HOAc 50 46 10 0 100 26f, 12g 
2c,d DMF/ n-butanol 90 26 28 13 68 13
h, 4i 
3c,d DMF/ n-butanol 100 23 34 20 63 11
h, 4i 
4c,d DMF/ n-butanol 120 11 39 28 58 10
h, 2i 
5d,j,k DMF/ n-butanol 120 25 30 17 64 11
h, 4 g, 4i 
6c DMSO 140 5 29 34 46 6g, 15i 
7c DSMO 160 9 25 39 39 8g, 3i 
8c DMSO 160 2 21 30 41 31g, 13i 
9e DMSO 160 5 26 34 43 27g 
10d,e DMF/ n-butanol 90 28 48 4 92 4
h, 3i 
a Residence time: 118 min; inlet A: 0.5 M of benzil and 0.5 M of isobutyraldehyde; inlet B: 
0.5 M of ammonium acetate and 0.6 M of benzylamine. b Based on the crude reaction 
mixture after GC analysis. c 2 equiv of acetic acid. d Products of inlet A are dissolved in 
DMF and products of inlet B in n-butanol. e 10 equiv of acetic acid. f Benzylamine. g 
Unidentified product(s). h N-benzylformamide. i N-(benzylidene) benzylamine. j 4 equiv 
of acetic acid. k Use of imine instead of aldehyde and amine. 
 
Then, higher boiling solvents were tested: n-butanol (bp = 116-118 °C), DMF 
(bp = 153 °C) and DMSO (bp = 189 °C). Because benzil 8a does not 
dissolve in n-butanol and NH4OAc does not dissolve in DMF, a mixture of 
these solvents was evaluated. Moreover, it is known that, compared to 
methanol as the solvent, n-butanol and also ethanol have a positive effect on 
                                        
12 This was based on the chemical resistance chart of the CYTOS® College System provided by CPC - Cellular 
Process Chemistry Systems GmbH. 
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the formation of some imidazoles starting from glyoxal instead of an α-
diketone.[319] 
 
Using the solvent systems n-butanol/DMF or DMSO, the effect of the 
temperature on the conversion was studied (Table 3.9, entries 2-4, 6 and 7). 
While at 90 °C there is still 26 % of benzil in the reaction mixture, an increase 
of the temperature to 140 °C shows only 5 % of benzil after 2 h of reaction. 
A problem occurring in both solvent systems, is the lack of selectivity and a 
tendency towards the formation of trisubstituted imidazole 11’d (no 
substituent on the nitrogen) was observed. This tendency was even stronger 
when DMSO was used as the solvent. Although previously stated that the 
working temperature has to be 10 °C lower than the boiling point of the 
solvent, one experiment was done near the boiling point temperature of n-
butanol (entry 4). In this experiment, a PRV was placed at the outlet of the 
microreactor in order to increase the boiling point of the solvent. It was 
observed that using a PRV in combination with the low flow rate of the 
pumps (in this case: 0.2 mL/min.pump), the residence time was not 
maintained. In order to keep the residence time constant, experiments with 
the PRV were done at higher flow rates, in combination with a stopped-flow 
regime. In this experiment, a little increase in conversion was observed. 
However, because the used pumps were not able to handle an increased 
pressure continuously and because there was only little increase in conversion, 
no further experiments were performed using this setup. 
 
Since using acetic acid as the solvent (Table 3.9, entry 1) gave no 
trisubstituted imidazole 11’d, it was thought that increasing the amount of 
acetic acid in the reaction mixture would be advantageous towards selectivity. 
Some experiments were repeated but now with a higher amount of acetic acid, 
i.e. 10 equivalents instead of 2 equivalents. When these conditions were 
applied using the DMF/n-butanol mixture (e.g. compare entries 2 and 10 of 
Table 3.9) it was shown that a fivefold increase of the acetic acid 
concentration gave a sixfold increase in selectivity towards the desired 
tetrasubstituted imidazole product. The GC-analysis of the crude reaction 
mixtures shows clearly the effect on the selectivity (Figure 3.17). This effect 
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on selectivity was already observed at a slight increase of acetic acid (entry 5). 
An excess of ten equivalents was therefore used for further optimisation. 
When the same experiment was conducted in DMSO, no selectivity increase 
occurred however (entry 7 and 9), which meant that besides the acid increase, 
also the solvent plays an important role in the selectivity issue. In one 
experiment, the order of mixing was changed: the α-diketone was combined 
with ammonium acetate, while the amine and the aldehyde were mixed 
together (entry 8). As a result, a higher amount of side-product formation was 
observed and the selectivity stayed the same. Further experiments focussed 
on the mixture of the aldehyde and the α-diketone. 
 
 
Figure 3.17: GC-analysis showing the effect of the amount of acetic acid on 
the selectivity towards tetrasubstituted imidazoles (Left: 2 equiv, Right: 10 
equiv, A = N-benzylformamide, B = N-(benzylidene)benzylamine, C = benzil, 
D = trisubstituted imidazole, E = tetrasubstituted imidazole). 
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Table 3.10: Distribution of the end products of the imidazole MCR during 
temperature optimisation.a 
Entry Solventb T (°C) 
Starting 
material 8a 
(%)c 
11f 
(%)c 
11’d 
(%)c
Selectivity 
(%) 
Other 
(%)c 
1 DMF/ n-butanol 90 28 48 4 92 4
f, 3g 
2j DMF/ n-butanol 90 42 32 3 91 5
f, 4g, 5h 
3d DMF/ n-butanol 90 16 53 6 90 11
f, 6h 
4 
NMP/ 
n-pentanol 120 10 79 6 93 5
h 
5d NMP/ n-pentanol 120 6 75 7 91 4
h, 6i 
6e NMP/ n-pentanol 115-135 11 65 5 93 6
i 
7 NMP/ n-hexanol 130 11 74 1 99 6
i 
8 NMP/ n-hexanol 140 8 72 5 94 9
i 
9 NMP/ n-octanol 160 11 54 7 89 13
i 
a Residence time: 118 min; inlet A: 0.5 M of benzil, 0.5 M of isobutyraldehyde and 2.5 M 
of acetic acid; inlet B: 0.5 M of ammonium acetate, 0.6 M of benzylamine and 2.5 M of 
acetic acid. b Products of inlet A are dissolved in DMF or NMP and products of inlet B in 
the primary alcohol. c Based on the crude reaction mixture after GC analysis. d fivefold 
residence time i.e. 9 h 50 min. e Batch procedure (vide infra, § 4.4.1). f N-benzylformamide. 
g N-(benzylidene)benzylamine. h Unidentified product(s). i N-benzylacetamide. j Use of 
imine instead of aldehyde and amine. 
 
Table 3.9 and 3.10 also give the major side-products, in addition to the 
trisubstituted imidazole. Some of the side-products were identified via GC-MS 
analysis. In the case of the DMF/n-butanol mixture, N-benzylformamide was 
detected which is formed from benzylamine and DMF. N-
(benzylidene)benzylamine was also frequently detected but the origin of this 
product is unclear. Probably the benzil was decomposed to benzaldehyde, 
which in turn was then converted to the imine. Literature procedures of a 
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photochemical,[320] an electrochemical[321] or a thermal acid-catalysed[322] 
decomposition of benzil are known. Moreover, in the thermal acid-catalysed 
procedure, an influence of the reactor wall on the decomposition was 
observed.[323] The use of a stainless steel reactor resulted in approximately 
25 % of single ring decomposition products, such as benzaldehyde.[322] In a 
quartz-walled reactor, no single ring decomposition products, but only 
rearrangement products (consisting of 2 aromatic rings) were observed. The 
difference was attributed to Ni-catalysis in the stainless steel reactor.[323] Thus, 
since our experiments were also done under acid-catalysed thermal conditions 
in a stainless steel microreactor, it is possible that the benzil is also 
decomposed under our experimental conditions.  
 
Because there was a clear temperature effect on the conversion (entries 2-4, 6 
and 7 of Table 3.9) and there was still a lot of starting material left in the 
reaction mixture, attempts were made to increase the conversion by 
increasing the temperature further. As a consequence, another solvent 
mixture was required since the boiling temperature of n-butanol is 117 °C. 
DMF was replaced by NMP (bp = 202 °C) and n-butanol was replaced by 
either n-pentanol (bp = 136-138 °C), n-hexanol (bp = 156-157 °C) or n-
octanol (bp = 196 °C), depending on the reaction temperature investigated 
(Table 3.10).  
 
From entry 4 in Table 3.10 it becomes clear that an increase in the 
temperature of 30 °C leads to a remarkable increase of the conversion and a 
shift towards the desired imidazole. Additional increase in temperature did 
not improve the conversion further (entries 7-9). Entries 3 and 5 are the 
results of a stopped-flow experiment. The residence time, and thus the 
reaction time, is increased by pausing the pumps at regular time intervals. In 
contrast to the Baylis-Hillman reaction, no or little differences occur when 
there is a fivefold increase of the reaction time. After two hours, no 
significant change of the conversion was observed in this MCR even under 
extensively extended reaction times, although there was still some α-diketone 
left in the reaction mixture. This presence of remaining α-diketone is evident, 
because formation of the trisubstituted side-product consumes two 
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equivalents of ammonium acetate. As a consequence, as long as there is no 
complete selectivity towards the tetrasubstituted imidazole, there is not 
enough ammonium acetate left to allow all the starting α-diketone to react. 
This was confirmed by a similar batch reaction were at different times a 
sample was taken and analysed by GC. Figure 3.18 shows these results. 
Comparing the results of the batch reaction after two hours with the 
microreactor reaction under similar conditions shows that the conversion is 
better in the microreactor system (Table 3.10, entries 4 and 6). The batch 
procedure was performed on 0.05 mol of benzil. Figure 3.18 shows that this 
gave 65 % conversion to the product after 2 h (equal to the residence time in 
the microreactor). Further increase was small (20 h: 67 %; 68 h: 71 %). At the 
given concentration (vide infra, § 4.4.1), the microreactor delivers 0.05 mol of 
benzil in 8 h 20 min with a conversion to the imidazole of 79 %. It must be 
emphasised that it was possible to stabilise the temperature in the 
microreactor on 120 °C, while in the batch procedure there was a constant 
fluctuation between 115 and 130 °C observed during the reaction, although a 
temperature control system was used. 
Some experiments were performed starting from an equimolar amount of 
preformed imine instead of the aldehyde and an excess of amine. Although 
otherwise expected, both results of this 3-CR showed a lower conversion 
compared with the equivalent 4-CR (Table 3.9, entries 4 and 5; Table 3.10, 
entries 1 and 2). 
 
Table 3.11: Final modification towards optimised production of tri- and 
tetrasubstituted imidazoles.a 
Entry Benzil (equiv) 
NH4OAc 
(equiv) 
Starting material 
8a (%)b 
11f 
(%)b 
11’d 
(%)b 
Selectivity 
(%) 
Other 
(%)b 
1 1 1 10 79 6 93 5d 
2 1 1 3 75 7 91 4e 
3 0.9 1 9 69 7 91 5e, 2f 
4 1 2 20 0 67 -- 7d 
a Residence time: 118 min; temperature: 120 °C; inlet A: 0,5 M of isobutyraldehyde, benzil 
and 2.5 M of acetic acid in NMP; inlet B: ammonium acetate, 0.6 M benzylamine and 2.5 
M of acetic acid in n-pentanol. b Based on the crude reaction mixture after GC analysis. c 
Without benzylamine. d Unidentified product(s). e N-benzylacetamide. f N-(benzylidene) 
benzylamine. 
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In a final attempt to force the reaction to completion, a slight excess of all the 
reagents compared to benzil 8a was used. Next to the selectivity problem, it 
was also thought that the low boiling isobutyraldehyde was partially lost due 
to the high reaction temperature, although no bubble formation was observed 
at first sight. As shown in Table 3.11, entry 3, this gave no improvement of 
the conversion. On the contrary, less of the desired imidazole was formed. 
Entry 2 is an experiment under the same reaction conditions as entry 1 and 
proves that the reaction is reproducible. Also, a reaction without benzylamine 
9a but with two equivalents of NH4OAc was performed. This shows that the 
reaction conditions are also applicable to produce the corresponding 
trisubstituted imidazoles (entry 4). An important side-product that is formed 
in the NMP/alcohol mixture is N-benzylacetamide (see Tables 3.10 and 3.11), 
which is formed from benzylamine and acetic acid.[324]  
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Figure 3.18: Course of the conversion towards the tetrasubstituted imidazole 
11f using conventional batch conditions. 
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3.3.3 Generality of the optimised reaction 
 
With the optimised conditions known, a variety of α-diketones 8, primary 
amines 9 and aldehydes 1 were tested in order to demonstrate the general 
applicability of microreactor technology to this MCR. The results are 
summarised in Table 3.12. The yields of the imidazoles, obtained by using the 
microreactor technology, were compared with those obtained by the 
microwave-assisted multicomponent reaction reported earlier.[29] The 
combination with isobutyraldehyde resulted in similar conversions for the 
microreactor reaction as compared to the microwave-assisted reaction (entries 
3, 5, 6 and 8), while in the case of benzaldehyde generally lower conversions 
were noticed for the microreactor method (entries 1, 2 and 9). One major 
exception is found in entry 7, in which the conversion is almost doubled, 
compared to the microwave reaction.  
 
The regioselectivity in entry 8 and 9 proved to be quite similar as in the 
microwave assisted reaction, with a preference for incorporation of the 
phenyl group next to the substituted nitrogen. For entry 8, the ratio for 
R1(Me:Ph) = 4.6 (compared to 4.0 in reference [29]) and for entry 9, 
R1(Me:Ph) = 5.2 (compared to 4.2 in reference [29]). The ratios were 
determined via the crude reaction mixture in GC and GC-MS. The structures 
of the different regioisomers were characterised by NOE-analysis. As an 
example, the Nuclear Overhauser Effects for both regioisomers of compound 
11h are given in Figure 3.19. By irradiating the CH2 of the benzylic group on 
the 1-position of the imidazole, only in the minor compound, an effect on the 
methyl group is seen, which proves that in the minor fraction the methyl 
group is on the 5-position. The microreactor technology is able to generate a 
variety of imidazoles in moderate to good yields with a throughput between 
5.5 and 39.5 g/day depending on the imidazole. Since no purified yields were 
mentioned in the microwave-assisted reaction, no comparisons on the 
isolated yields can be made (although the work up is analogous in both 
setups). The main advantage of the microreactor procedure is the possibility 
for multigram-scale production of these highly substituted imidazoles. While 
microwave-assisted reactions are batch procedures mostly on a small scale, 
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although recently some continuous procedures are developed,[129-132,325] the 
microreactor now allows to produce these imidazoles in a continuous way. 
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Figure 3.19: Results of the NOE experiments (in percentage) after irradiation 
of the benzylic CH2. 
 
3.3.4 Conclusions 
 
In conclusion, it was possible to optimise the four-component condensation 
towards tri- and tetrasubstituted imidazoles using a microreactor procedure. 
Using a modified solvent system of NMP/n-pentanol (v/v 1:1) at 120 °C, and 
a 1:1:1:1.2:10 ratio of α-diketone 8, aldehyde 1, ammonium acetate, primary 
amine 9 and acetic acid, respectively, with a final concentration of 0.25 M of 
the α-diketone in the microreactor, a variety of imidazoles was produced. The 
use of acetic acid was essential to increase the selectivity towards the 
tetrasubstituted imidazoles. However, due to the formation of side-products, 
still a purification step using flash chromatography was necessary, which was 
the major drawback of this continuous procedure. It was possible to obtain a 
throughput of up to 40 g imidazole a day. 
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Table 3.12: General production of tri- and tetrasubstituted imidazoles.a 
N
NR
2
R1
R3
R4
11  (R3 = H)
11' (R3 = H)
_
 
Entry R1/R2 R3 R4 Product
Conversion (%) 
Selectivity (%) Yield (%)c Throughput (g/day) 
11 11’ [29]b 
1 Me H Ph 11’a -- 64d 83 -- 29 7.2 
2 Me i-Pr Ph 11b 39d nd 61 100 18 5.5 
3 Me Bn i-Pr 11c 67e 7e 66 91 47 15.4 
4 Ph H i-Pr 11’d -- 71f 85 -- 46 17.4 
5 Ph i-Pr i-Pr 11e 62f 10f 65 86 37 16.2 
6 Ph Bn i-Pr 11f 85f 8f 90 91 78 39.5 
7 Ph Ph Ph 11g 49f 18f 30 73 48 25.7 
8 Me/Ph Bn i-Pr 11h 89f nd 84 100 47 19.6 
9 Me/Ph Ph Ph 11i 38f 8f 73 83 24 10.7 
--: Not applicable. nd: No trisubstituted imidazole detected. a General conditions: residence time: 118 min; temperature: 120 °C; inlet A: 
0.5 M of α-diketone, 0.5 M of aldehyde and 2.5 M of acetic acid in NMP; inlet B: 0.5 M of ammonium acetate, 0.6 M of amine and 2.5 M 
of acetic acid in n-pentanol. b Conversion based on the MCR under microwave conditions. c After purification via flash chromatography. 
d,e,f Conversion based on analysis of crude reaction mixture in GC and GC-MS: calculated on residual aldehyde,d aminee or α-diketonef. 
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3.4 α-AMINOPHOSPHONATE SYNTHESIS 
3.4.1 Introduction 
 
α-Aminophosphonates are considered as important compounds, with several 
biological activities[35-37] due to their structural analogy with the corresponding 
α-amino acids. The most important example is glyphosate. Traditionally, α-
aminophosphonates can be formed via two pathways. The most interesting 
reaction pathway is via a three-component reaction in which an aldehyde, an 
amine and a di- or trialkyl phosphite react together in a one-pot setup. This 
method is better known as the Kabachnik-Fields reaction.[326,327] However, 
this procedure suffers from moderate yields and a limited scope. A second 
method, known as the Pudovik reaction, starts initially from the preformed 
imine.[328-330] In fact, this is a two-stage process, in which the dialkyl phosphite 
is added to the imine in the second step. Both methods are very well 
investigated, both from a mechanistic point of view[326,327,331] as well as 
towards optimisation studies[332,333]. Mostly, the use of catalysts is necessary 
for the 3-CR.[334-339] However, in 1952 Fields already produced α-
aminophosphonates under solvent and catalyst free conditions.[340,341] 
For the optimisation of α-aminophosphonate formation under microreactor 
conditions, we initially started from the Fields’ procedure which was modified 
to be suitable for the microreactor setup. 
 
3.4.2 Optimisation study using microreactor technology 
 
The aldimines used in this study were synthesised by treatment of the 
aldehyde with a primary amine in dichloromethane in the presence of 
anhydrous magnesium sulfate. After filtration and evaporation, the imines 
were isolated in almost quantitative yields. Fields’ two-component reaction is 
fast, high-yielding and moreover has a 100 % atom efficiency.[340] Since the 
microreactor has two inlets, this reaction seemed applicable to switch to a 
continuous process, except for the solvent-free conditions. Because of the 
high viscosities of the end products and the risk of crystallisation (the end 
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products were mainly crystalline), a solvent is needed to switch to a 
microreactor synthesis, in order to prevent clogging of the capillary tubes. 
Therefore, the initial step concerned the selection of an appropriate solvent in 
which the reaction proceeds rapidly since the maximum residence time of the 
microreactor utilised is approximately two hours. Complete conversion is 
required in this time in order to prevent laborious separation of the end 
product and reagents. The benzylidene-isopropylamine 12a was used for 
optimisation of the reaction conditions (Scheme 3.9). 
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14a12a
H
N
HP(O)(OMe)2
P(OMe)2
HN
O
 
Scheme 3.9: Formation of α-aminophosphonate 14a starting from the 
preformed imine. 
 
In literature, the most common solvent utilised for this type of addition is 
dichloromethane. This solvent gave, however, unsatisfactory results as 
compared to the solvent-free conditions (Table 3.13). The reaction proceeded 
much slower and moreover, the reaction did not go to completion. When 
other solvents (acetonitrile, diethyl ether, methanol[342] and toluene[343]) were 
screened, methanol seemed to give the fastest reaction, without formation of 
any side-products. Diethyl ether gave almost no reaction and acetonitrile 
resulted in the formation of side-products. Toluene provided reasonable 
results while MeOH obviously was the solvent of choice. Under batch 
conditions, four hours of reflux in methanol, which still is longer than the 
maximal residence time of the microreactor, still left 6 % of starting imine in 
the reaction mixture. 
 
Monitoring the reaction by 31P-NMR, a dramatic drop of the reaction rate 
was noticed at the end of the reaction when reagents become limiting. 
Therefore, two equivalents of phosphite were used, decreasing the reaction 
time considerably to 80 min with 100 % conversion, which was now below 
the residence time of the microreactor. Distilling the excess of phosphite 
Results and Discussion 
- 96 - 
from the reaction mixture was not successful, resulting in a partially 
breakdown of the product. Moreover, it proved to be hard to remove the 
excess phosphite completely. Finally, an acid base-extraction after evaporation 
of the methanol in vacuo resulted in the total removal of the phosphite and the 
α-aminophosphonate 14a was recovered in high yield (94 %). 
 
Table 3.13: Solvent optimisation in the batch formation of α-
aminophosphonate 14a. 
Entry Solvent Conversion after 1.5 h (mol %)a 
Conversion after 22 h 
(mol %)a 
1 Neat 91 -- 
2 Dichloromethane 2 73 
3 Acetonitrile 14 58b 
4 Diethyl ether 1 32 
5 Methanol 90 94c 
6 Toluene 76 95 
--: Not determined. a Determined by 31P-NMR. b Formation of side-products. c No 
change after 3.5 h. 
 
The reaction was further tested to a variety of aldehydes, amines and 
phosphites and seemed to be generally applicable (74-97 % yield).[38] Only in 
the case of diisopropyl phosphite, somewhat lower yields were observed. The 
reaction was further tested using purified methanol and dialkyl phosphite, to 
check the need for acid catalysis. During mechanistic studies, it was suggested 
that acid catalysis via a small degree of hydrolysis of phosphite reagent 
occurred.[344] However, yields and purities were comparable with previous 
experiments, which proved that no acid catalysis was necessary. In further 
experiments, no purification of the reagents was done. 
 
The next step of the research comprised the evaluation of the α-
aminophosphonate synthesis in the microreactor. Therefore, reaction 
parameters such as the residence time, the amount of phosphite, the 
temperature and the concentration have been varied. There are, however, 
some restrictions concerning the temperature and the concentration. The 
reaction temperature is limited by the boiling point of the solvent in order to 
avoid cavitation effects in the reactor which gives undeterminable residence 
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times and uncontrollable reaction conditions. The concentration on the other 
hand is limited in order to prevent crystallisation of the end product which 
could cause clogging of the capillary tubes. 
 
First, the optimised batch conditions were tested (Table 3.14, entry 1), which 
resulted in a complete conversion and a comparable yield. Entries 2 to 4 show 
attempts to diminish the amount of phosphite. However, no complete 
conversion could be achieved, even when higher residence times were applied. 
When a higher concentration was applied in the reactor, a higher production 
rate of α-aminophosphonate could be achieved with less solvent consumption. 
However, increasing the concentration to 40 mass% resulted in incomplete 
conversion, whereas a 20 mass% concentration seemed to be optimal (entries 
5 and 6). In the case of 40 mass% imine, this meant an input concentration of 
the imine of 80 mass% (or 0.875 mL/mL). The dialkyl phosphite input was a 
neat solution. A possible explanation of the lower conversion is that the 
higher viscosity diminishes the diffusion process which is an important 
feature in the small channels of the microreactor. Also the flow was doubled 
to study this influence (entry 7), but this resulted also in incomplete 
conversion. 
 
Because of the low boiling point of methanol, it was difficult to increase the 
temperature. As an alternative, higher alcohols were tested as a solvent in 
order to evaluate the influence of the temperature (entries 8-11) and to obtain 
lower residence times for a higher output. With n-butanol as a solvent, the 
residence time could be diminished to 26 minutes with 100 % conversion, but 
due to transesterification side-products were formed. Analysing the 31P NMR 
spectrum of entry 8 showed 3 peaks in the dialkyl phosphite region (δ = 11.1 
(59 %), 9.8 (37 %) and 8.4 (4 %) ppm) and 3 peaks in the α-
aminophosphonate region (δ = 26.8 (91 %), 25.7 (6 %) and 24.2 (3 %) ppm). 
The main peaks were the dimethyl phosphite and the desired α-
aminophosphonate, respectively. The peak at 8.4 ppm accounted for di-n-
butyl phosphite, which proved that some transesterification of the phosphite 
occurred during the reaction. In literature, the 31P shift between dimethyl and 
di-n-butyl (N-benzyloxycarbonylamino)(4-nitrophenyl)-methylphosphonate 
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was 2.5 ppm.[345] Related compounds showed a similar shift. The 31P peak of 
the n-butyl methyl compound was found between the other two peaks.[346] 
Based on these findings, it was assumed that the other 2 products formed 
were the α-aminophosphonates with the different alkyl chains. Decreasing the 
reaction time did not result in a loss of the side-products. About 9 to 12 % of 
the conversion resulted in the transesterified side-products. Since the goal was 
to obtain only the dimethyl α-aminophosphonate, further experiments were 
performed to optimise the procedure. It must be emphasised however that, if 
the alkyl substituent on the phosphorus does not matter (e.g. if the product is 
hydrolysed in a further step), it is possible to use these conditions and thus 
obtain higher throughputs. In a final optimisation experiment, a switch was 
made to sec-butanol, because it was believed to reduce the transesterification 
due to a higher steric hindrance. Unfortunately, in this case even more 
transesterification was observed (there was 100 % conversion, but only 82 % 
was converted to the dimethyl α-aminophosphonate). 
 
Table 3.14: Optimisation of the α-aminophosphonate 14a formation in the 
microreactor. 
Entry 
Mass 
% in 
MR 
Residence 
time (min) Solvent 
T 
(°C)
Dimethyl 
phosphite 
(equiv) 
Conversion 
(mol %) 
Yield 
(%)a 
1 10 78 MeOH 50 2 100 85 
2 10 78 MeOH 50 1.5 94 83 
3 10 78 MeOH 50 1.6 94 82 
4 10 78 MeOH 50 1.75 95 89 
5 20 78 MeOH 50 2 100 82 
6 40 78 MeOH 50 2 67 24 
7 10 44 MeOH 50 2 93 83 
8 10 44 n-BuOH 100 2 100 b 
9 10 26 n-BuOH 100 2 100 b 
10 10 17 n-BuOH 100 2 94 b 
11 10 26 sec-BuOH 85 2 100 b 
a Yield after acid base extraction. b Side-products due to transesterification. 
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3.4.3 Generality of the procedure 
 
Again the generality of this method was investigated by varying the amine and 
the aldehyde. As can be seen in Table 3.15, the continuous process allowed us 
to synthesise more than 10 grams α-aminophosphonate per hour (or more 
then 250 g per day) without having the risk of handling big amounts of 
unpleasant chemicals in the lab. Several derivatives can be produced without 
alteration of the method, simply by switching of the aldimine. 
 
Table 3.15: Continuous synthesis of different α-aminophosphonates under 
optimised conditions in the microreactor.a 
Entry Product R1 R2 R3 Yield (%) Throughput (g/day)
1 14a Ph i-Pr Me 82 247.2 
2 14b 2-phenylethenyl i-Pr Me 91 256.8 
3 14c c-Hex i-Pr Me 78 232.8 
4 14d i-Pr Bn Me 68 196.8 
5 14e 2-furyl allyl Me 72 225.6 
a Conditions: 20 mass% imine, 2 equiv phosphite, residence time of 78 min. 
 
3.4.4 Switch to the 3-CR 
 
In a second stage, attempts were made to perform the three-component 
reaction in a microreactor setup (Scheme 3.10). In preliminary studies, it was 
already seen that aldimine formation was possible in the given residence time 
range. The results of these experiments are listed in Table 3.16. A first 
experiment was based on the optimised conditions of the Pudovik type 
reaction (Table 3.16, entry 1). In order to prevent as much as possible the 
competition between the phosphite addition to the aldehyde and to the imine, 
the phosphite was always mixed with the amine. Secondly, the amounts of 
aldehyde and amine were calculated to obtain 20 mass% imine in the 
microreactor, which is the same as in the optimised procedure. The molar 
aldehyde/amine ratio was 1:1. Investigating the crude reaction mixture of the 
first experiment by 1H NMR showed that no benzaldehyde or imine was left. 
In the 31P spectrum, 4 peaks were observed, of which one was the excess of 
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dimethyl phosphite. The peak at 26.9 ppm was the α-aminophosphonate. 
Another peak (δ = 24.4 ppm) appeared to be the dimethyl-
(phenylhydroxymethyl)phosphonate 121.[347,348] Based on both spectra, a ratio 
of 35:65 in disfavour of the α-aminophosphonate was calculated. After acid 
base extraction, about 20 % of the α-aminophosphonate was retained. The 
fourth peak in the 31P spectrum at 6.6 ppm remained unclear. To further 
improve the outcome of the reaction, an orthoester was added in an 
equimolar amount. It was believed that the orthoester could promote the 
imine formation by capturing the water and thus promoting the addition of 
phosphite to the imine instead of to the aldehyde. An increase of the yield 
was observed, which became bigger with longer reaction times. Unfortunately, 
a maximum yield of 49 % was obtained. The crude spectrum of entry 3 still 
showed the formation of the side-product 121. However, the ratio was 
increased to 83:17, which shows that the addition of the orthoester indeed 
promotes the imine formation. 
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Scheme 3.10: The α-aminophosphonate 3-CR. 
 
Table 3.16: The 3-CR reaction with formation of α-aminophosphonates in the 
microreactor.a 
Entry Residence time (min) Solvent 
T 
(°C)
Dialkyl 
phosphite 
Trialkyl 
orthoformate 
Yield 
(%)b 
1 78 MeOH 50 Me No 20 
2 78 MeOH 50 Me Yes (Me) 39 
3 118 MeOH 50 Me Yes (Me) 49 
4 118 EtOH (96 %) 70 Et Yes (Et) 48 
5 118 EtOH (abs) 70 Et Yes (Et) 28 
a Conditions: 20 mass% aldehyde and amine, 2 equiv phosphite. b Yield after acid base 
extraction. 
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Final attempts were made to increase the yield by using ethanol to work at 
higher temperatures (entry 4 and 5). In order to prevent the transesterification 
observed in previous experiments, diethyl phosphite and triethyl 
orthoformate were used instead of the dimethylated products. While in 
previous cases no imine was observed anymore, in these experiments, about 
10 mol% imine was not converted to the α-aminophosphonate. Also in this 
case, the addition side-product was observed. Strangely, working with 
absolute ethanol gave even the worst results.    
 
3.4.5 Conclusions 
 
Based on a known procedure in batch conditions, the two-component 
reaction between an imine (that was formed in batch conditions) and 
phosphite was evaluated for working under microreactor conditions. After 
some optimisation steps, of which the solvent optimisation was the most 
important, it was possible to produce several α-aminophosphonates with an 
outcome that was higher than 190 g/day. A further conversion of the 
sequential batch imine formation and the continuous phosphite addition 
towards a three-component Kabachnik-Field reaction failed due to a 
combination of low conversions and a lack of selectivity towards the α-
aminophosphonate. 
 
Results and Discussion 
- 102 - 
3.5 ISOCHROMENONE SYNTHESIS 
3.5.1 Introduction 
 
An interesting MCR recently described the production of 3-amino-4-
(arylamino)-1H-isochromen-1-ones 17 (Scheme 3.11). This type of 
isocoumarin is of great interest due to the possibility of forming base pairs 
with guanine due to the ‘donor-acceptor’ similarity with cytosine.[39] 
Unfortunately, the reaction proceeds via a modified Strecker reaction, in 
which the highly toxic hydrogen cyanide is needed. In order to avoid large 
quantities of HCN, the idea of using microreactor technology for the 
production of this isochromen-1-one was proposed. In the past, specialised 
microreactor systems were already assembled to synthesise HCN via the 
Andrussov process, an industrial process to produce large quantities of HCN 
by reacting methane and ammonia in the presence of oxygen (vide supra, § 
2.4.3).[40,349] Until now, there is no literature known about the in situ 
production of HCN in a microreactor system for further reaction in the 
microreactor.  
 
The MCR to form the 3-amino-4-(arylamino)-1H-isochromen-1-ones 17 
consists of a Strecker reaction-intramolecular nucleophilic addition-
tautomerisation sequence. First, the cyanide anion is added to the imine 122, 
followed by an attack of the carboxy group onto the nitrile to form an O-acyl 
imidate 124. This compound tautomerises towards the final structure 17. The 
in situ generation of the hydrogen cyanide results from the addition of acetic 
acid to potassium cyanide.  
 
3.5.2 Optimisation study using microreactor technology 
 
As stated in earlier chapters, the optimisation of a reaction under 
microreactor conditions always contains a number of important steps: the 
order of mixing of the starting materials, the residence time (flow rate), the 
concentration of the reagents and the solvent choice are of major importance 
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to get a good production of the desired compound. Table 3.17 summarises 
the results of this optimisation.  
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Scheme 3.11: Mechanism of the 3,4-diamino-1H-isochromen-1-ones 17 
formation. 
 
A primary experiment was based on the reaction conditions provided by 
Opatz and Ferenc (Table 3.17, entry 1).[39] Some changes had to be made, 
however, to fit the microreactor setup: 
 
1. The reaction temperature was lowered from 65 to 50 °C, since 
temperatures approaching the boiling point of the solvent (less than 10 °C 
under the boiling point) provide irregular residence times due to partial 
evaporation of the solvent (in this case methanol). 
2. The concentration of the reagents in the microreactor was lowered by 
50 % due to the limited solubility of KCN (the maximum solubility of KCN 
in methanol at room temperature is approximately 0.48 M). Moreover, other 
solvents could not be used because of the low solubility of KCN in these 
solvents. 
3. The maximum residence time of the system (approximately 2 h) was 
used instead of 3 h. For safety reasons and in order to generate HCN only in 
situ, the potassium cyanide and the acetic acid were pumped separately into 
the microreactor. 
Results and Discussion 
- 104 - 
Table 3.17: Optimisation of the production of 3-amino-4-(arylamino)-1H-
isochromen-1-ones 17 under microreactor conditions.a 
H
O
OH
O
1.2 equiv KCN 16, 2 equiv HOAc
2 equiv RNH2 9 (R = aryl)
NH
O
O
NH2
MeOH, 50 °C
15 17
R
 
Entry Residence time (min) Concentration of 15 (M)b Yield (%)
c Output (g/day) 
1 118 0.2 Cloggingd -- 
2 118 0.15 Clogging -- 
3 118 0.1 67 9.8 
4 39.2 0.2 Clogging -- 
5 39.2 0.15 43-66 28.1-43.2 
6e 29.3 0.2 49 56.9 
7 19.6 0.2 46-54 80.2-94.1 
8f 5 0.2 48 13.9 
9f 0.83 0.2 51 88.8 
--: Not applicable. a Temperature: 50 °C; inlet A: 2-formyl benzoic acid and 2 equiv acetic 
acid in methanol; inlet B: 1.2 equiv potassium cyanide and 2 equiv amine in methanol; the 
residence time was calculated according to equation (4.1). b Concentration of the reagents 
in the reactor. c After crystallisation. d By ‘clogging’ the formation of crystals in the tubes 
and the subsequent blockage of the tubes is indicated. e Partial clogging occurred after the 
first sample. f The sample was taken at the end of the microreactor. 
 
This experiment gave no good results because crystals of the end product 
were formed in the tubing at the end of the reactor which led to clogging of 
the system. Since the crystallisation only occurred at the end of the tubing, it 
can be explained by a combination of a high product concentration and a 
saturation effect. Because the microreactor output was flushed with nitrogen 
for safety reasons (removal of traces of HCN), the solvent was partially 
removed at the end of the system due to evaporation. This initiated 
crystallisation due to saturation and led after some time to crystals appearing 
everywhere in the end tubing. In an attempt to solve this problem, the setup 
was changed by submerging the end tubing in the solvent with or without the 
use of an ultrasound bath to prevent nucleation in the tube. Both alternatives 
appeared to be insufficient, although putting the end tubing in the solvent 
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meant that slower crystallisation occurred. The use of ultrasound gave only 
smaller crystals: more nucleation and less growth, which seemed to be in 
accordance with the literature.[350] A decrease to a concentration of 0.10 M of 
starting material was finally enough to prevent blocking of the system (Table 
3.17, entry 3). In order to increase the amount of product produced in a 
certain time, a combination of residence time decrease and concentration 
increase was tested. In the case of 0.20 M of starting material, the residence 
time had to be lowered to one-sixth of the maximal residence time to prevent 
clogging (entry 7). A reduction to approximately 30 min gave no initial 
crystallisation in the tubing, but after a longer run, partial blocking of the 
system was observed (entry 6). Final tuning of the reaction conditions to 0.15 
M of starting material and a residence time of approximately 40 min gave a 
maximum yield of 66 % (entry 5). Although some daily outputs (g/day) were 
higher in other cases, this optimal setup was chosen because of the higher 
yields.  
 
Next to these results, a different setup was applied. Since no crystallisation 
occurred after the microreactor, a HPLC pump was installed between the 
microreactor and the RTU by means of a T-junction (Figure 3.20). Through 
this pump an immiscible perfluorated solvent, Fluorinert® FC-70, was 
introduced to the reaction flow. This method created plugs of the reaction 
mixture, which was mixed in the microreactor, separated from each other by 
the immiscible solvent, with lengths depending on the flow rates of the 
pumps.[351] Preliminary tests showed that the ratio of flow rates of the 
reaction solution and the Fluorinert® FC-70 input were of importance. Using 
a flow rate of the HPLC pump that was too high or too low gave a flow in 
the direction of the microreactor or the Fluorinert® FC-70 input respectively, 
instead of in the direction of the RTU. Indeed, during some preliminary tests, 
whereby an aqueous methylene blue solution was used instead of the reaction 
mixture, a flow in the direction of the Fluorinert® FC-70 was observed at 
flow rates of the HPLC pump lower than 0.5 mL/min, irrespective of the 
flow rate of the piston pumps (between 0.4 mL/min and 12.8 mL/min). If 
the flow rate of the HPLC pump was above 5 mL/min, a pressure built up (> 
6 bar) was observed and the pump was automatically switched off. At these 
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high flow rates, the Fluorinert® FC-70 flow was also directed to the 
microreactor, which gave these high pressures due to the pumping of the 
piston pumps in the opposite direction. 
 
 
Figure 3.20: Reaction setup of the microreactor system: (above left) normal 
setup; (middle) plug formation; (above right) adjusted setup. A = input 
reagents, B = microreactor, C = RTU, D = output reaction mixture, E = 
input Fluorinert® FC-70. 
 
Based on the research of Ismagilov and coworkers,[123,137,352] the idea was 
proposed that the immiscible solvent will drive the product further through 
the system, even if there was crystallisation in the plugs itself. Table 3.18 
shows the results of this setup. Although installation of the pump directly 
after the mixing zone of the microreactor is a better method to study the 
effect of the plug formation, this was practically impossible due to the specific 
construction of the microreactor. So it must be emphasised that already some 
reaction (but no crystallisation) takes place before the plug formation. The 
results show that the yields in this particular setup are lower than in the 
normal setup (Table 3.17, entry 5). However, it must be emphasised that, 
even at those high concentrations, no clogging was observed in the tubes. It 
was even possible to work at higher concentrations of reaction product and 
longer residence times without the problem of crystallisation in the tubing 
system (Table 3.17, entry 4 and Table 3.18, entry 1). The immiscible solvent 
forms an oily layer between the wall of the microreactor and the plug, which 
prevents the crystals accumulating on the walls of the reactor.[123,352] Figure 
3.21 shows the formation of plugs in the tubes. An additional advantage is 
Results and Discussion 
- 107 - 
that, owing to the immiscibility and, moreover, the rapid separation of the 
solvent, the quite expensive Fluorinert® FC-70 can be reused directly via a 
loop by simple separation from the reaction mixture. 
 
 
Figure 3.21: Example of the plug formation after the microreactor (blue plugs: 
aqueous methylene blue solution). 
 
From an economical point of view, Table 3.18, entry 1 provides the best 
conditions since it has the highest yield and the lowest consumption of 
Fluorinert® FC-70 (highest rmf, Equation 3.2). The reaction mixture fraction 
(rmf) is the fraction of the microreactor output that comes from the reaction 
mixture. The rmf is calculated as follows: 
 
Fluorinertmixturereaction
mixturereaction
VV
V
(-) +=rmf   (3.2) 
 
with Vreaction mixture = volume of the reaction mixture in the sample (mL) 
 VFluorinert = volume of Fluorinert® FC-70 in the sample (mL) 
 
The only disadvantage is the somewhat higher residence time which leads to a 
longer start up procedure. Due to the additional flow of the Fluorinert® FC-
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70, the residence time τ of the system was also calculated in a different 
manner, given by Equation 3.3: 
 
HPLCtotal
RTU
total
ormicroreact
rr
V
r
V(min) τ ++=  with rtotal = 2 rpiston pump (3.3) 
 
with Vmicroreactor = inner volume of the microreactor (mL) 
 VRTU = inner volume of the RTU (mL) 
 rtotal = total flow rate of the 2 piston pumps (mL/min)  
 rpiston pump = flow rate of the piston pump (mL/min) 
 rHPLC = flow rate of the HPLC pump (mL/min) 
 
Table 3.18: Production of 3-amino-4-(arylamino)-1H-isochromen-1-one 17 
under microfluidic plug flow conditions.a 
Entry Residence time (min)b 
Reaction mixture fraction 
(rmf)c Yield (%)
d Output (g/day) 
1 50 0.71 50 25.7 
2 30 0.20 42 6.2 
3 23 0.33 44 10.6 
a Temperature: 50 °C; inlet A: 0.4 M of 2-formyl benzoic acid and 0.8 M of acetic acid in 
methanol; inlet B: 0.48 M of potassium cyanide and 0.8 M of amine in methanol; the 
residence time was calculated according to Equation 3.3. b The rmf was calculated 
according to Equation 3.2. c After crystallisation. 
 
3.5.3 Safety of the procedure 
 
As mentioned in the introduction, one of the important advantages of 
microreactor technology is the possibility of using in a safe way toxic reagents 
which cannot be used in a conventional reaction setup without considerable 
safety risks. Because of the small dimensions of the microreactor (2 mL), only 
minor amounts of the toxic reagent are formed. It is obvious that there will 
always be a HCN release in the original setup due to the excess of KCN used 
in the procedure. In this particular case, it was supposed that no hydrogen 
cyanide was released at the end of the reaction setup, in the case that 
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equimolar (or lower) quantities of KCN were used. In order to test this, first a 
hydrogen cyanide spot test was used.[353,354] The colour reaction is based on 
the oxidation of 4,4”-methylenebis(N,N-dimethylaniline) 125 in the presence 
of HCN and copper ethylacetoacetate. The salts of these cations 126 formed, 
give a blue colour, while the starting base is colourless (Scheme 3.12). 
However, this test provides only qualitative results. 
 
In both the batch and the microreactor system, coloration of the reagent was 
detected in the headspace of the crude reaction mixture, which proved that 
HCN was released. The only difference between both setups was a slower 
colouration in the case of the microreactor setup. It was supposed that in the 
case of the microreactor setup, less HCN was released during the reaction 
since the cyanide had more time to react (and thus to disappear) before being 
released to the environment, while in the batch procedure there is a constant 
exposure to the air. 
 
2 CuAc2 +
N N
+ HCN
N N
N N
or Ac- +2 CuCN + 3 HAc
Ac = ethyl acetoacetate
125
126
 
Scheme 3.12: Reaction that induces a blue colour when HCN is present. 
 
Therefore, it was necessary to develop a suitable, easy and economic method 
to measure the amount of HCN that was released during the reaction. Among 
the different potentiometric, fluorescent and colorimetric procedures to 
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measure HCN, such as e.g. the use of an acridinium salt[355] or the oxidation 
of CN- to CN+,[356,357] a procedure based on the measurement of free (non-
complexed) cyanide and HCN in water solutions was used. The original 
method is a standard procedure used by the U.S. Environmental Protection 
Agency (EPA) for measuring free (non-complexed) cyanide and HCN in 
drinking water, natural surface waters, domestic and industrial wastewaters 
and in soil extracts.[358] In order to get the CN- ions in the correct form to 
quantify them (i.e. in an aqueous solution), another modification of a standard 
procedure of the EPA was applied.[359] 
To measure the output of HCN gas and also for safety reasons, the outlet of 
the RTU is set under nitrogen atmosphere. This gas solution is then put in a 1 
N NaOH solution to absorb the HCN of the system via neutralisation and 
salt formation. The final concentration of cyanide ions is then measured using 
the modified EPA method. 
The calculation of the possible theoretical minimum (due to the excess of 
HCN) and maximum (if no conversion at all to the end product is achieved) 
amount of HCN released at the end of the microreactor in the optimised 
procedure (Table 3.17, entry 5) gave values of 0.162-0.972 mg/mL (162-972 
mg/L) aqueous solution. This was based on a 25 min collection of sample at 
steady state conditions. Based on these theoretical results, it was decided to 
use the titration method and not the colorimetric method for the HCN 
measurement. This titration method is used for cyanide concentrations 
exceeding 0.1 mg/L. The titration is based on the following reaction: 
 
Ag+ + 2 CN- Æ [Ag(CN)2]- 
 
When all the CN- ions are complexed, an excess of AgNO3 gives 
complexation of the silver ions with the rhodanine indicator. This results in a 
change of colour from yellow to pink and further on to brownish-pink.   
 
To check the reliability of the modified procedure, different tests were 
performed. First of all, a solution of KCN in water or in a NaOH solution 
was made and titrated with AgNO3. This experiment was repeated 3 times 
and all the titrations gave an outcome of 99-102 % KCN. This showed that 
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the titration procedure is reliable. It must be emphasised that the colour 
change was not easily visible and some experience was necessary to detect the 
end point of the titration. 
In a second experimental setup, a solution of acetic acid in methanol was 
added slowly to KCN. The final solution was stirred for 3 h at 50 °C to 
imitate the final experimental batch setup. This was set under nitrogen 
atmosphere and the gas solution was put in a NaOH-scrubber. Titration of 
the NaOH solutions, gave 83-88 % of the theoretical maximum outcome. 
Since the titration itself gave excellent results, this meant there was no 
complete HCN conversion or some loss of HCN during the scrubbing 
procedure. The use of 50 mL of 0.25 N NaOH as a scrubber solution gave 
somewhat lower HCN capture than a solution of 125 mL of 1 N NaOH. 
Probably this was due to a tenfold higher amount of NaOH combined with a 
higher volume of scrubber solution, so there was more time and opportunity 
for the HCN in the gas to react with the NaOH. Therefore, it was decided to 
work with the second scrubber solution. Since in both batch and continuous 
experiments the same procedure for HCN capture will be used, these results 
will have no effect on the final conclusions. It only has to be stated that the 
final results will give an underestimation of approximately 15 % of the actual 
HCN release. 
 
In the microreactor procedure, different fractions were collected: the start up 
fraction (i.e. before steady state), 2 steady state fractions and the shutdown 
fraction (i.e. when the reagent solutions at the inlet are changed back to the 
solvent to clean the microreactor). Table 3.19 shows the results of the 
samples at steady state conditions. 
 
For the batch reaction, the HCN capture method was slightly modified. It 
was supposed that a continuous flow of nitrogen would flush away the HCN 
immediately, giving the cyanide no time to react with the 2-formyl benzoic 
acid 15. Therefore, the solution of 2-formyl benzoic acid, aniline and KCN in 
methanol was first put under a nitrogen atmosphere for half an hour. After 
the nitrogen flow was switched off, the acetic acid was slowly added to the 
reaction mixture by means of a syringe pump at a flow of 10 mL/h. The 
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reaction mixture was then refluxed for 3 h. Finally, the reaction mixture was 
again flushed for half an hour with nitrogen to remove the residual amount of 
HCN in the solution. The amount of HCN in the scrubber solution was 
determined in the same way as for the microreactor setup. The results are also 
given in Table 3.19.  
It can clearly be noted that there is a difference in performance between the 
batch and microreactor conditions. The amount of HCN released in the 
environment is at least 2 orders of magnitude higher in the batch reaction. 
This means that the system under microreactor conditions is much safer. 
Also, in the batch procedure there is a considerable difference in HCN release 
at the different scales as can be seen from Table 3.19. The amount of HCN 
released at the scale of 250 mL is relatively lower than the release at 25 mL. In 
this particular case, this tenfold scale up has a positive effect. This clearly 
shows that scaling up under batch conditions has an effect on the reaction 
conditions, while this is not the case under microreactor conditions. Once the 
microreactor procedure is started up, which means running at steady state 
conditions, the system constantly runs at the same conditions. A tenfold 
increase in scale (from 25 to 250 mL), e.g. by numbering up (i.e. the number 
of reactors is increased instead of the volume of the reactor) the optimised 
conditions, just means a tenfold increase in HCN release. 
 
Table 3.19: HCN release during microreactor and batch conditions. 
Scale 
(mL) 
Batch Microreactor Ratio 
(batch/micro-
reactor) 
Amount 
HCN (mg) 
% of 
theoretical 
amount 
Amount 
HCN (mg) 
% of 
theoretical 
amount 
25 17-20 14-17 0.04-0.08 0.04-0.06 213-500 
250 73 6 0.40-0.80 0.04-0.06 91-183 
 
Another interesting part of this research was the follow up of the HCN 
release during a total cycle of a continuous procedure, i.e. the start up, the 
steady state and the shutdown. In Figure 3.22, the outcome of the experiment 
is shown. This clearly shows that the start up and the shutdown of a 
continuous procedure have effects on the quality of the product outcome. As 
can be seen in the figure, there are big fluctuations in HCN release between 2 
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different experiments in the start up and shut down fraction. This is probably 
due to the non steady state conditions during these two periods, wherein the 
concentrations of the product are constantly changing. Only under steady 
state a relatively constant release of HCN is measured in one experiment and 
also between the experiments. The relative standard deviation for the steady 
state measurements is around 5 %.13  
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Figure 3.22: HCN release during a continuous microreactor cycle. 
 
3.5.4 Degradation 
 
The 3-amino-4-(arylamino)-1H-isochromen-1-one 17 appeared to be unstable 
in solution. Several solvents (chloroform, DMSO, methanol, acetone) were 
tested and led to degradation after some days. DMSO gave degradation after 
one week towards the starting product and 3-oxo-1-(arylamino)-1,3-
dihydroisobenzofuran-1-carboxamide 127 (Figure 3.23).[360] The other 
solvents gave complex mixtures of degradation products. This led to the fact 
that during the sample collection and evaporation of the solvent, a nitrogen 
atmosphere was necessary to prevent degradation of the end product. Once 
the crystals were separated and dried, the 3-amino-4-(arylamino)-1H-
                                        
13 This value is calculated if the first steady state measurement of experiment 2 is seen as an outlier. If not, a relative 
standard deviation of 23 % is obtained. 
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isochromen-1-ones 17 are stable, even in open air. The bottleneck of the 
procedure was the purification of the end product which led to the testing of 
several methods to purify the end product. Direct evaporation of the reaction 
mixture gave formation of a mixture of end product, amine and side-products. 
Using an extraction of the mixture gave too much amine in the final extract, 
so that the end product was not able to crystallise. Attempts were made to 
develop an extraction procedure which removes the excess of amine out of 
the mixture, prior to crystallisation, based on a known purification method 
for primary, secondary and tertiary amines by adjustment of the pH.[361] This 
was without any success, since in all the trials, still too much amine was left. 
Therefore, the purification was finally based on evaporation under nitrogen, 
followed by a filtration and drying of the crystals. The results of Table 3.17, 
3.18 and 3.20 are based on this purification procedure. 
 
HN
Ar
O
O
NH2
O
127  
Figure 3.23: Side-product of 3-amino-4-(arylamino)-1H-isochromen-1-one 17 
that is formed in the presence of DMSO. 
 
3.5.5 Scope of the reaction 
 
Finally, the optimised procedure was tested for different amines. When 
anilines were used, moderate to good yields were achieved (Table 3.20, entry 
1-4). Allylamine was converted mostly to the Strecker product 128 (37 %), 
while 4-allylamino-3-iminoisochroman-1-one 124h was only produced in 6 % 
yield (Figure 3.24). Apparently, when non-aromatic amines are used the imino 
tautomer is more stable than the corresponding enamine tautomer. 
 
A production rate higher than 60 g/day was achieved for some adducts. 
When comparing the yields of the batch procedure and the microreactor 
procedure, higher yields in most batch procedures were observed. This is easy 
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to explain, since in the batch procedure crystallisation occurs in the round-
bottom flask during the reaction, which promotes a shift towards the 
formation of the end product. In the microreactor procedure, crystallisation 
needs to be avoided due to clogging problems. Nevertheless, scale up of this 
reaction is more advantageous in the case of the microreactor procedure. The 
most important reason is that more severe precautions are needed due to the 
formation of high concentrations of HCN in the scale up of the batch 
reaction, while in the case of the microreactor procedure this is possible by 
simple numbering up without changing the reaction conditions. Furthermore, 
the procedure is continuous, which guarantees a more constant quality of the 
end product in comparison to different batch reactions. 
 
128
O
NH
NH
O
N
N
O
124h  
Figure 3.24: The non-tautomerised end product 124h and the Strecker 
product 128 when allylamine is used as the amine compound. 
 
Table 3.20: Production of different 3-amino-4-(arylamino)-1H-
isochromenones 17 using the CYTOS® College System. a 
Entry Amine 9 Product Yield (%)b Yield (%)c Output (g/day)
1 Aniline 17a 66 82 43.2 
2 3-Methoxyaniline 17b 75 88 54.7 
3 3-Methylaniline 17c 69 60 47.5 
4 4-Methoxyaniline 17d 62 78 45.4 
5 4-Methylaniline 17e 91 82 62.6 
6 4-Fluoraniline 17f 89 -- 62.4 
7 N-Methylaniline 17g 49 64 33.8 
8 Allylamine 124h 6d -- 3.4 
--: Not described. a Residence time: 39.2 min; temperature: 50 °C; inlet A: 0.3 M of 2-
formyl benzoic acid and 0.6 M of acetic acid in methanol; inlet B: 0.36 M of potassium 
cyanide and 0.6 M of amine in methanol. b Microreactor procedure, after crystallisation. c 
Batch procedure, after crystallisation[39]. d No crystallisation occurred and the reaction 
mixture was subjected to column chromatography which gave product 124h. 
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3.5.6 Conclusions 
 
A multicomponent reaction was studied and optimised to produce 3-amino-
4-(arylamino)-1H-isochromen-1-ones via in situ generation of HCN. This is 
the first chemical reaction in a microreactor system in which HCN is 
generated and further reacted in the microreactor. Moderate to good yields 
were achieved, which gave an outcome of up to 60 g/day of 3-amino-4-
(arylamino)-1H-isochromen-1-ones. To avoid that crystallisation occurred in 
the system, 2 types of solutions were possible. The first and most obvious 
one was a decrease in residence time together with a decrease in 
concentration of the starting materials. A second approach was based on an 
alternative and easy setup, using plug flow, and allowed to work at higher 
concentrations. When using an aliphatic amine, the final tautomerisation 
towards the end product did not proceed and a competition with the 
appropriate Strecker reaction was seen. Finally, a qualitative and quantitative 
comparison was made between the batch and microreactor setup for the safe 
use of HCN. It was concluded that the release of HCN in the air was 
approximately 2 orders of magnitude smaller in the case microreactor 
technology was used. 
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3.6 SYNTHESIS OF 1H-ISOCHROMENO[3,4-d]IMIDAZOL-5-
ONES 
3.6.1 Introduction 
 
Using the previously formed 3,4-diamino-1H-isochromen-1-ones 17 under 
microreactor conditions with in situ formation of hydrogen cyanide, a ring 
closure of the vicinal amino groups was evaluated in order to attach an 
imidazole core to the molecule. Until now, this skeleton was only detected 
once in a side reaction for the production of 3H-indeno[2,1-d]imidazol-8-ones 
135 starting from the addition of N-substituted amidines 131 to ninhydrin 130 
(Scheme 3.13).[362] These compounds 135 are members of the 
indenoimidazoles, which show biological effects such as analgesic, anti-
inflammatory and anticonvulsive activity.[363,364] Some related compounds, 
which contain the chromenone instead of the isochromenone structure 
(Figure 3.25), are known to have an interesting biological activity as 
phosphodiesterase inhibitor for the treatment of allergic or immunity-
associated diseases[365] and as central nerve system depressants[366]. 
 
X
N
N
R1 R
2
129
O
R1 = H, alkyl, (hetero)aryl
R2 = H, alkyl
X = O, S  
Figure 3.25: 1H-(thio)chromeno[3,4-d]imidazol-4-ones 129, as an example of 
compounds with a chromenone structure showing biological activity. 
 
3.6.2 Optimisation study using microreactor technology 
 
After the microreactor synthesis and the isolation of the starting 3-amino-4-
(arylamino)-1H-isochromen-1-one 17, a subsequent microreactor 
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modification was envisaged to decorate the scaffold via the synthesis of a 
physiologically interesting imidazole moiety. 
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Scheme 3.13: Formation of 1H-isochromeno[3,4-d]imidazol-5-ones 19 as a  
side-product during the synthesis of 3H-indeno[2,1-d]imidazol-8-ones 135. 
 
The initial part of the research consisted of the search for compatible reaction 
conditions for the ring closure in the microreactor. Scheme 3.14 displays the 
ring closure using orthoesters. A set of different reaction conditions based on 
known ring closures to imidazole structures[367-369] was evaluated in batch to 
find suitable parameters for the implementation to microreactor conditions. 
Table 3.21 summarises the results of the optimisation of the reaction. 
 
In these initial batch studies, three different acids, either in catalytic or in 
equimolar amounts, were tested to obtain the ring closed product. The acid 
was necessary to activate the orthoester. In the case of ethyl orthoformate 
(EtO)3CH 18a, a catalytic amount of p-TsOH was enough to push the 
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reaction to completion (entry 1). An analogue procedure with HCl (entry 2) 
yielded the end product also in quantitative amounts, but much faster. In 
both these procedures, the orthoester was used as a solvent. In the case TFA 
was used as the acid catalyst (entry 3), almost quantitative yields were 
obtained. In this reaction setup, dichloromethane was utilised as solvent. All 
these batch procedures resulted in solubility problems of the starting 
compound, which needed to be overcome before testing the reaction under 
microreactor conditions. When dichloromethane was used as solvent, it was 
possible to dissolve the 3-amino-4-phenylamino-1H-isochromen-1-one 17a 
only in small amounts (less than 0.1 M). In case the orthoester itself served as 
solvent, even worse results were obtained. Since this concentration is too low 
to perform a continuous reaction with a reasonable output, other solvents 
were tested. It appeared that only DMF and related solvents were suitable to 
dissolve larger amounts of the starting compound. 
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Scheme 3.14: Formation of 1H-isochromeno[3,4-d]imidazol-5-ones 19. 
 
If ethyl orthoacetate (EtO)3CCH3 18b was used as orthoester, only an 
intermediate product was formed in the case of HCl (entry 4) and p-TsOH 
(entry 5). It seemed that the cyclisation with (EtO)3CCH3 18b was more 
demanding.[367] It was seen that the reaction did not go to completion and 
based on the spectral data it was assumed that ethyl N-(1-oxo-4-phenylamino-
1H-isochromen-3-yl)acetimidate 136i was isolated as the intermediate (Figure 
3.26). Only in the case TFA was used as the catalyst, complete cyclisation was 
obtained in excellent yields (entry 6). 
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Figure 3.26: Ethyl N-(1-oxo-4-phenylamino-1H-isochromen-3-yl)acetimidate 
136i formed as an intermediate. 
 
Table 3.21: Ring closure to 1H-isochromeno[3,4-d]imidazol-5-ones 19 under 
batch conditions. 
Entry Orthoester Conditions Reaction time (h) Yield (%)c 
1 (EtO)3CH A 3 quantitative 
2 (EtO)3CH B 0.5 quantitative 
3 (EtO)3CH C 2 97 
4 (EtO)3CCH3 A 6 intermediate 136i 
5 (EtO)3CCH3 B 2.5 intermediate 136i 
6 (EtO)3CCH3 C 2 96 
A: 1 mmol of compound 17a and 0.1 mmol of p-toluenesulfonic acid monohydrate (p-
TsOH) were added to 10 mL of the orthoester 18a or 18b at room temperature.[367] B: 1 
mmol of compound 17a and 1 mmol of 12.1 N HCl were added to 5 mL of the 
orthoester 18a or 18b at room temperature.[367] C: 1 mmol of compound 17a, 0.5 mmol of 
trifluoro acetic acid (TFA) and 5 mmol of the orthoester 18a or 18b were added to 10 mL 
of dichloromethane at room temperature.[368] 
 
To optimise the reaction under microreactor conditions, different parameters 
were analysed: solvent, reaction time, temperature, concentration and the 
ratio of start product 17, catalyst and orthoester 18. The optimisation was 
started based on the reaction conditions of the p-TsOH catalysed ring closure. 
Due to the low solubility of the start product 17a, DMF was the solvent of 
choice. Table 3.22 shows the optimisation efforts. As can be seen from the 
table, the optimal reaction temperature was room temperature (entry 2). Both 
an increase or a decrease of the reaction temperature led to worse results. In 
the case of 0 °C (entry 1), the final reaction mixture contained only starting 
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product and end product, while at 100 °C (entry 4) the intermediate was 
detected together with the end product. Increasing the catalytic amount of p-
TsOH gave rise to the formation of trace amounts of a side-product. After 
analysis of the 1H-NMR spectrum, it became clear that the side-product was 
ethyl p-toluene sulfonate (p-TsOEt, entries 5 and 6). If the excess of 
orthoester was increased, similar effects occurred (entries 7 and 8). In the case 
of a 50:50 solvent mixture (orthoester/DMF, entry 9), no complete 
conversion was achieved and the amount of p-TsOEt increased even to 11 
mol% in the mixture. 
The concentration of the starting product was finally doubled to 0.2 M with a 
similar outcome as entry 2 (entry 10). A final optimisation step resulted in the 
decrease of the residence time (entries 11-13). It was possible to decrease the 
residence time to approximately half an hour. Further decrease resulted in 
incomplete conversion. The optimised conditions were: 0.2 M starting 
product 17a in DMF was mixed at room temperature in the microreactor with 
a mixture of 0.1 equivalents of p-TsOH and 5 equivalents of (EtO)3CH 18a 
in DMF with a total residence time in the microreactor and RTU of 30 min. 
 
Although complete conversion and reasonable yields were already obtained 
after the RTU with the initial reaction conditions (entry 2), the further 
optimisation tests were performed in order to achieve a complete conversion 
after the microreactor unit (i.e. after 5 min of reaction instead of 118 min). 
Comparison of the conversion results after the microreactor and after the 
RTU, showed that in most cases complete conversion was easily obtained in 
the latter case, which is obvious due to the prolonged reaction time. On the 
other hand, after the microreactor a mean conversion of only 50 % was 
achieved. However, the different optimisation steps were not successful in 
order to get a complete conversion. The best result was obtained in the case 
of a twenty-fivefold excess of (EtO)3CH 18a (81 %, entry 8). In all reaction 
samples taken after the microreactor, traces of the intermediate 136a, p-
TsOEt or both were detected. 
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Table 3.22: Optimisation of the ring closure of 19a under microreactor 
conditions.a 
Entry T 
(°C) 
p-TsOH 
(equiv) 
(EtO)3CH 
(equiv) 
After microreactor After RTU 
Conversion 
(%)b 
Yield 
(%)c 
Conversion 
(%)b 
Yield 
(%)c 
1 0 0.1 5 41 24 78 58 
2 RT 0.1 5 58 28 100 86 
3 50 0.1 5 52 19 100 87 
4 100 0.1 5 0 0 67 27 
5 RT 0.2 5 52 29 100 78 
6 RT 0.5 5 60 28 100 82 
7 RT 0.1 10 46 22 100 79 
8 RT 0.1 25 81 50 100 76 
9 RT 0.1 60 19 14 90 67 
10d RT 0.1 5 54 43 100 82 
11d,f RT 0.1 5 -- -- 100 80 
12d,f RT 0.1 5 -- -- 100 88 
13d,g RT 0.1 5 -- -- 97 43 
--: Not measured. a Inlet A: 0.1 M of 17a in DMF; inlet B: (EtO)3CH 18a and p-TsOH in 
DMF; residence time after microreactor: 5 min; residence time after RTU: 118 min. b 
Based on the integration signals in the 1H NMR spectrum. c Based on the total mass of 
end product collected from the rough mixture and the degree of conversion. d Inlet A: 0.2 
M of 17a in DMF. e Residence time after RTU: 59 min. f Residence time after RTU: 29.5 
min. g Residence time after RTU: 19.6 min. 
 
A final attempt to achieve complete conversion at the end of the microreactor 
resulted from stopped-flow experiments in previous work (vide supra, § 3.2.4 
and 3.3.2).[151,158,247] Based on the optimised results for the output after the 
microreactor in Table 3.22 (which gave a conversion of around 50 %, entry 2), 
it was decided to double the residence time in the microreactor twice: one 
time to achieve a theoretically 100 % conversion and a second time as a safety 
margin. This led to a flow period of 1 min alternated with a pump stop period 
of 3 min. Table 3.23 shows the results of this study. Entry 1 shows that this 
setup did not result in complete conversion. An increase of the residence time 
by increasing the stop period (entry 3) gave even a lower conversion. Longer 
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residence times were not examined since it is not interesting from a practical 
point of view due to the very low flow rates resulting in a low output per time 
unit. A final attempt was made by increasing the excess of orthoester since 
this gave better results in the optimisation procedure (Table 3.22, entry 8). In 
this case, it gave only similar results. So, it was not possible to get complete 
conversion after the microreactor. 
 
Table 3.23: Use of the stopped-flow technique in the optimisation of the 
reaction output at the microreactor outlet.a 
Entry Stop-flow 
(min-min) 
Residence time 
(min) 
(EtO)3CH 
(equiv) 
After microreactor 
Conversion (%)b Yield (%)c 
1 3-1 20 5 84 61 
2 3-1 20 25 87 59 
3 5-1 30 5 60 35 
a Inlet A: 0.2 M of 17a in DMF; inlet B: (EtO)3CH 18a and 0.02 M of p-TsOH in DMF; 
room temperature; stopped-flow technique. b Based on the integration signals in the 1H 
NMR spectrum. c Based on the total mass of end product in the crude mixture and the 
degree of conversion. 
 
The goal to achieve complete conversion after the microreactor was to 
combine the reaction with a continuous extraction in the RTU, since initial 
tests with a continuous extraction gave better performances in product 
recovery. An optimised work up procedure had to be evaluated, since DMF is 
difficult to remove from the reaction mixture. 
 
Several work up conditions were tested such as a basic extraction in the 
presence of NaHCO3 and different acidic work ups (HCl, acetic acid) in batch 
mode and also via a micro-extraction 14  in basic medium. Under batch 
conditions, several extraction steps were necessary to remove all DMF in 
both basic and acid extractions, which resulted in a loss of approximately 
20 % of the product. The HCl-based extraction gave the best performance in 
                                        
14 During the micro-extraction, the reaction mixture was dissolved in an equal amount of CH2Cl2 and was pumped 
via one inlet of the microreactor, while the extraction medium was pumped via the other inlet (successively 60 mL of 
H2O, 60 mL of NaHCO3 solution and 60 mL of H2O).  
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DMF removal, while the acetic acid based extraction was the worst. Since the 
microreactor used in this study is made of stainless steel, no continuous HCl 
extraction was possible, so only the basic extraction was tested in the micro-
extraction procedure. This gave a recovery of 97 % of the end product. The 
main disadvantage here was the lower performance in DMF removal. After 
extraction, the mixture still existed for approximately 50 % of DMF. 
Unfortunately, although good recovery results were obtained, this micro-
extraction was not applicable due to the incomplete conversion achieved after 
the microreactor. All the previous results were therefore worked up using the 
HCl-based batch extraction procedure. 
 
3.6.3 Generality of the reaction 
 
Finally, the generality of the optimised conditions were tested. This was 
accompanied by some additional problems. The results are shown in Table 
3.24. Entries 2 and 4 already indicate that the optimised reaction conditions 
are not general for all starting materials. However, after elongation of the 
residence time to approximately 2 h, all the end products without substituent 
on the 2-position were completely converted to the 1H-isochromeno[3,4-
d]imidazol-5-ones 19 (entry 3 and entry 7-9). The only exception was the 3-
tolyl substituted compound 17c that was only converted in 48 % to the end 
product after the maximal residence time of 2 h (entry 5).  
 
In the case of more sterically demanding orthoesters, such as triethyl 
orthoacetate 18b, trimethyl orthovalerate 18c and trimethyl orthobenzoate 
18d, it was not possible to obtain a complete conversion at the end of the 
RTU under the given conditions. Since under batch conditions, the reaction 
to achieve ring closure was faster with TFA (Table 3.21), it was decided to 
check this harsher procedure under microreactor conditions for the reactions 
that did not proceed or proceeded only partially. It had to be taken into 
account that there was no known effect of the TFA concentration on the 
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inside of the microreactor. 15  In the case of the 3-tolyl substituted 1H-
isochromen-1-one 17c, it was possible to obtain a complete conversion of the 
reaction (entry 6). For the other substituents, it was only possible to obtain a 
partial conversion (entries 11-13). This was due to the bulky substituent that 
had to be incorporated which lowered the reaction rate. 
 
A possible reaction mechanism for the formation of the 1H-
isochromeno[3,4-d]imidazol-5-ones 19 is presented in Scheme 3.15. In the 
reaction mixture to produce the phenyl substituted compound (entry 13), a 
large amount of methyl benzoate was detected. When investigating the 1H 
NMR spectrum of the crude mixture of the n-butyl substituted compound 
(entry 12), there were also some peaks detected which could lead to the 
corresponding methyl pentanoate. No ester formation is possible during the 
reaction itself, since no water is present. So it is suggested that the 
intermediate product 138 formed during the reaction is converted to the ester 
139 during the quenching of the reaction and the subsequent work up. 
Reinvestigating the spectra of the reactions with triethyl orthoacetate 18b, 
showed also a small amount of ethyl acetate.  
 
In the case of complete conversion to the end products, no extra purification 
was necessary. But when only partial conversion was obtained, the 1H-
isochromeno[3,4-d]imidazol-5-ones 19 were further purified by crystallisation. 
Using the method optimised in this study, it was possible to produce a small 
library of 1H-isochromeno[3,4-d]imidazol-5-ones 19 applying microreactor 
technology. 
 
 
                                        
15 Oral communication with the manufacturers of the microreactor device learned that there was no knowledge 
about the effect of TFA on stainless steel 1.4571 (German Standard). It was decided to work under very dry 
conditions, using fresh DMF. 
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Scheme 3.15: Suggested reaction mechanism of the ring closure towards the 
1H-isochromeno[3,4-d]imidazol-5-ones 19 and the formation of side-products. 
 
The ideal procedure would be a two step sequence formation of 1H-
isochromeno[3,4-d]imidazol-5-ones initially starting from 2-formyl benzoic 
acid 15 without the need for intermediary work up. Unfortunately, as already 
stated in the discussion, the 3-amino-4-(arylamino)-1H-isochromen-1-ones 
had the tendency to crystallise in methanol once they were produced in a 
reasonable amount. Similar to other research,[157] a solvent switch, and a 
simultaneous purification, between both reactions was necessary before the 
ring closing reaction could be performed. This was a disadvantage of the 
procedure. Attempts were made to produce the 1H-isochromeno[3,4-
d]imidazol-5-one in a one step procedure starting from 2-formyl benzoic acid, 
but without any success. 
 
 
 
Results and Discussion 
- 127 - 
Table 3.24: Optimised conditions to produce 1H-isochromeno[3,4-
d]imidazol-5-ones 19 in the microreactor.a 
Entry R1 R2 Product
Conversion 
(%)b 
Yield 
(%)c 
Output 
(g/day) 
1d Ph H 19a 100 88 53.0 
2d 3-Methoxyphenyl H 19b 46 7 4.8g 
3e 3-Methoxyphenyl H 19b 100 55 9.4 
4d 3-Tolyl H 19c 34 8 5.0g 
5e 3-Tolyl H 19c 48 27 4.3g 
6f 3-Tolyl H 19c 100 69 11.0 
7e 4-Methoxyphenyl H 19d 100 75 12.7 
8e 4-Tolyl H 19e 100 78 12.5 
9e 4-Fluorophenyl H 19f 100 92 14.9 
10e Ph CH3 19i 0 0 0 
11f Ph CH3 19i 52 36 5.8g 
12f Ph C4H9 19j 27 18 3.4g 
13f Ph Ph 19k 2 1 0.2g 
a General conditions: inlet A: 0.2 M of 17 in DMF; inlet B: acid and 1.0 M of 18 in DMF; 
room temperature, sampling at the RTU outlet. b Based on the integration signals in the 
1H NMR spectrum. c Based on the total mass of end product collected from the rough 
mixture and the degree of conversion. d Residence time: 29.5 min, acid: 0.02 M p-TsOH. e 
Residence time: 118 min, acid: 0.02 M p-TsOH. f Residence time: 118 min, acid: 0.1 M 
TFA. g Purification via crystallisation. 
 
3.6.4 Other ring closing methods 
 
Next to the previous optimised procedure, attempts were made to broaden 
the scope of the reaction including other substituents on the 2-position of the 
imidazole moiety, because of the small variability of the orthoesters. Among a 
wide variety of ring closing methods of diamino aryl compounds, a lot of 
procedures were rejected, because of problems related to the compatibility 
with the microreactor system.[370-377] A method using silica treated with thionyl 
chloride for the formation of benzimidazoles was not feasible due to the solid 
nature of the reagents.[370] Other methods using solids,[371,372] such as a 
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manganese dioxide mediated tandem oxidation process[371] and a L-proline 
mediated benzimidazole synthesis[372] were also not applicable. The use of a 2-
step procedure was also not suitable.[373,374] In the first procedure, 1,2-
diphenylamines reacted with an aldehyde to the corresponding 
benzimidazolines. These require an oxidative step with aerial oxygen or 
elemental sulphur to obtain the benzimidazole.[373] The other 2-step 
procedure involved a condensation reaction of the 1,2-diphenylamines with 
carboxylic acid under 1-propane phosphonic cyclic anhydride catalysis, 
followed by dehydratation towards the end product.[374] An efficient 
procedure using (bromodimethy)sulfonium bromide was not evaluated 
because of the corrosive effect of the bromine ions on the stainless steel 
microreactor,[375] other procedures using chlorine likewise[376,377].  
 
Finally, three literature procedures, using acetic acid as dehydratation 
compound,[378] or 1,4-benzoquinone[379,380] or Oxone®[381] as oxidation agent 
were tested first on a batch process to produce compound 19l, but only the 
last procedure gave good results (Table 3.25). Using the Oxone® mediated 
procedure, a variety of imidazoles were produced in batch conditions. A 
major problem to implement this procedure to a microreactor setup was the 
rapid precipitation of the Oxone® when put in contact with DMF. Also the 
end product precipitated during the reaction. To prevent this in the 
microreactor, the goal was to use a similar setup as in the 1H-isochromen-1-
one synthesis: a 2-phasic system with Fluorinert® to prevent contact of the 
precipitate with the microreactor wall was evaluated. Therefore, the 
Fluorinert® was added at the microreactor inlet were the Oxone® solution was 
injected. A scheme of the reaction setup is given in Figure 3.27. Initial 
experiments were made using only the Oxone® solution (so without any other 
reagent) to test the procedure. Unfortunately, it was seen that, after a short 
period of normal flow, clogging of the microreactor occurred. Even by 
changing the solution to a higher water content or by lowering the 
concentration of Oxone®, precipitation occurred with subsequent clogging as 
a consequence. Therefore, this method for 1H-isochromeno[3,4-d]imidazol-5-
one synthesis was not further evaluated. 
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Table 3.25: Different methods for the ring closure towards the 1H-
isochromeno[3,4-d]imidazol-5-ones. 
O
NH
NH2
O
O
O
N
N
17a 19k  (R = Ph)
19l   (R = 4-nitroPh)
19m (R = i-Pr)
19n (R = c-Hex)
Conditions
+
R H
O
1
R
 
Entry Conditions Product Yield (%) Reference 
1 10 equiv 1a, 5 % HOAc in DMA, 120 °C 
19l No reaction [378] 
2 1 equiv 1a, 1 equiv 1,4-benzoquinone, DMF, reflux 
19l Complex 
reaction mixture 
[379,380] 
3 1.1 equiv 1a, 0.65 equiv Oxone
®, 
DMF/water (30:1), RT 
19l 58 (25a)  [381] 
4 1.1 equiv aldehyde, 0.65 equiv Oxone®, DMF/water (30:1), RT 
19k 31 [381] 
5 1.1 equiv aldehyde, 0.65 equiv Oxone®, DMF/water (30:1), RT 
19m 43 [381] 
6 1.1 equiv aldehyde, 0.65 equiv Oxone®, DMF/water (30:1), RT 
19n 56 [381] 
a After crystallisation. 
 
 
Figure 3.27: Setup for the Oxone® mediated reaction. A = input reagents 
(input Oxone® via the T-junction with E), B = microreactor, C = RTU, D = 
output reaction mixture, E = input Fluorinert® FC-70. 
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3.6.5 Conclusions 
 
Starting from 3-amino-4-(arylamino)-1H-isochromen-1-ones, produced under 
microreactor conditions, different procedures were tested to ring close the 
vicinal amino groups towards an imidazole moiety. Only one procedure, 
which used orthoesters, proved to be suitable under microreactor conditions. 
This reaction was further optimised. Attempts to completely convert the 3-
amino-4-(arylamino)-1H-isochromen-1-ones towards the 1H-isochromeno 
[3,4-d]imidazol-5-ones in the microreactor itself, failed. After optimisation, it 
was possible to apply this method under microreactor conditions leading to a 
small library of compounds with a new 1H-isochromeno[3,4-d]imidazol-5-one 
skeleton. Moderate to good yields were obtained and in the case of complete 
conversion of the reaction, a continuous output of up to 53 g/day of end 
product was achieved. However, depending on the substrate, some extra 
adjustments were necessary during the generalisation. 
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Chapter 4 - Experimental Procedures 
 
4.1 GENERAL EQUIPMENT 
4.1.1 NMR spectrometry 
 
1H NMR spectra (300 MHz), 13C NMR spectra (75 MHz), 31P NMR spectra 
(121 MHz) and 19F NMR spectra (282 MHz) were recorded on a Jeol Eclipse 
FT 300 NMR spectrometer. The compounds were diluted in deuterated 
solvents and peaks are relative to tetramethylsilane (TMS) as internal standard. 
Peak assignments were accomplished by using COSY, DEPT, HSQC and 
HMBC spectra.  
 
4.1.2 Infrared spectrometry 
 
Infrared spectra were measured with a Perkin-Elmer Spectrum One FT-IR 
spectrophotometer. For liquid samples, spectra were recorded by putting a 
small drop of product between two sodium chloride plates. For crystalline 
products, a small amount was mixed with potassium bromide and pressed to 
a transparent potassium bromide plate. 
 
4.1.3 Mass spectrometry 
 
Low resolution mass spectra of pure compounds were recorded via direct 
injection on an Agilent 1100 Series LC/MSD type SL mass spectrometer with 
Electron Spray Ionisation geometry (ESI 70 eV) and using a Mass Selective 
Detector (quadrupole). If crude reaction mixtures were analysed, the mass 
spectrometer was preceded by a HPLC reversed phase column with a diode 
array UV/VIS detector. High resolution mass spectra were obtained on a 
Finnigan MAT 95 XPAPI-GC-Trap tandem Mass spectrometer system. 
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4.1.4 Gas chromatography 
 
Gas chromatography analysis was performed on an Agilent 6890 Series. The 
column that was used was of the type Alltech EC-5 with a film thickness of 
0.25 µm (length 30.0 m, i.d. 250 µm) with helium as the carrier gas. The GC 
was connected to a FID detector (H2 gas). 
 
4.1.5 Melting point 
 
Melting points of crystalline products were measured with a Büchi B-540 
apparatus and are uncorrected. 
 
4.1.6 Column chromatography  
 
For purification of crude reaction mixtures, column chromatography was 
applied. For the packing of the column, silica gel (Acros Organics, particle size 
0.035-0.070 mm, pore diameter ca. 6 nm) was used. Solvent systems were 
obtained via thin-layer chromatography (TLC) analysis (Merck, Kieselgel 
60F254, precoated 0.25 mm). UV light, adsorption with iodine vapours or 
colouration with KMnO4 were used for detection of the compounds on the 
silica plates. 
 
4.1.7 Reagents 
 
The reagents were used without prior purification, unless otherwise stated. 
Fluorinert® FC-70 was purchased from Acros Organics. 
 
4.1.8 Elemental analysis 
 
Elemental analysis was performed with a Perkin Elmer 2400 Series 2 Elemental 
Analyser. 
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4.1.9 Microreactor system 
 
The microreactor used in this study is a CYTOS® College System provided by 
CPC-Cellular Process Chemistry Systems GmbH (Figure 3.1).[176] The CYTOS® 
College System microreactor consists of several stacked plates with 
microstructures in the sub-millimeter range (width approximately 100 µm). 
The internal volume of the microreactor itself is 2 mL (Vmicroreactor) and that of 
the RTU is 45 mL (VRTU) so the total volume (Vtotal) of the system is 47 mL. 
For the moving of reaction mixtures or solvents, pumping was pressure-
driven via 2 valveless rotary piston dispensing pumps (pump: Ismatec®, 
REGLO-CPF Digital, pump head: Fluid Metering Inc., FMI 005, ceramic piston, 
5-50µL/stroke). Cooling or heating of the system was provided by an external 
circuit via a circulation thermostat (Peter Huber Kältemaschinenbau GmbH, Huber 
Unistat Tango). 
 
4.2 GENERAL MICROREACTOR SETUP 
 
Unless otherwise stated, the general procedure for a reaction under 
microreactor conditions was as follows. First, the system was cooled or 
heated at the desired temperature using the thermostat. The pumps were 
calibrated at the desired flow rate (rpiston pump), according to the desired 
residence time τ, using the solvent of the reaction. The residence time τ was 
calculated by the following formula: 
 
total
total
r
V(min) τ =  with rtotal = 2 rpiston pump (4.1) 
 
with Vtotal = inner volume of the microreactor and RTU (mL) 
 rtotal = total flow rate of the 2 piston pumps (mL/min)  
 rpiston pump = flow rate of the piston pump (mL/min) 
 
Meanwhile, both solutions with the appropriate reagents were prepared in a 
measuring cylinder. Care has to be taken that no solid particles were present 
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in the solutions. The reagent solutions were connected to the inlets of the 
microreactor system. The pumps were started and the flow rate was 
controlled by measuring both incoming and outcoming volume per time unit. 
At the outlet, the end product was collected at steady state conditions, i.e. 
after minimal 1.6 τ. When enough sample volume was taken, the reaction 
mixtures at the inlet were replaced again by the solvent and the system was 
flushed with at least 2 times the inner volume of the device. The sample was 
finally analysed according to the procedure mentioned in the experiments. 
 
4.3 BAYLIS-HILLMAN STUDY 
4.3.1 General procedure in batch mode (Table 3.1, entry 1) 
 
For the Baylis-Hillman reaction in batch mode, the procedure of Yu et al.[236] 
was followed. In a round-bottom flask, 4-nitrobenzaldehyde (151 mg, 1 
mmol), DABCO (112 mg, 1 equiv), and methyl acrylate (272 µL, 3 equiv) 
were mixed in 10 mL of water/1,4-dioxane (v/v 1:1). The solution was stirred 
for different time intervals (see Figure 3.5) after which the mixture was 
partitioned with 150 mL of tert-butyl methyl ether and 80 mL of water. The 
organic phase was washed with 2 times 50 mL of brine, dried with MgSO4 
and filtered, and the solvent was evaporated. A 1H-NMR spectrum of the 
crude mixture was recorded. The degree of conversion was calculated using 
the integration of the signals in the 1H-NMR spectrum. The yield of the 
reaction was calculated from the total mass of end product collected and the 
degree of conversion. The other results were obtained in the same way, 
except for minor changes such as concentration and the lack of stirring the 
mixture. 
 
4.3.2 General procedure using the microreactor (Table 3.2) 
 
For entry 1, a solution of 0.2 M 4-nitrobenzaldehyde and 0.2 M DABCO in a 
water/1,4-dioxane (v/v 1:1) mixture was prepared and transferred in a 
measuring cup. Another solution of 0.6 M methyl acrylate was prepared in the 
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same solvent mixture and transferred to a second measuring cup. Both 
measuring cups were connected to the CYTOS® College System and the 
general microreactor setup was followed. At the outlet, about 10 mL 
sample was quenched with 10 mL of 1 N HCl and collected for analysis. The 
work up of the reaction mixture was performed using the procedure of Yu et 
al. (vide supra, § 4.3.1).[236] The degree of conversion and the yield were 
calculated in the same way as in the batch procedure. The other results in 
Table 3.2 were obtained in the same way, except for changes such as 
concentration, ratio of reagents, mixing of reagents, temperature, flow rate, 
catalyst, as stated with the experiments. 
For the results of Table 3.3, reagents were dissolved in sulfolane and a 
different work up procedure was used.[187] The 10 mL sample was diluted with 
20 mL of water and extracted with 3 times 30 mL of diethyl ether. The 
combined organic layers were washed with brine, dried with MgSO4 and 
filtered, and the solvent was evaporated. The degree of conversion and the 
yield were calculated in the same way as in the batch procedure. 
In Table 3.4, the aldehyde and alkene were varied. A ratio for 
aldehyde/DABCO/alkene of 1:1:3 was maintained and the further procedure 
was in accordance with the general procedure in the microreactor. In the case 
of concentrations above 0.1 M aldehyde, the aldehyde and DABCO were 
dissolved in a 3:7 (v/v) mixture of water and 1,4-dioxane. The alkene was 
added to a 7:3 (v/v) water/1,4-dioxane mixture and was continuously stirred 
to have a homogeneous solution. 
 
4.3.3 Stopped-flow technique (Table 3.5) 
 
In the experiments with the stopped-flow technique, the same conditions 
were used as in the general microreactor setup. The goal was a fivefold 
increase in residence time. A flow time of 1 min was chosen, so the stop time 
was 4 min. With a total volume of 47 mL and a flow rate of 0.2 
mL/min.pump, this led to a total residence time increase from 1 h 58 min to 
9 h 50 min. 
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Compounds 4a,g,h,[382] 4b-e,[236] and 4f[383] are known compounds, and their 
spectroscopic data matched those reported in the literature. 
 
Methyl 2-[hydroxy-(4-nitrophenyl)-methyl]acrylate 4a 
 
1H NMR (300 MHz, CDCl3, ppm): δ = 3.29 (1 H, d, J 
= 6.3 Hz, OH), 3.75 (3 H, s, OCH3), 5.64 (1 H, d, J = 
6.1 Hz, CHOH), 5.87 (1 H, s, C=CH2), 6.40 (1 H, s, 
C=CH2), 7.58 (2 H, d, J = 8.8 Hz, arom. H), 8.21 (2 H, d, J = 8.8 Hz, arom. 
H). 
 
Methyl 2-[hydroxy-(3-nitrophenyl)-methyl]acrylate 4b 
 
1H NMR (300 MHz, CDCl3, ppm): δ = 3.00-3.80 (1 H, 
br s, OH), 3.69 (3 H, s, OCH3), 5.67 (1 H, s, CHOH), 
5.98 (1 H, s, C=CH2), 6.42 (1 H, s, C=CH2), 7.53 (1 H, t, 
J = 8.0 Hz, arom. H), 7.76 (1 H, d, J = 7.7 Hz, arom. H), 8.12 (1 H, m, arom. 
H), 8.25 (1 H, d, J = 1.7 Hz, arom. H). 
 
Methyl 2-[hydroxy-pyridin-2-yl-methyl]acrylate 4c 
 
1H NMR (300 MHz, CDCl3, ppm): δ = 3.74 (3 H, s, OCH3), 
4.83 (1 H, d, J = 5.2 Hz, OH), 5.62 (1 H, d, J = 3.9 Hz, 
CHOH), 5.97 (1 H, br s, C=CH2), 6.36 (1 H, br s, C=CH2), 
7.22 (1 H, ddd, J = 7.5, 5.0, 1.1 Hz, arom. H), 7.42 (1 H, d, J = 8.0 Hz, arom. 
H), 7.68 (1 H, td, J = 7.7, 1.7 Hz, arom. H), 8.55 (1 H, d, J = 4.7 Hz, arom. 
H). 
 
Methyl 2-[furan-2-yl-hydroxymethyl]acrylate 4d 
 
1H NMR (300 MHz, CDCl3, ppm): δ = 3.25 (1 H, br s, OH), 
3.77 (3 H, s, OCH3), 5.60 (1 H, t, J = 1.1 Hz, CHOH), 5.96 
(1 H, br s, C=CH2), 6.26 (1 H, br s, =CH), 6.33 (1 H, dd, J = 
3.2, 1.9 Hz, =CH), 6.39 (1 H, br s, C=CH2), 7.38 (1 H, m, CHO). 
OH
OMe
O
O2N
OH
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O
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Methyl (2E)-3-(furan-2-yl)-2-hydroxymethyl acrylate 89 
 
IR (KBr, cm-1): νmax = 3505, 1685 (C=O), 1644, 1439, 1374, 
1271, 1218, 1093, 1015, 775. 1H NMR (300 MHz, CDCl3, 
ppm): δ = 2.52 (1 H, br s, OH), 3.84 (3 H, s, OCH3), 4.79 (2 
H, s, CH2), 6.52 (1 H, dd, J = 3.6, 1.7 Hz, C=CH), 6.73 (1 H, d, J = 3.6 Hz, 
=CH), 7.45 (1 H, s, CH=CCH2), 7.58 (1 H, d, J = 1.7 Hz, CHO). 13C NMR 
(75 MHz, CDCl3, ppm): δ = 52.3 (OCH3), 58.2 (CH2), 112.5 (C=CH), 117.7 
(=CH), 126.8 (CC=O), 127.5 (CH=CCH2), 145.5 (CHO), 150.7 (CO), 168.5 
(C=O). LRMS (70 eV, ES+): m/z = 165 (M - OH-). Elem. anal.: calculated for 
C9H10O4: C, 59.34 %, H, 5.53 %, O, 35.13 %, found: C, 59.19 %, H, 5.50 %, 
O, 35.31 %. Brown oil. Rf (PE/EA 70:30) =0.17. 
 
Methyl 2-[hydroxy-(5-nitrofuran-2-yl)-methyl]acrylate 4e 
 
1H NMR (300 MHz, CDCl3, ppm): δ = 3.55 (1 H, br s, 
OH), 3.80 (3 H, s, OCH3), 5.58 (1 H, br s, CHOH), 
6.07 (1 H, d, J = 0.8 Hz, C=CH2), 6.50 (1 H, br s, 
C=CH2), 6.57 (1 H, dd, J = 3.9, 0.8 Hz, arom. H), 7.29 (1 H, d, J = 3.9 Hz, 
arom. H). 
 
Methyl 3-hydroxy-2-methylene-pentanoate 4f 
 
1H NMR (300 MHz, CDCl3, ppm): δ = 0.95 (3 H, t, J = 7.4 
Hz, CH3), 1.61-1.70 (2 H, m, CH2), 3.70 (1 H, br s, OH), 3.79 
(3 H, s, OCH3), 4.35 (1 H, t, J = 6.3 Hz, CHOH), 5.81 (1 H, 
br s, C=CH2), 6.25 (1 H, br s, C=CH2). 
 
2-[Hydroxy-(4-nitrophenyl)-methyl]acrylonitrile 4g 
 
1H NMR (300 MHz, CDCl3, ppm): δ = 2.59 (1 H, br s, 
OH), 5.47 (1 H, br s, CHOH), 6.12 (1 H, d, J = 1.1 Hz, 
C=CH2), 6.20 (1 H, d, J = 1.4 Hz, C=CH2), 7.62 (1 H, d, J 
= 8.5 Hz, arom. H), 8.28 (1 H, d, J = 8.8 Hz, arom. H). 
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3-[Hydroxy-(4-nitrophenyl)-methyl]but-3-en-2-one 4h 
 
1H NMR (300 MHz, CDCl3, ppm): δ = 2.36 (3 H, s, CH3), 
3.54 (1 H, br s, OH), 5.69 (1 H, br s, CHOH), 6.08 (1 H, d, 
J = 1.1 Hz, C=CH2), 6.28 (1 H, br s, C=CH2), 7.55 (1 H, d, 
J = 8.3 Hz, arom. H), 8.17 (1 H, d, J = 8.8 Hz, arom. H). 
 
4.3.4 Effect of RTU 
4.3.4.1 Description of the 1-line chip 
 
The chip used in this experiment was a 1-line chip (Figure 4.1), with 2 reagent 
inlets, 1 quenching inlet and 1 product outlet. The quenching of the reaction 
was internal. The chip was fabricated using standard microfabrication 
processes. The channels were formed in 4 inch silicon wafers by deep reactive 
ion etching (BOSCH-type process) using a mask of photoresist. Inlet holes 
were fabricated using powder-blasting. The silicon wafer was bonded to Pyrex 
glass by anodic bonding (T = 400 ºC, Umax = 1000 V, t = 20 min) and then 
diced into separate chips. The use of only (oxidised) silicon and glass makes 
the chip compatible with a wide range of organic solvents and reaction 
temperatures. Channel dimensions are 50 µm x 51 µm (width x depth). The 
geometry of the reaction chamber was approximately 50 µm x 50 µm x 90 m. 
The mixer was a small modification (increase of the number of segments, 
decrease of mixer area) of an in-plane passive microfluidic mixer with 
modified Tesla structures.[98] 
 
4.3.4.2 Experiment with the 1-line chip (Figure 3.13) 
 
In the first solution (0.2 M of 5-nitro-2-furaldehyde and 0.2 M of methyl 
acrylate), 1.41 g (10 mmol) of 5-nitro-2-furaldehyde and 2.73 mL (30 mmol) 
of methyl acrylate were mixed together in a 50 mL mixture of water/1,4-
dioxane (v/v 1:1). The solution was sonicated for 30 minutes. The methyl 
acrylate was added after the sonication in order to prevent reaction. For the 
OH O
O2N
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second solution (0.2 M DABCO), 1.12 g (10 mmol) of DABCO was added to 
a 50 mL mixture of water/1,4-dioxane (v/v 1:1). The solution was also 
sonicated for 30 minutes. The quenching reagent was a 1 N solution of HCl. 
This solution was degassed overnight with N2. 
 
 
Figure 4.1: Scheme of the 1-line chip. 
 
Before filling the inlet syringes with the reaction solution or quenching 
solution, the solution was filtered through a Millipore filter (Millex® GV 0.22 
µm) to avoid particles to enter the chip. Care had to be taken that no bubbles 
were present in the syringes to avoid non-reproducible residence times. The 
syringes were connected to the chip via silicon capillaries (i.d. 100 µm). The 
experiment was started at an initial flow rate of 2.0 µL/min.syringe. After a 
preflushing stage to reach steady state conditions, 2 samples of approximately 
15 µL were collected. Then the flow rate was adjusted to 1.5 µL/min.syringe 
and the same procedure was followed. This was repeated for the following 
flow rates: 1.0, 0.8, 0.6 and 0.4 µL/min.syringe. From the collected samples, 
10 µL was taken to perform an extraction. To the reaction mixture, 10 µL of 
water and 30 µL of tert-butyl methyl ether were added. The mixture was 
vigorously stirred by using a vortex mixer. The phases separated in 2 layers 
and a 1 µL sample of the upper layer was injected in the GC. Calculations of 
the conversions were based on the peak areas of starting aldehyde 1e and 
Baylis-Hillman adduct 4e, relative to n-nonane. 
Inlet A Inlet B
OutletInlet C
Quenching 
mixer
Inlet mixer
Reaction chamber
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4.3.4.3 Experiment with the CYTOS® College System (Figure 3.10 and 
3.13) 
 
The procedure was somewhat different from the general microreactor 
setup. Following solutions were prepared. 
 
For the first solution (0.2 M of 5-nitro-2-furaldehyde and 0.2 M of methyl 
acrylate), 2.54 g (18 mmol) of 5-nitro-2-furaldehyde was mixed in a 90 mL 
mixture of water/1,4-dioxane (v/v 1:1). The mixture was sonicated for 30 
min. Then, 4.89 mL (54 mmol) of methyl acrylate were added and the 
solution was shortly stirred to obtain a homogeneous mixture. In the second 
solution (0.2 M DABCO), 2.02 g (18 mmol) of DABCO was added to a 90 
mL mixture of water/1,4-dioxane (v/v 1:1) and subjected to 30 min 
sonication. Since the quenching was external, no degassing of the quenching 
reagent, which was a 1 N solution of HCl, was necessary. 
 
The solutions were connected to the inlet of the CYTOS® microreactor 
system. The experiment was started at an initial flow rate of 0.2 
mL/min.pump. After a preflushing stage to reach steady state conditions, a 
sample of approximately 10 mL were collected in a 10 mL solution of the 
quenching reagent. The sample was taken immediately after the microreactor 
device. Then the flow rate was adjusted to 0.4 mL/min.pump and the same 
procedure was followed. This was repeated for the following flow rates: 0.8, 
1.2, 1.6, 2.0, 4.0 and 8.0 mL/min.pump. For the samples after the RTU, the 
experiment was performed at a flow rate of 4.7, 9.4 and 18.8 mL/min.pump. 
From the collected samples, 100 µL was taken to perform an extraction: to 
every reaction mixture, 100 µL of water and 300 µL of tert-butyl methyl ether 
were added. The mixture was vigorously stirred using a vortex mixer. The 
phases separated in 2 layers and a 1 µL sample of the upper layer was injected 
in the GC. Calculations of the conversions were based on the peak areas of 
starting aldehyde 1e and Baylis-Hillman adduct 4e, relative to n-nonane. 
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4.3.4.4 Experiment in batch (Figure 3.13) 
 
A 10 mL sample of both solutions prepared in § 4.3.4.3 was put together and 
vigorously stirred. A sample of 50 µL was taken after 15 s, 30 s, 50 s, 1 min, 2 
min and 4 min. The samples were worked up and analysed according to a 
similar procedure as previously mentioned. 
 
All other experiments were obtained in a similar way as the methods 
described above, with some minor changes such as the mixing of compounds 
or the use of sonication. 
 
4.3.5 The aza-Baylis-Hillman reaction 
4.3.5.1 Synthesis of 4-methyl-N-(4-nitrobenzylidene)benzenesulfonamide 
6 
 
The synthesis of 6 was based on a known procedure.[270,384] Generally, 1.51 g 
4-nitrobenzaldehyde 1a (10 mmol) and 1.71 g p-toluenesulfonamide 5 (1 
equiv, 10 mmol) were heated under reflux in 70 mL of toluene with a Dean-
Stark apparatus. Reflux was continued overnight, with azeotropic removal of 
water. The mixture was allowed to cool, followed by evaporation of the 
solvent under reduced pressure. Recrystallisation of the product in 
chloroform/petroleum ether yielded a light yellow solid in 90 % yield. 
Spectral data were in accordance with literature data.[385] 
 
1H NMR (300 MHz, CDCl3, ppm): δ = 2.46 (3 H, s, 
CH3), 7.39 (2 H, d, J = 8.3 Hz, arom. H), 7.91 (2 H, d, 
J = 8.3 Hz, arom. H), 8.12 (2 H, d, J = 8.8 Hz, arom. 
H), 8.33 (2 H, d, J = 8.8 Hz, arom. H), 9.11 (1 H, s, 
N=CH). 
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4.3.5.2 Reaction setup in the microreactor (Table 3.9) 
 
For entry 4, a solution of 0.15 M 4-methyl-N-(4-nitrobenzylidene) 
benzenesulfonamide 6 and 0.15 M DABCO in DMF was prepared and 
transferred in a measuring cup. Another solution of 0.45 M methyl acrylate 
was prepared in the same solvent and transferred to a second measuring cup. 
Both measuring cups were connected to the CYTOS® College System and the 
general microreactor setup was followed. At the outlet, about 10 mL 
sample was collected for analysis. The reaction mixture was diluted with 50 
mL of ethyl acetate and was subsequently washed with 50 mL 0.1 N HCl, 50 
mL saturated NaHCO3 and 50 mL brine. The organic phase was dried with 
MgSO4 and the solvent was evaporated after filtration. A 1H-NMR spectrum 
of the crude mixture was recorded. The degree of conversion was calculated 
using the integration of the signals in the 1H-NMR spectrum. The yield of the 
reaction was calculated from the total mass of end product collected and the 
degree of conversion. The other results were obtained in the same way, 
except for minor changes. 
 
Methyl 2-[4-nitrophenyl(toluene-4-sulfonylamino)methyl]acrylate 7 
 
Spectral data were in accordance with literature data.[386] 
 
1H NMR (300 MHz, CDCl3, ppm): δ = 2.41 (3 H, s, 
CH3), 3.63 (3 H, s, OCH3), 5.36 (1 H, d, J = 9.4 Hz), 
5.82 (1 H, s, =CH2), 5.94 (1 H, d, J = 9.6 Hz), 6.24 (1 
H, s, =CH2), 7.25 (2 H, d, J = 8.5 Hz, arom. H), 7.40 (2 
H, d, J = 9.1 Hz, arom. H), 7.67 (2 H, d, J = 8.3 Hz, arom. H), 8.10 (2 H, d, J 
= 8.5 Hz, arom. H). 
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4.4 IMIDAZOLES 
4.4.1 General procedure in batch mode (Table 3.10, entry 6 and 
Figure 3.18) 
 
In a round-bottomed flask, benzil (10.5 g, 50 mmol), isobutyraldehyde (3.6 g, 
1 equiv), ammonium acetate (3.86 g, 1 equiv), benzylamine (6.42 g, 1.2 equiv) 
and acetic acid (30.0 g, 10 equiv) were mixed and diluted to 200 mL with a 
NMP/n-pentanol (1:1 v/v) solvent mixture. The temperature was controlled 
at 120 °C with an IKA® ETS-D4 electronic thermometer. At regular time 
intervals an aliquot of the mixture was taken for GC analysis. 
 
4.4.2 General procedure in the microreactor (Table 3.12, entry 6) 
 
For the optimised production of 1-benzyl-2-isopropyl-4,5-diphenyl-1H-
imidazole 11f, a mixture of 0.5 M benzil, 0.5 M isobutyraldehyde and 2.5 M 
acetic acid in NMP was prepared and transferred to a measuring cup. In a 
second measuring cup a mixture of 0.5 M NH4OAc, 0.6 M benzylamine and 
2.5 M acetic acid in n-pentanol was prepared. Both measuring cups were 
connected to the CYTOS® College System and the general microreactor 
setup was followed. At the outlet, about 10 mL of sample was collected for 
analysis. An aliquot of the crude reaction mixture was taken for GC and GC-
MS analysis. The work up of the reaction mixture consisted of the removal of 
the solvent mixture of n-pentanol, NMP and acetic acid by high-vacuum 
distillation. Afterwards, the residue was dissolved in 25 mL of CH2Cl2 and the 
organic fraction was washed one time with 100 mL of saturated NaHCO3 and 
two times with 100 mL of water. The organic fraction was dried with MgSO4 
and after filtration the solvent was evaporated. The product was purified 
through flash chromatography (PE/EA 70:30). All the entries in Table 3.12 
were obtained following the same procedure. Instead of 0.5 M NH4OAc and 
0.6 M amine, 1.0 M of NH4OAc is used in entries 1 and 4. Flash 
chromatography varied in the used solvent mixtures (see Rf values). 
 
 
Experimental Procedures 
- 144 - 
4,5-Dimethyl-2-phenyl-1H-imidazole 11’a 
 
IR (KBr, cm-1): νmax = 3700-3300 (NH), 2355, 2343 (NH), 
1624, 1454, 1404 (C=C and C=N). 1H NMR (300 MHz, 
CDCl3, ppm): δ = 2.19 (6 H, s, 2 x CH3), 7.24-7.37 (3 H, m, 
arom. H), 7.78-7.82 (2 H, m, arom. H). 13C NMR (75 MHz, 
CDCl3, ppm): δ = 10.9 (2 C, CH3), 124.8 (2 C, CHarom.), 128.0 (CHarom.), 128.3 
(2 C, Cq), 128.8 (2 C, CHarom.), 130.6 (Cq), 144.2 (C=N). LRMS (70 eV, ES+): 
m/z = 173 (M + H+). HRMS: calculated for C11H12N2 + H+: 173.1073, found: 
173.1070. Mp (°C): 222. Light brown crystals. Rf (PE/EA 30:70) = 0.17. 
 
1-Isopropyl-4,5-dimethyl-2-phenyl-1H-imidazole 11b 
 
IR (NaCl, cm-1): νmax = 1639, 1595, 1462, 1446 (C=C and 
C=N), 1393, 1371, 1287 (C-N and CH(CH3)2). 1H NMR (300 
MHz, CDCl3, ppm): δ = 1.45 (6 H, d, J = 6.9 Hz, CH(CH3)2), 
2.19 (3 Ha, s, CH3), 2.32 (3 Hb, s, CH3), 4.57 (1 H, septet, J = 
6.9 Hz, CH(CH3)2), 7.33-7.49 (5 H, m, arom. H). 13C NMR (75 MHz, CDCl3, 
ppm): δ = 11.0 (CbH3), 12.5 (CaH3), 22.2 (CH(CH3)2), 48.3 (CH(CH3)2), 122.6 
(Cq), 128.4 (2 C, CHarom.), 128.5 (Cpara), 129.6 (2 C, CHarom.), 132.2 (Cq), 134.4 
(Cq), 146.2 (C=N). LRMS (70 eV, ES+): m/z = 215 (M + H+). HRMS: 
calculated for C14H18N2 + H+: 215.1543, found: 215.1541. Brown oil. Rf (EA 
100) = 0.15. 
 
1-Benzyl-2-isopropyl-4,5-dimethyl-1H-imidazole 11c 
 
IR (KBr, cm-1): νmax = 1653, 1607, 1496, 1432 (C=C and C=N), 
1357, 1324, 1306 (C-N and CH(CH3)2). 1H NMR (300 MHz, 
CDCl3, ppm): δ = 1.24 (6 H, d, J = 6.9 Hz, CH(CH3)2), 1,98 (3 H, 
s, CH3), 2.18 (3 H, s, CH3), 2.88 (1 H, septet, J = 6.9 Hz, 
CH(CH3)2), 5.01 (2 H, s, CH2), 6.91 (2 H, d, J = 6.6 Hz, arom. H), 
7.21-7.33 (3 H, m, arom. H). 13C NMR (75 MHz, CDCl3, ppm): δ 
= 8.9 (CH3), 12.8 (CH3), 22.1 (CH(CH3)2), 26.3 (CH(CH3)2), 46.4 (CH2), 121.6 
(Cq), 125.6 (2 C, CHarom.), 127.5 (Cpara), 128.9 (2 C, CHarom.), 131.7 (Cq), 137.3 
(Cq), 151.5 (C=N). LRMS (70 eV, ES+): m/z = 229 (M + H+). HRMS: 
calculated for C15H20N2 + H+: 229.1699, found: 229.1703. Mp (°C): 104. 
Brown crystals. Rf (PE/EA 50:50) = 0.32. 
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2-Isopropyl-4,5-diphenyl-1H-imidazole 11’d 
 
IR (KBr, cm-1): νmax = 3700-3300 (NH), 2369, 2362, 2341 
(NH); 1620, 1519, 1444, 1426 (C=C and C=N). 1H NMR (300 
MHz, CDCl3, ppm): δ = 1.41 (6 H, d, J = 7.1 Hz, CH(CH3)2), 
3.16 (1 H, septet, J = 7.1 Hz, CH(CH3)2), 7.20-7.39 (8 H, m, 
arom. H), 7.59 (2 H, d, J = 7.1 Hz, arom. H), 8.75 (1 H, br s, 
NH). 13C NMR (75 MHz, CDCl3, ppm): δ = 21.8 (2 C, 
CH(CH3)2), 28.4 (CH(CH3)2), 127.2 (2 C, CHarom.), 127.8 (4 C, CHarom.), 128.6 
(4 C, CHarom.), 133.2 (2 C, Cq), 153.2 (C=N), 2 quaternary carbons were not 
detected.  LRMS (70 eV, ES+): m/z = 263 (M + H+). HRMS: calculated for 
C18H18N2 + H+: 263.1543, found: 263.1541. Mp (°C): 241. White powder. Rf 
(PE/EA 70:30) = 0.24. 
 
1,2-Diisopropyl-4,5-diphenyl-1H-imidazole 11e 
 
IR (KBr, cm-1): νmax = 1601, 1508, 1462, 1446 (C=C and 
C=N), 1389, 1375, 1357, 1302, 1270 (C-N and CH(CH3)2). 1H 
NMR (300 MHz, CDCl3, ppm): δ = 1.39 (6 H, d, J = 7.1 Hz, 
NCH(CH3)2), 1.46 (6 H, d, J = 6.9 Hz, CCH(CH3)2), 3.18 (1 H, 
septet, J = 6.9 Hz, CCH(CH3)2), 4.30 (1 H, septet, J = 7.1 Hz, 
NCH(CH3)2), 7.03-7.16 (3 H, m, arom. H), 7.31-7.45 (7 H, m, 
arom. H). 13C NMR (75 MHz, CDCl3, ppm): δ = 22.7 (2 C, CCH(CH3)2), 22.9 
(2 C, NCH(CH3)2), 27.8 (CCH(CH3)2), 47.2 (NCH(CH3)2), 125.8 (CHarom.), 
126.8 (2 C, CHarom.), 127.4 (1 C, C), 128.0 (2 C, CHarom.), 128.5 (CHarom.), 128.8 
(2 C, CHarom.), 131.9 (2 C, CHarom.), 132.8 (Cq), 135.3 (Cq), 136.6 (Cq), 152.6 
(C=N). LRMS (70 eV, ES+): m/z = 305 (M + H+). HRMS: calculated for 
C21H24N2 + H+: 305.2012, found: 305.2009. Mp (°C): 172. White powder. Rf 
(PE/EA 70:30) = 0.50. 
 
1-Benzyl-2-isopropyl-4,5-diphenyl-1H-imidazole 11f 
 
IR (KBr, cm-1): νmax = 1602, 1509, 1496, 1454, 1417 (C=C 
and C=N), 1362, 1335, 1320 (C-N and CH(CH3)2). 1H 
NMR (300 MHz, CDCl3, ppm): δ = 1.33 (6 H, d, J = 6.9 Hz, 
CH(CH3)2), 2.90 (1 H, septet, J = 6.9 Hz, CH(CH3)2), 4.99 
(2 H, s, CH2), 6.89-6.93 (2 H, m, benzylic. Hortho), 7.07-7.35 
(11 H, m, arom. H), 7.48-7.52 (2 H, m, arom. H). 13C NMR 
(75 MHz, CDCl3, ppm): δ = 22.1 (2 C, CH(CH3)2), 26.7 
(CH(CH3)2), 46.8 (CH2), 125.8 (2 C, benzylic CHortho), 126.1 (CHarom.), 127.0 
(2 C, CHarom.), 127.5 (CHarom.), 128.1 (2 C, CHarom.), 128.3 (Cq), 128.4 (CHarom.), 
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128.8 (2 C, CHarom.), 128.9 (2 C, CHarom.), 131.1 (2 C, CHarom.), 131.5 (Cq), 
135.1 (Cq), 136.8 (Cq), 137.7 (Cq), 153.3 (C=N). LRMS (70 eV, ES+): m/z = 
353 (M + H+). HRMS: calculated for C25H24N2 + H+: 353.2012, found: 
353.2011. Mp (°C): 129. White crystals. Rf (PE/EA 70:30) = 0.52. 
 
1,2,4,5-Tetraphenyl-1H-imidazole 11g 
  
IR (KBr, cm-1): νmax = 1597, 1497, 1480, 1441 (C=C and 
C=N), 1396, 1375 (C-N). 1H NMR (300 MHz, CDCl3, 
ppm): δ = 7.03-7.06 (2 H, m, arom. H), 7.12-7.15 (2 H, m, 
arom. H), 7.19-7.31 (12 H, m, arom. H), 7.42-7.45 (2 H, m, 
arom. H), 7.59-7.63 (2 H, m, arom. H). 13C NMR (75 
MHz, CDCl3, ppm): δ = 126.7 (CHarom.), 127.5 (2 C, 
CHarom.), 128.1 (CHarom.), 128.2 (2 C, CHarom.), 128.3 (2 C, 
CHarom.), 128.4 (2 C, CHarom.), 128.4 (2 C, CHarom.), 128.5 (2 C, CHarom.), 129.1 
(2 C, CHarom.), 129.2 (2 C, CHarom.), 130.6 (Cq), 130.8 (Cq), 131.0 (Cq), 131.2 (2 
C, CHarom.), 134.6 (Cq), 137.2 (Cq), 138.4 (Cq), 147.0 (C=N). LRMS (70 eV, 
ES+): m/z = 373 (M + H+). HRMS: calculated for C27H20N2 + H+: 373.1699, 
found: 373.1712. Mp (°C): 216. Transparent crystals. Rf (PE/EA 70:30) = 
0.50. 
 
1-Benzyl-2-isopropyl-4-methyl-5-phenyl-1H-imidazole (MAJOR) + 1-
Benzyl-2-isopropyl-5-methyl-4-phenyl-1H-imidazole (minor) 11h 
 
IR (Major KBr, Minor NaCl, cm-1): νmax = 
MAJOR 1607, 1497, 1465, 1450, 1425 
(C=C and C=N), 1354, 1317 (C-N and 
CH(CH3)2). minor 1658, 1606, 1512, 1497, 
1455 (C=C and C=N), 1381, 1357, 1337 
(C-N and CH(CH3)2). 1H NMR (300 
MHz, CDCl3, ppm): δ = MAJOR 1.27 (6 
H, d, J = 6.9 Hz, CH(CH3)2), 2.24 (3 H, s, 
CH3), 2.84 (1 H, septet, J = 6.9 Hz, CH(CH3)2), 5.02 (2 H, s, CH2), 6.89 (2 H, 
d, J = 6.6 Hz, arom. H), 7.16-7.36 (8 H, m, arom. H). minor 1.31 (6 H, d, J = 
6.9 Hz, CH(CH3)2), 2.25 (3 H, s, CH3), 2.95 (1 H, septet, J = 6.9 Hz, 
CH(CH3)2), 5.12 (2 H, s, CH2), 6.97 (2 H, d, J = 6.6 Hz, arom. H), 7.20-7.41 
(6 H, m, arom. H), 7.65-7.68 (2 H, m, arom. H). 13C NMR (75 MHz, CDCl3, 
ppm): δ = MAJOR 13.4 (CH3), 22.1 (2 C, CH(CH3)2), 26.5 (CH(CH3)2), 46.9 
(CH2), 125.7 (2 C, CHarom.), 127.5 (CHarom.), 127.7 (CHarom.), 128.1 (Cq), 128.6 
(2 C, CHarom.), 128.8 (2 C, CHarom.), 130.3 (2 C, CHarom.), 130.9 (Cq), 133.9 (Cq), 
137.9 (Cq), 152.8 (C=N). minor 10.3 (CH3), 22.1 (2 C, CH(CH3)2), 26.6 
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(CH(CH3)2), 46.5 (CH2), 122.9 (Cq), 125.7 (2 C, CHarom.), 126.1 (CHarom.), 
127.5 (2 C, CHarom.), 127.7 (CHarom.), 128.4 (2 C, CHarom.), 129.0 (2 C, CHarom.), 
135.8 (Cq), 136.4 (Cq), 137.0 (Cq), 152.6 (C=N). LRMS (70 eV, ES+): m/z = 
MAJOR 291 (M + H+). minor 291 (M + H+). HRMS: MAJOR calculated for 
C20H22N2 + H+: 291.1856, found: 291.1860. minor calculated for C20H22N2 + 
H+: 291.1856, found: 291.1861. Mp (°C):  MAJOR 116. Light brown crystals. 
Rf (PE/EA 70:30) = 0.27. minor Brown oil. Rf (PE/EA 70:30) = 0.41. 
 
4-Methyl-1,2,5-triphenyl-1H-imidazole (MAJOR) + 5-Methyl-1,2,4-
triphenyl-1H-imidazole (minor) 11i 
 
IR (KBr, cm-1): νmax = MAJOR 1596, 
1493, 1465, 1441 (C=C and C=N), 
1397, 1382, 1364 (C-N). minor 1597, 
1494, 1471, 1444 (C=C and C=N), 
1400, 1382 (C-N). 1H NMR (300 MHz, 
CDCl3, ppm): δ = MAJOR 2.38 (3 H, s, 
CH3), 7.00-7.07 (4 H, m, arom. H), 
7.18-7.30 (9 H, m, arom. H), 7.32-7.35 (2 H, m, arom. H). minor 2.26 (3 H, s, 
CH3), 7.14-7.31 (7 H, m, arom. H), 7.37-7.49 (6 H, m, arom. H), 7.78-7.81 (2 
H, m, arom. H). 13C NMR (75 MHz, CDCl3, ppm): δ = MAJOR 13.6 (CH3), 
127.2 (CHarom.), 128.1 (6 C, CHarom.), 128.3 (2 C, CHarom.), 128.9 (2 C, CHarom.), 
129.2 (2 C, CHarom.), 130.3 (2 C, CHarom.), 130.4 (Cq), 130.6 (Cq), 130.7 (Cq), 
135.8 (Cq), 137.6 (Cq), 146.1 (C=N). minor 11.3 (CH3), 126.3 (Cq), 126.5 
(CHarom.), 127.4 (2 C, CHarom.), 128.0 (CHarom.), 128.2 (2 C, CHarom.), 128.3 (2 C, 
CHarom.), 128.5 (4 C, CHarom.), 128.8 (1 C, CHarom.), 129.7 (2 C, CHarom.), 130.8 
(Cq), 135.3 (Cq), 137.6 (Cq), 137.8 (Cq), 146.3 (C=N). LRMS (70 eV, ES+): 
m/z = MAJOR 311 (M + H+). minor 311 (M + H+). HRMS: MAJOR 
calculated for C22H18N2 + H+: 311.1543, found: 311.1540. minor calculated for 
C22H18N2 + H+: 311.1543, found: 311.1543. Mp (°C):  MAJOR 206. White 
powder. Rf (PE/EA 70:30) = 0.32. minor 123. Brown crystals. Rf (PE/EA 
70:30) = 0.47. 
 
4(5)-Methyl-2,5(4)-diphenyl-1H-imidazole 11’j 
 
IR (KBr, cm-1): νmax = 3210 (NH), 2355, 2333 (NH), 1657, 
1591, 1498, 1463 (C=C and C=N), 1400, 1379 (C-N). 1H 
NMR (300 MHz, CDCl3, ppm): δ = 2.40 (3 H, s, CH3), 
7.20-7.40 (6 H, m, arom. H), 7.56-7.59 ppm (2 H, m, arom. 
H), 7.83-7.86 (2 H, m, arom. H). 13C NMR (75 MHz, CDCl3, ppm): δ = 12.7 
(CH3), 125.2 (2 C, CHarom.), 126.8 (CHarom.), 126.8 (2 C, CHarom.), 128.1 (Cq), 
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128.6 (CHarom.), 128.7 (2 C, CHarom.), 128.9 (2 C, CHarom.), 130.0 (2 C, Cq), 
133.1 (Cq) , 145.0 (C=N). LRMS (70 eV, ES+): m/z = 235 (M + H+). HRMS: 
calculated for C16H14N2 + H+: 235.1230, found: 235.1228. Mp (°C): 55. 
Yellow powder. Rf (PE/EA 70:30) = 0.20. 
 
4.5 α-AMINOPHOSPHONATES 
4.5.1 Synthesis of aldimines 
 
Unless otherwise stated, the aldimines were prepared as follows. A mixture of 
aldehyde (10 mass%) with an equimolar amount of amine were dissolved in 
dichloromethane. If the amine was volatile, a slight excess was used. 
Magnesium sulfate was added and the mixture was stirred overnight. After 
filtration of the MgSO4, the dichloromethane was evaporated and the 
aldimine was obtained in high yield and purity. 
 
Benzylidene-isopropylamine 12a 
 
1H NMR (300 MHz, CDCl3, ppm): δ = 1.27 (6 H, d, J = 6.3 Hz, 
CH3), 3.53 (1 H, septet, J = 6.3 Hz, NCH), 7.39-7.41 (3 H, m, 
arom. H), 7.70-7.72 (2 H, m, arom. H), 8.31 (1 H, s, N=CH). 
 
 
Isopropyl-(3-phenylpropenylidene)amine 12b 
 
1H NMR (300 MHz, CDCl3, ppm): δ = 1.23 (6 H, d, J = 6.3 
Hz, CH3), 3.41 (1 H, septet, J = 6.3 Hz, NCH), 6.91 (1 H, d, 
J = 2.2 Hz, =CH), 6.92 (1 H, s, =CH), 7.26-7.38 (3 H, m, 
arom. H), 7.44-7.48 (2 H, m, arom. H), 8.05 (1 H, dd, J = 5.5, 
3.0 Hz, N=CH). 
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(Cyclohexylmethylidene)isopropylamine 12c 
 
1H NMR (300 MHz, CDCl3, ppm): δ = 1.13 (6 H, d, J = 6.3 Hz, 
CH3), 1.10-1.40 (5 H, m, cHexyl), 1.60-1.85 (5 H, m, cHexyl), 
2.05-2.20 (1 H, m, cHexyl), 3.22 (1 H, septet, J = 6.3 Hz, NCH), 
7.47 (1 H, d, J = 5.8 Hz, N=CH). 
 
Benzyl-isobutylidene-amine 12d 
 
1H NMR (300 MHz, CDCl3, ppm): δ = 1.11 (6 H, d, J = 6.9 
Hz, CH3), 2.42-2.58 (1 H, m, CH), 4.56 (2 H, s, NCH2), 7.20-
7.38 (5 H, m, arom. H), 7.66 (1 H, d, J = 5.0 Hz, N=CH). 
 
Allyl-(furan-2-ylmethylidene)amine 12e 
 
1H NMR (300 MHz, CDCl3, ppm): δ = 4.23 (2 H, dd, J = 6.1, 
1.4 Hz, NCH2), 5.10-5.28 (2 H, m, =CH2), 5.95-6.10 (1 H, m, 
CH=CH2), 6.46-6.49 (1 H, m, =CH), 6.75-6.77 (1 H, d, =CH), 
7.52 (1 H, br s, =CHO), 8.10 (1 H, br s, N=CH). 
 
4.5.2 Synthesis of α-aminophosphonates 
4.5.2.1 General batch procedure for α-aminophosphonate synthesis 
 
A mixture of aldimine (5 mmol) and dialkyl phosphite (10 mmol) in methanol 
was refluxed for one to three hours (depending on the type of the imine). 
After reaction, the solvent was evaporated in vacuo and the residue was 
dissolved in 10 mL of dichloromethane and extracted with 10 mL of 1 N HCl. 
The aqueous phase was washed 2 times with 10 mL of dichloromethane. 
Afterwards, the aqueous phase was basified using 1 N NaOH and was 
extracted 3 times with 10 mL of dichloromethane. The combined organic 
fractions were dried over MgSO4. After filtration and evaporation the α-
aminophosphonates were obtained in high purity. 
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4.5.2.2 General microreactor procedure starting from the imine (Table 
3.15) 
 
In the optimised procedure, MeOH was added to 28.0 g of imine (40 mass%) 
to obtain a 70 mL solution in the measuring cup. In the second measuring 
cup, MeOH was added to 2 equivalents of dimethyl phosphite to create a 70 
mL solution. Both measuring cups were connected to the CYTOS® College 
System and the general microreactor setup was followed. At the outlet, 
about 10 mL was collected for analysis. The work up of the reaction mixture 
was performed by means of the same acid base extraction as in the batch 
procedure. The conversion was calculated from the 1H-NMR spectrum of the 
reaction mixture before work up. 
 
4.5.2.3 General procedure starting from the aldehyde and amine (Table 
3.16, entry 3) 
 
In the optimised procedure, a solution of benzaldehyde (20.2 g, 0.19 mol, 
28.9 mass%) and trimethyl orthoformate (20.2 g, 1 equiv, 0.19 mol, 28.9 
mass%) was transferred to a measuring cup and adjusted to 70 mL with 
MeOH. In a second measuring cup, another solution was made, containing 
isopropylamine (11.2 g, 1 equiv, 0.19 mol, 16 mass%) and dimethyl phosphite 
(41.9 g, 2 equiv, 0.38 mol, 59.9 mass%), which was adjusted to 70 mL with 
MeOH. Both measuring cups were connected to the CYTOS® College 
System and the general microreactor setup was followed. At the outlet, 
about 10 mL was collected for analysis. The work up of the reaction mixture 
was performed by means of the acid base extraction, similar as in the batch 
procedure. The conversion was calculated from the 1H-NMR spectrum of the 
reaction mixture before work up. Spectral data were in accordance with 
literature.[38] 
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Dimethyl isopropylaminophenylmethyl phosphonate 14a 
 
1H NMR (300 MHz, CDCl3, ppm): δ = 0.99 (3 H, d, J = 6.1 
Hz, CH3), 1.02 (3 H, d, J = 6.3 Hz, CH3), 1.84 (1 H, br s, 
NH), 2.68 (1 H, septet, J = 6.3 Hz, NCH), 3.51 (3 H, d, JHP = 
10.5 Hz, OCH3), 3.78 (3 H, d, JHP = 10.5 Hz, OCH3), 4.17 (1 
H, d, JHP = 22.3 Hz, CHP), 7.27-7.43 (5 H, m, arom. H). 31P NMR (121 MHz, 
CDCl3, ppm): δ = 26.99. 
 
Diethyl isopropylaminophenylmethyl phosphonate 14’a 
 
1H NMR (300 MHz, CDCl3, ppm): δ = 0.99 (3 H, d, J = 6.9 
Hz, NCH(CH3)2), 1.01 (3 H, d, J = 6.9 Hz, NCH(CH3)2), 1.11 
(3 H, t, J = 6.9 Hz, OCH2CH3), 1.30 (3 H, t, J = 6.9 Hz, 
OCH2CH3), 1.80 (1 H, br s, NH), 2.68 (1 H, septet, J = 5.8 
Hz, NCH), 3.70-3.83 (1 H, m, OCH2CH3), 3.88-4.01 (1 H, m, OCH2CH3), 
4.06-4.22 (3 H, m, OCH2CH3 and CHP), 7.24-7.42 (5 H, m, arom. H). 31P 
NMR (121 MHz, CDCl3, ppm): δ = 24.74. 
 
Dimethyl (2E)-1-isopropylamino-3-phenylprop-2-enyl phosphonate 14b 
 
1H NMR (300 MHz, CDCl3, ppm): δ = 1.03 (3 H, d, J = 
6.1 Hz, CH3), 1.09 (3 H, d, J = 6.3, CH3), 1.56 (1 H, br s, 
NH), 2.95 (1 H, septet, J = 6.3 Hz, NCH), 3.78 (3 H, d, 
JHP = 10.5 Hz, OCH3), 3.83 (3 H, d, JHP = 10.5 Hz, 
OCH3), 3.82 (1 H, ddd, JHP = 20.0, J = 8.5, 0.8 Hz, CHP), 6.12 (1 H, ddd, J = 
15.8, 8.5, JHP = 5.8 Hz, PhCH=CH), 6.61 (1 H, dd, J = 16.0, JHP = 4.7 Hz, 
PhCH=CH), 7.21-7.43 (5 H, m, arom. H). 31P NMR (121 MHz, CDCl3, ppm): 
δ = 27.02. 
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Dimethyl cyclohexylisopropylaminomethyl phosphonate 14c 
 
1H NMR (300 MHz, CDCl3, ppm): δ = 0.99 (3 H, dd, J = 6.1, 
3.0 Hz, CH3), 1.03 (3 H, dd, J = 6.2, 3.0 Hz, CH3), 1.09-1.45 
(6 H, m, cHexyl and NH), 1.58-1.83 (6 H, m, cHexyl), 2.77 (1 
H, dt, JHP = 16.8, J = 3.0 Hz, CHP), 2.92-3.02 (1 H, m, 
NCH), 3.75 (3 H, d, JHP = 10.5 Hz, OCH3), 3.78 (3 H, d, JHP = 10.5 Hz, 
OCH3). 31P NMR (121 MHz, CDCl3, ppm): δ = 31.77. 
 
Dimethyl 1-benzylamino-2-methylpropyl phosphonate 14d 
 
1H NMR (300 MHz, CDCl3, ppm): δ = 1.01 (3 H, d, J = 6.9 Hz, 
CH3), 1.02 (3 H, dd, J = 6.6, JHP = 1.1 Hz, CH3), 1.78 (1 H, br s, 
NH), 2.08-2.23 (1 H, m, NCH), 2.78 (1 H, dd, JHP = 14.5, J = 
3.5 Hz, CHP), 3.76 (3 H, d, JHP = 10.5 Hz, OCH3), 3.79 (3 H, d, JHP = 10.5 
Hz, OCH3), 3.84 (1 H, dd, JAB = 12.6, JHP = 1.4 Hz, CHaHbPh), 4.02 (1 H, d, 
JAB = 12.9 Hz, CHaHbPh), 7.21-7.39 (5 H, m, arom. H). 31P NMR (121 MHz, 
CDCl3, ppm): δ = 31.72. 
 
Dimethyl allylaminofuran-2-ylmethyl phosphonate 14e 
 
1H NMR (300 MHz, CDCl3, ppm): δ = 1.83 (1 H, br s, NH), 
2.96 (1 H, dd, JAB = 13.8, J = 6.6 Hz, CH2), 3.18 (1 H, dd, JAB 
= 13.9, J = 5.5 Hz, CH2), 3.53 (3 H, d, JHP = 10.5 Hz, OCH3), 
3.69 (3 H, d, JHP = 10.5 Hz, OCH3), 4.06 (1 H, d, JHP = 22.0 Hz, CHP), 4.96-
5.08 (2 H, m, =CH2), 5.61-5.77 (1 H, m, CH2CH=), 6.22-6.28 (2 H, m, =CH), 
7.30-7.32 (1 H, m, CHO). 31P NMR (121 MHz, CDCl3, ppm): δ = 24.15. 
 
4.6 ISOCHROMENONE SYNTHESIS 
4.6.1 Batch procedure 
 
The batch procedure was based on a literature procedure.[39] Generally, 3.00 g 
of 2-formyl benzoic acid (20 mmol, 1 equiv) and 2.40 g of acetic acid (40 
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mmol, 2 equiv) in 25 mL of methanol were added to a solution of 1,56 g of 
potassium cyanide (24 mmol, 1.2 equiv) and 40 mmol of the corresponding 
amine (2 equiv) in 25 mL of methanol. The outlet was connected to a 
sequence of 2 flasks of 3 M NaOH to trap the residual HCN released. The 
mixture was heated to reflux for an additional 3 h. After cooling, the 
crystalline product was collected via filtration, washed with methanol and 
water and dried with P4O10. 
 
4.6.2 Optimised procedure under microreactor conditions (Table 
3.17, entry 5) 
 
In a measuring cylinder, 3.15 g of 2-formyl benzoic acid (21 mmol, 1 equiv) 
and 2.52 g of acetic acid (42 mmol, 2 equiv) were dissolved in 70 mL of 
methanol. The other measuring cylinder contained 3.91 g of aniline (42 mmol, 
2 equiv) and 1.64 g of potassium cyanide (25.2 mmol, 1.2 equiv) dissolved in 
70 mL of methanol. Both solutions were connected to the inlets of the device. 
The outlet was connected to a measuring cylinder, which was for his part 
connected to a sequence of 2 flasks of 3 M NaOH to trap the residual HCN 
released. The outlet of the RTU was constantly kept under a nitrogen 
atmosphere. The general microreactor setup was followed. About 30 mL 
was collected for work up. The work up consisted of the removal of the 
solvent via evaporation under a N2 atmosphere. The residual mixture was 
filtered and the crystals were washed with methanol and water. The crystals 
were dried with P4O10. 
 
4.6.3 General procedure for the plug flow reactions (Table 3.18) 
 
A concentration of 0.4 M of 2-formyl benzoic acid was used instead of 0.3 M 
(vide supra, § 4.6.2). The other reagents were used in the same ratio. Both 
solutions were connected to the microreactor inlets. A HPLC pump was 
connected between the microreactor and the RTU via a T-connection (see 
Figure 3.20). A solution of Fluorinert® FC-70 was connected to the pump. 
The flow rates (rpiston pumps and rHPLC) were calculated by measuring the 
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outgoing volume of reaction mixture and Fluorinert® FC-70. The residence 
time τ was calculated as follows: 
 
HPLCtotal
RTU
total
ormicroreact
rr
V
r
V(min) τ ++=  with rtotal = 2 rpiston pump (3.3) 
 
with Vmicroreactor = inner volume of the microreactor (mL) 
 VRTU = inner volume of the RTU (mL) 
 rtotal = total flow rate of the 2 piston pumps (mL/min)  
 rpiston pump = flow rate of the piston pump (mL/min) 
 rHPLC = flow rate of the HPLC pump (mL/min) 
 
The reaction mixture fraction (rmf) at the output was calculated as follows: 
 
Fluorinertmixturereaction
mixturereaction
VV
V
(-) +=rmf   (3.2) 
 
with Vreaction mixture = volume of the reaction mixture in the sample (mL) 
 VFluorinert = volume of Fluorinert® FC-70 in the sample (mL) 
 
Fluorinert® FC-70 was separated and the rest of the work up was identical to 
the procedure described in § 4.6.2. To recuperate the Fluorinert® FC-70, the 
fluorous solvent was extracted once with an equal amount of 
dichloromethane and once with an equal amount of water.  
 
4.6.4 Qualitative HCN measurement 
 
For the qualitative detection of HCN, a known HCN spot test was used.[353] 
The HCN detection solution was made as follows. Approximately 5 mg of 
copper ethyl acetoacetate and 4,4’’-methylenebis(N,N-dimethylaniline) were 
dissolved in 1 to 2 mL of chloroform. To make a HCN detection paper, a 
filter paper of approximately 3 cm Ø was made and moisturised with a drop 
of the detection solution. The colourless detection paper was put at the outlet 
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of the reaction mixture. The appearance of a blue colour indicated a positive 
result. This was tested on a 25 mL batch scale and on the microreactor setup. 
For both evaluations, the procedures described above were used with one 
important modification. In order to test not the excess of KCN, an equimolar 
amount of KCN was used instead of the normal 1.2 equivalents. 
 
4.6.5 Quantitative HCN measurement 
4.6.5.1 Titration procedure 
 
The titration procedure is based on a known procedure of the EPA.[358,359] For 
the indicator solution, 20 mg of 5-(4-dimethylaminobenzylidene)rhodanine 
(C12H12N2OS2) was dissolved in 100 mL of acetone. The standard silver 
nitrate solution was made as follows. Approximately 5 g of AgNO3 was 
crushed and dried to constant weight at 50 °C. Exactly 1.6324 g of dried 
AgNO3 was weighed and dissolved in 500 mL of distilled water. For the CN- 
measurement in the batch procedures, this solution was used for titration. In 
the microreactor procedure, this solution was diluted 200 times before use as 
titration agent because of the low CN- concentrations. 
 
The 125 mL NaOH solution (which contains the CN- ions) was diluted to 
250 mL with distilled water. Exactly 50 mL was pipetted and titrated with the 
silver nitrate solution until the end point was reached. Because of the difficult 
visibility of the colour change, the solution was continuously compared with a 
solution at the end point. This procedure was repeated at least 3 times. Also a 
blank NaOH solution was titrated to correct for background CN- ions. The 
molar amount of CN- ions in the batch procedure was calculated as follows: 
 
1000
50
2502
M
C)V(V
(mmol)CN
3
3
AgNO
AgNOblancotitration ⋅⋅⋅⋅−=−  (4.4) 
 
with Vtitration = volume of silver nitrate solution necessary to reach the end 
 point of titration of the sample (mL) 
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 Vblanco = volume of silver nitrate solution necessary to reach the end 
 point of titration of a blanco sample (mL) 
 
3AgNO
C  = silver nitrate concentration (3.2692 x 10-3 g/mL) 
 
3AgNO
M = molecular weight of silver nitrate (169.87 g/mol)   
 
For the microreactor procedure this was also divided with 200, to correct for 
the dilution of the silver nitrate solution. 
 
4.6.5.2 Reliability tests 
 
To optimise the CN- capture and the titration procedure for this particular 
reaction setup, different tests were performed. 
 
1. Reliability test 
 
For every new solution of silver nitrate that was made, a known amount of 
KCN was dissolved in distilled water and titrated with the silver nitrate 
solution (3.2692 x 10-3 g/mL). 
 
2. Recuperation test 
 
A two neck flask was filled with 0.293 g of potassium cyanide (4.5 mmol) in 
15 mL methanol. One outlet was connected to a gas scrubber which was 
filled with 50 mL of 0.25 N NaOH or with 125 mL of 1 N NaOH. Via the 
other outlet, a solution of 0.450 g of acetic acid (7.5 mmol) in 10 mL 
methanol was slowly added to the KCN solution. Meanwhile, the reaction 
mixture was heated at 50 °C for 3 h. Afterwards, the gas scrubber was 
disconnected and the NaOH solution was subjected to the titration procedure. 
 
4.6.5.3 Batch procedure to measure the HCN release (250 mL) 
 
A three neck flask was filled with a mixture of 5.63 g of 2-formyl benzoic acid 
(37.5 mmol, 1 equiv), 6.98 g of aniline (75 mmol, 2 equiv) and 2.93 g of 
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potassium cyanide (45 mmol, 1.2 equiv) in 250 mL of methanol. The flask 
was connected to a gas scrubber which was filled with 125 mL of 1 N NaOH. 
The whole system was flushed for 30 min with nitrogen. Meanwhile, a syringe 
was filled with 4.33 mL of acetic acid (4.50 g, d = 1.04 g/mL, 75 mmol, 2 
equiv). After 30 min, the nitrogen was shut down. The acetic acid was added 
via a syringe pump (at a flow rate of 10 mL/h) while the mixture was heated. 
After adding the acetic acid, the mixture was heated at reflux for another 3 h. 
Finally, the mixture was cooled down, while the system was again flushed for 
30 min with nitrogen. Afterwards, the gas scrubber was disconnected and the 
NaOH solution was subjected to the titration procedure. For the setup on a 
25 mL scale, the above procedure was identical, with exception of the 
amounts of reagent that has to be divided by 10. 
 
4.6.5.4 Microreactor procedure to measure the HCN release 
 
For the microreactor procedure, the setup was identical to the optimised 
procedure described in § 4.6.2. The only exception was that a gas scrubber, 
which was filled with 125 mL of 1 N NaOH, was connected to the end of the 
RTU. The system was started up and the first fraction was collected. After 
collection of the first fraction (start up fraction), this fraction and the first gas 
scrubber were removed carefully. Meanwhile, a second collection flask (steady 
state fraction) and gas scrubber were connected. The same procedure was 
repeated for the third fraction (steady state fraction). For the fourth fraction 
(shutdown fraction), the same procedure was used but in the meanwhile the 
reaction flasks at the inlet were replaced by solvent in order to flush the 
system. Finally, the different NaOH solutions in the gas scrubbers were 
subjected to the titration procedure. 
 
4.6.6 Spectral data of the 3,4-diamino-1H-isochromen-1-ones 
 
The spectral data of compounds 17a-e and 17g were in accordance with the 
literature.[39] 
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3-Amino-4-(phenylamino)-1H-isochromen-1-one 17a 
 
1H NMR (300 MHz, DMSO, ppm): δ = 6.52-6.62 (5 H, m, H-
2’, H-4’, H-6’ and NH2), 6.82 (1 H, s, NH), 7.03-7.12 (4 H, m, 
H-5, H-7, H-3’ and H-5’), 7.52 (1 H, ddd, J = 8.1, 7.1, 1.4 Hz, 
H-6), 7.92 (1 H, dd, J = 8.0, 0.8 Hz, H-8). 
 
 
3-Amino-4-(3-methoxyphenylamino)-1H-isochromen-1-one 17b 
 
1H NMR (300 MHz, DMSO, ppm): δ = 3.63 (3 H, s, 
OCH3), 6.11-6.22 (3 H, m, H-2’, H-4’ and H-6’), 6.54 (2 
H, s, NH2), 6.83 (1 H, s, NH), 6.96 (1 H, t, J = 8.1 Hz, H-
5’), 7.04-7.11 (2 H, m, H-5 and H-7), 7.53 (1 H, ddd, J = 
8.1, 7.0, 1.4 Hz, H-6), 7.91 (1 H, dd, J = 8.0, 0.8 Hz, H-8). 
 
3-Amino-4-(3-methylphenylamino)-1H-isochromen-1-one 17c 
 
1H NMR (300 MHz, DMSO, ppm): δ = 2.15 (3 H, s, CH3), 
6.36-6.43 (3 H, m, H-2’, H-4’ and H-6’), 6.53 (2 H, s, NH2), 
6.75 (1 H, s, NH), 6.94 (1 H, t, J = 8.0 Hz, H-5’), 7.03-7.12 
(2 H, m, H-5 and H-7), 7.53 (1 H, ddd, J = 8.1, 7.0, 1.4 Hz, 
H-6), 7.92 (1 H, dd, J = 7.8, 0.8 Hz, H-8). 
 
3-Amino-4-(4-methoxyphenylamino)-1H-isochromen-1-one 17d 
 
1H NMR (300 MHz, DMSO, ppm): δ = 3.62 (3 H, s, 
OCH3), 6.47 (1 H, s, NH), 6.50 (2 H, s, NH2), 6.52 (2 H, 
d, J = 8.8 Hz, H-2’ and H-6’), 6.70 (2 H, d, J = 8.8 Hz, H-
3’ and H-5’), 7.04-7.11 (2 H, m, H-5 and H-7), 7.52 (1 H, 
ddd, J = 8.5, 7.1, 1.4 Hz, H-6), 7.91 (1 H, d, J = 7.4 Hz, 
H-8). 
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3-Amino-4-(4-methylphenylamino)-1H-isochromen-1-one 17e 
 
1H NMR (300 MHz, DMSO, ppm): δ = 2.14 (3 H, s, CH3), 
6.45-6.51 (4 H, m, H-2’, H-6’ and NH2), 6.62 (1 H, s, NH), 
6.88 (2 H, d, J = 8.3 Hz, H-3’ and H-5’), 7.01-7.11 (2 H, m, 
H-5 and H-7), 7.52 (1 H, ddd, J = 8.3, 7.0, 1.4 Hz, H-6), 7.91 
(1 H, dd, J = 7.7, 0.8 Hz, H-8). 
 
3-Amino-4-(4-fluorophenylamino)-1H-isochromen-1-one 17f 
 
IR (KBr, cm-1): νmax = 3474, 3375, 3303, 3158, 1748 (C=O), 
1631, 1602, 1547, 1508, 1482, 1351, 1302, 1266, 1220, 1151, 
1098, 1026, 982, 822, 760, 678, 507. 1H NMR (300 MHz, 
DMSO, ppm): δ = 6.53-6.59 (4 H, m, H-2’, H-6’ and NH2), 
6.79 (1 H, s, NH), 6.91 (2 H, pseudo-t, J = 8.8 Hz, H-3’ and 
H-5’), 7.03-7.11 (2 H, m, H-5 and H-7), 7.53 (1 H, pseudo-t, J = 7.7 Hz, H-6), 
7.92 (1 H, dd, J = 8.0, 0.8 Hz, H-8). 13C NMR (75 MHz, DMSO, ppm): δ = 
91.3 (C-4), 114.1 (C-2’ and C-6’, d, JC-F = 6.9 Hz), 114.6 (C-8a), 115.9 (C-3’ 
and C-5’, d, JC-F = 21.8 Hz), 120.1 (C-5), 122.7 (C-7), 129.9 (C-8), 135.5 (C-6), 
142.2 (C-4a), 144.9 (C-1’), 155.4 (C-4’, d, JC-F = 229.0 Hz), 156.8 (C-3), 160.9 
(C=O). 19F NMR (282 MHz, DMSO, ppm): δ = -128.6 (1 F, septet, J = 4.0 
Hz). LRMS (70 eV, ES+): m/z = 271 (M + H+). Mp (°C): 191.0-191.3. Yellow 
powder. Rf (PE/EA 50:50) = 0.52. 
 
3-Amino-4-(methylphenylamino)-1H-isochromen-1-one 17g 
 
1H NMR (300 MHz, DMSO, ppm): δ = 3.16 (3 H, s, CH3), 
6.60-6.66 (3 H, m, H-2’, H-4’ and H-6’), 6.70-6.74 (3 H, m, H-
5 and NH2), 7.04-7.17 (3 H, m, H-7, H-3’ and H-5’), 7.48 (1 H, 
ddd, J = 8.1, 7.0, 1.4 Hz, H-6), 7.94 (1 H, dd, J = 8.0, 0.8 Hz, 
H-8). 
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4-Allylamino-3-imino-isochroman-1-one 124h 
 
IR (KBr, cm-1): νmax = 3349, 3178 (2 x NH), 1689, 1675 (C=O 
and C=N). 1H NMR (300 MHz, DMSO, ppm): δ = 3.59 (1 H, 
dd, J = 15.7 Hz, 7.1 Hz, NHCHaHb), 4.51-4.58 (1 H, pseudo-
dd, J = 15.7 Hz, 4.7 Hz, NHCHaHb), 5.11 (1 H, s, NCH), 5.16 
(1 H, pseudo-d, J = 11.8 Hz, CH=CHaHb), 5.20 (1 H, pseudo-d, 
J = 5.2 Hz, CH=CHaHb), 5.80-5.93 (1 H, m, CH=CHaHb), 7.50-7.72 (5 H, m, 
arom. H + C=NH), 8.05 (1 H, s, NH). ). 13C NMR (75 MHz, DMSO, ppm): 
δ = 43.2 (NHCH2), 62.4 (C-4), 117.7 (=CH2), 122.4 (C-7), 122.8 (C-5), 128.6 
(C-8), 131.4 (C-8a), 131.7 (C-6), 133.3 (=CH), 141.5 (C-4a), 167.6 (C=O), 
168.5 (C=NH). LRMS (70 eV, ES+): m/z = 217 (M + H+). Mp (°C): 200.0-
201.0. White powder. Rf (CH2Cl2/MeOH 95:5) = 0.21. 
 
2-Allyl-3-oxo-2,3-dihydro-1H-isoindole-1-carbonitrile 128 
 
Spectral data were according to literature.[387] 
 
1H NMR (300 MHz, CDCl3, ppm): δ = 3.91 (1 H, ddt, J = 
15.4, 8.0, 0.8 Hz, NCHaHb), 4.79 (1 H, ddt, J = 15.4, 4.7, 1.4 
Hz, NCHaHb), 5.34-5.43 (3 H, m, CH=CH2 and CHCN), 
5.80-5.93 (1 H, m, CH=CH2), 7.59-7.72 (3 H, m, arom. H), 
7.90 (1 H, d, J = 7.3 Hz, arom. H). 
 
4.7 SYNTHESIS OF 1H-ISOCHROMENO[3,4-d]IMIDAZOL-5-
ONES 
4.7.1 Batch reactions (Table 3.21) 
 
Condition A:[367] 
0.252 g (1 mmol, 1 equiv) of compound 17a and 19 mg (0.1 mmol, 0.1 equiv) 
of p-tosyl sulfonic acid monohydrate were added to 10 mL of the orthoester 
18a or 18b. The mixture was stirred at room temperature. After completion 
of the reaction, followed by TLC, the mixture was poured in 50 mL of ethyl 
N
N
O
O
NH
NH
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acetate and was washed twice with 50 mL of saturated NaHCO3. The water 
phase was extracted 2 times with 50 mL of ethyl acetate and the combined 
organic layers were dried with MgSO4. The MgSO4 was filtered and the 
solvent was evaporated to obtain the end product. 
 
Condition B:[367] 
0.252 g (1 mmol, 1 equiv) of compound 17a and 83 µL (1 mmol, 1 equiv) of 
12.1 N HCl were added to 5 mL of the orthoester 18a or 18b. The mixture 
was stirred at room temperature. After completion of the reaction, followed 
by TLC, the mixture was poured in 50 mL of dichloromethane and was 
washed twice with 50 mL of saturated NaHCO3. The water phase was 
extracted 2 times with 50 mL of dichloromethane and the combined organic 
layers were dried with MgSO4. The MgSO4 was filtered and the solvent was 
evaporated to obtain the end product. 
 
Condition C:[368] 
0.252 g (1 mmol, 1 equiv) of compound 17a, 37 µL (0.5 mmol, 0.5 equiv) of 
trifluoro acetic acid and 5 mmol (5 equiv) of the orthoester 18a or 18b were 
added to 10 mL of dichloromethane. The mixture was stirred at room 
temperature. After completion of the reaction, followed by TLC, the mixture 
was poured in 50 mL of dichloromethane and was washed twice with 50 mL 
of saturated NaHCO3. The water phase was extracted 2 times with 50 mL of 
dichloromethane and the combined organic layers were dried with MgSO4. 
The MgSO4 was filtered and the solvent was evaporated to obtain the end 
product. 
 
4.7.2 Optimised procedure in the microreactor (Table 3.22, entry 12) 
 
3-amino-4-(phenylamino)-1H-isochromen-1-one 17a (3.53 g, 14 mmol) was 
dissolved in 70 mL of N,N-dimethyl formamide in a measuring cylinder. The 
other measuring cylinder contained p-toluene sulfonic acid monohydrate 
(0.266 g, 1.4 mmol) and triethyl orthoformate 18a (10.36 g, 70 mmol) 
dissolved in 70 mL of N,N-dimethyl formamide. Both solutions were 
connected to the inlets of the device and the general microreactor setup 
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was followed. About 10 mL of the reaction mixture was quenched with 20 
mL of water. Another 80 mL of water was added to the mixture after 
collection and this was extracted with 50 mL of dichloromethane. The 
organic phase was subsequently washed with 100 mL of water, 2 times 100 
mL of 0.5 N HCl and 100 mL of brine. The organic phase was dried with 
MgSO4. After filtration of the drying agent, the solvent was evaporated to 
obtain the end product 19a.  
This procedure has been used to obtain the results of Table 3.22, entry 12. 
The other results were obtained in the same way, except for minor changes 
such as concentration, temperature, flow rate (~ τ), equivalents of reagents 
and starting 3-amino-4-(arylamino)-1H-isochromen-1-one 17 as stated with 
the experiments. In the case of incomplete conversions, such as the samples 
at the microreactor outlet, a 1H NMR spectrum of the crude mixture was 
recorded. In both starting products 17 and end products 19, the anisotropic 
effect of the carbonyl moiety causes a significant downfield shift of the 
aromatic ortho-protons (respectively H-8 and H-6). This results in a shift of 
both signals from the rest of the aromatic signals and makes a clear 
integration possible. The degree of conversion was calculated using the 
integration of these signals in the 1H NMR spectrum. The yield of the 
reaction was calculated from the total mass of end product collected and the 
degree of conversion. 
In the experiments with the stopped-flow technique (Table 3.23), the same 
conditions were used as in the general microreactor procedure. Samples were 
taken only at the microreactor outlet. A flow time of 1 min was chosen, and a 
stop time of 3 or 5 min. With a total volume of 2 mL and a flow rate of 0.2 
mL/min.pump, the total residence time increased from 3 min to 12 or 18 min 
respectively. 
In Table 3.24, entries 6, 11, 12 and 13, 0.5 equivalents of trifluoro acetic acid 
were used instead of 0.1 equivalents of p-toluene sulfonic acid monohydrate 
and also fresh DMF was used. 
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4.7.3 Spectral data of the 1H-isochromeno[3,4-d]imidazol-5-ones 
 
1-Phenyl-1H-isochromeno[3,4-d]imidazol-5-one 19a 
 
IR (KBr, cm-1): νmax = 3436, 3136, 1729 (C=O), 1718, 1616, 1498, 
1470, 1418, 1380, 1316, 1218, 1070, 1037, 1017, 824, 777, 760, 
706, 683, 644, 554. 1H NMR (300 MHz, CDCl3, ppm): δ = 6.94 
(1 H, d, J = 8.0 Hz, H-9), 7.36 (1 H, td, J = 7.6, 1.0 Hz, H-7), 
7.46-7.56 (4 H, m, H-2, H-8, H-2’ and H-6’), 7.63-7.68 (3 H, m, 
H-3’, H-4’ and H-5’), 8.35 (1 H, d, J = 8.0 Hz, H-6). 13C NMR 
(75 MHz, CDCl3, ppm): δ = 109.0 (C-9b), 119.0 (C-9), 119.2 (C-5a), 126.7 (3 
C, C-7, C-2’ and C-6’), 129.7 (C-9a), 130.2 (3 C, C-3’, C-4’ and C-5’), 132.3 
(C-6), 134.9 (C-8), 136.3 (C-1’), 136.5 (C-2), 151.4 (C-3a), 161.7 (C=O). 
LRMS (70 eV, ES+): m/z = 263 (M + H+). Mp (°C): 221.7-222.4. Yellow 
crystals. Rf (PE/EA 50:50) = 0.32. 
 
1-(3-Methoxyphenyl)-1H-isochromeno[3,4-d]imidazol-5-one 19b 
 
IR (KBr, cm-1): νmax = 3089, 1735 (C=O), 1619, 1605, 1494, 
1477, 1417, 1377, 1334, 1271, 1222, 1064, 1029, 845, 798, 
757, 684. 1H NMR (300 MHz, CDCl3, ppm): δ = 3.89 (3 H, s, 
OCH3), 7.00-7.03 (2 H, m, H-9 and H-2’),  7.09 (1 H, ddd, J 
= 7.7, 1.5, 0.8 Hz, H-4’ or H-6’), 7.16 (1 H, ddd, J = 8.3, 2.5, 
0.8 Hz, H-4’ or H-6’), 7.37 (1 H, pseudo-td, J = 7.6, 1.2 Hz, 
H-7), 7.48-7.54 (2 H, m, H-8 and H-5’), 7.55 (1 H, s, H-2), 8.37 (1 H, pseudo-
d, J = 7.4 Hz, H-6). 13C NMR (75 MHz, CDCl3, ppm): δ = 55.8 (OCH3), 
109.0 (C-9b), 112.3 (C-2’), 115.9 (C-4’ or C-6’), 118.7 (C-4’ or C-6’), 119.2 (C-
9 and C-5a), 126.6 (C-7), 129.7 (C-9a), 130.9 (C-5’), 132.3 (C-6), 134.8 (C-8), 
136.4 (C-2), 137.3 (C-1’), 151.3 (C3-a), 160.8 (C-3’), 161.7 (C=O). LRMS (70 
eV, ES+): m/z = 293 (M + H+). Mp (°C): 166.6-167.2. Orange yellow powder. 
Rf (PE/EA 50:50) = 0.32. 
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1-m-Tolyl-1H-isochromeno[3,4-d]imidazol-5-one 19c 
 
IR (KBr, cm-1): νmax = 3126, 1732 (C=O), 1615, 1550, 1494, 
1472, 1414, 1378, 1333, 1216, 1068, 1043, 1019, 809, 762, 708, 
684, 636. 1H NMR (300 MHz, CDCl3, ppm): δ = 2.50 (3 H, s, 
CH3), 6.96 (1 H, d, J = 8.0 Hz, H-9), 7.27-7.53 (6 H, m, H-7, H-
8, H-2’, H-4’, H-5’ and H-6’), 7.54 (1 H, s, H-2), 8.37 (1 H, dd, J 
= 8.0, 0.8 Hz, H-6). 13C NMR (75 MHz, CDCl3, ppm): δ = 21.5 
(CH3), 109.0 (C-9b), 119.1 (C-9 and C-5a), 123.7 (C-6’), 126.6 (C-7), 127.1 (C-
2’), 129.8 (C-9a), 129.9 (C-5’), 130.9 (C-4’), 132.3 (C-6), 134.9 (C-8), 136.2 (C-
1’), 136.5 (C-2), 140.6 (C-3’), 151.3 (C-3a), 161.8 (C=O). LRMS (70 eV, ES+): 
m/z = 277 (M + H+). Mp (°C): 166.4-168.6. Brown orange powder. Rf 
(PE/EA 70:30) = 0.17. 
 
1-(4-Methoxyphenyl)-1H-isochromeno[3,4-d]imidazol-5-one 19d 
 
IR (KBr, cm-1): νmax = 3100, 1741 (C=O), 1618, 1550, 1509, 
1476, 1413, 1380, 1303, 1261, 1027, 835, 757. 1H NMR (300 
MHz, CDCl3, ppm): δ = 3.95 (3 H, s, OCH3), 6.93 (1 H, d, J = 
8.0 Hz, H-9), 7.08-7.16 (2 H, m, H-3’ and H-5’), 7.34-7.40 (1 
H, m, H-7), 7.40-7.44 (2 H, m, H-2’ and H-6’), 7.46-7.50 (1 H, 
m, H-8), 7.52 (1 H, s, H-2), 8.39 (1 H, pseudo-d, J = 8.0 Hz, 
H-6). 13C NMR (75 MHz, CDCl3, ppm): δ = 55.8 (OCH3), 
109.3 (C-9b), 115.2 (C-3’ and C-5’), 118.9 (C-9), 119.2 (C-5a), 126.6 (C-7), 
128.0 (C-2’ and C-6’), 128.9 (C-1’), 129.9 (C-9a), 132.3 (C-6), 134.8 (C-8), 
136.7 (C-2), 151.1 (C-3a), 160.8 (C-4’), 161.8 (C=O). LRMS (70 eV, ES+): 
m/z = 293 (M + H+). Mp (°C): 169.2-169.4. Pale yellow powder. Rf (PE/EA 
70:30) = 0.22. 
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1-p-Tolyl-1H-isochromeno[3,4-d]imidazol-5-one 19e 
 
IR (KBr, cm-1): νmax = 3117, 1736 (C=O), 1619, 1509, 1476, 1421, 
1380, 1334, 1215, 1138, 1067, 1033, 822, 757, 685, 525. 1H NMR 
(300 MHz, CDCl3, ppm): δ = 2.53 (3 H, s, CH3), 6.96 (1 H, d, J 
= 8.0 Hz, H-9), 7.34-7.52 (6 H, m, H-7, H-8, H-2’, H-3’, H-5’ 
and H-6’), 7.53 (1 H, s, H-2), 8.38 (1 H, pseudo-d, J = 8.0 Hz, H-
6). 13C NMR (75 MHz, CDCl3, ppm): δ = 21.5 (CH3), 109.1 (C-
9b), 119.0 (C-9), 119.2 (C-5a), 126.4 (2 C, C-2’ and C-6’), 126.6 (C-7), 129.8 
(C-9a), 130.7 (2 C, C-3’ and C-5’), 132.3 (C-6), 133.7 (C-1’), 134.8 (C-8), 136.5 
(C-2), 140.5 (C-4’), 151.3 (C-3a), 161.8 (C=O). LRMS (70 eV, ES+): m/z = 
277 (M + H+). Mp (°C): 170.3-171.4. Pale yellow powder. Rf (PE/EA 70:30) 
= 0.34. 
 
1-(4-Fluorophenyl)-1H-isochromeno[3,4-d]imidazol-5-one 19f 
 
IR (KBr, cm-1): νmax = 3139, 1717 (C=O), 1618, 1553, 1508, 1418, 
1382, 1333, 1300, 1253, 1209, 1159, 1142, 1087, 1065, 1033, 
1019, 846, 765, 735, 687, 659, 612, 551. 1H NMR (300 MHz, 
CDCl3, ppm): δ = 6.89 (1 H, d, J = 7.7 Hz, H-9), 7.31-7.42 (3 H, 
m, H-7, H-3’ and H-5’), 7.49-7.55 (4 H, m, H-2, H-8, H-2’ and 
H-6’), 8.38 (1 H, dd, J = 8.0, 1.1 Hz, H-6). 13C NMR (75 MHz, 
CDCl3, ppm): δ = 109.2 (C-9b), 117.3 (C-3’ and C-5’, d, JC-F = 
22.9 Hz), 118.8 (C-9), 119.2 (C-5a), 126.8 (C-7), 128.7 (C-2’ and C-6’, d, JC-F = 
8.0 Hz), 129.5 (C-9a), 132.3 (C-1’, d, JC-F = 3.4 Hz), 132.4 (C-6), 134.9 (C-8), 
136.6 (C-2), 151.3 (C-3a), 161.7 (C=O), 163.3 (C-4’, d, JC-F = 254.2 Hz). 19F 
NMR (282 MHz, CDCl3, ppm): δ = -109.3 (1 F, septet, J = 4.0 Hz). LRMS 
(70 eV, ES+): m/z = 281 (M + H+). Mp (°C): 223.4-224.8. Orange yellow 
powder. Rf (PE/EA 50:50) = 0.38. 
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2-Methyl-1-phenyl-1H-isochromeno[3,4-d]imidazol-5-one 19i 
 
IR (KBr, cm-1): νmax = 3573, 3436, 3058, 1734 (C=O), 1622, 
1599, 1556, 1499, 1396, 1363, 1317, 1301, 1266, 1213, 1069, 
1018, 998, 787, 752, 700, 682, 544, 514. 1H NMR (300 MHz, 
CDCl3, ppm): δ = 2.32 (3 H, s, CH3), 6.57 (1 H, d, J = 8.2 Hz, 
H-9), 7.27 (1 H, td, J = 7.7, 1.1 Hz, H-7), 7.39 (1 H, td, J = 7.7, 
1.4 Hz, H-8), 7.44-7.47 (2 H, m, H-2’ and H-6’), 7.62-7.69 (3 H, 
m, H-3’, H-4’ and H-5’), 8.30 (1 H, d, J = 8.0 Hz, H-6). 13C NMR (75 MHz, 
CDCl3, ppm): δ = 13.7 (CH3), 109.1 (C-9b), 118.0 (C-9), 118.6 (C-5a), 125.8 
(C-7), 127.8 (C-2’ and C-6’), 130.1 (C-9a), 130.4 (C-3’, C-4’ and C-5’), 132.2 
(C-6), 134.8 (C-8), 136.3 (C-1’), 145.5 (C-2), 150.4 (C-3a), 161.9 (C=O). 
LRMS (70 eV, ES+): m/z = 277 (M + H+). Mp (°C): 243.4-244.0. Yellow 
crystals. Rf (PE/EA 50:50) = 0.26. 
 
2-Butyl-1-phenyl-1H-isochromeno[3,4-d]imidazol-5-one 19j 
 
IR (KBr, cm-1): νmax = 2957, 2935, 2862, 1721 (C=O), 1620, 
1592, 1548, 1486, 1393, 1357, 1263, 1064, 1017, 768, 707, 685. 
1H NMR (300 MHz, CDCl3, ppm): δ = 0.85 (3 H, t, J = 7.4 Hz, 
CH3), 1.30 (2 H, sextet, J = 7.4 Hz, CH2CH3), 1.68 (2 H, quintet, 
J = 7.7 Hz, CH2CH2CH3), 2.57 (2 H, t, J = 7.7 Hz, CCH2), 6.50 
(1 H, d, J = 8.0 Hz, H-9), 7.27 (1 H, t, J = 7.6 Hz, H-7), 7.37 (1 
H, t, J = 7.6 Hz, H-8), 7.42-7.46 (2 H, m, H-2’ and H-6’), 7.62-
7.71 (3 H, m, H-3’, H-4’ and H-5’), 8.34 (1 H, d, J = 8.2 Hz, H-6). 13C NMR 
(75 MHz, CDCl3, ppm): δ = 13.8 (CH3), 22.4 (CH2CH3), 26.8 (CCH2), 30.2 
(CH2CH2CH3), 108.9 (C-9b), 118.0 (C-9), 118.7 (C-5a), 125.7 (C-7), 128.1 (C-
2’ and C-6’), 130.2 (C-9a), 130.4 (C-3’, C-4’ and C-5’), 132.2 (C-6), 134.7 (C-8), 
136.2 (C-1’), 149.4 (C-2), 150.6 (C-3a), 162.0 (C=O). LRMS (70 eV, ES+): 
m/z = 319 (M + H+). Mp (°C): 140.6-141.7. Pale yellow crystals. Rf (PE/EA 
70:30) = 0.24. 
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1,2-Diphenyl-1H-isochromeno[3,4-d]imidazol-5-one 19k 
 
IR (KBr, cm-1): νmax = 3841, 3737, 3673, 3650, 3568, 1732 
(C=O), 1618, 1509, 1494, 1382, 1068, 1024, 755, 694. 1H 
NMR (300 MHz, CDCl3, ppm): δ = 6.59 (1 H, d, J = 8.2 Hz, 
H-9), 7.21-7.70 (12 H, m, H-7, H-8 and arom. H), 8.38 (1 H, 
d, J = 7.7 Hz, H-6). 13C NMR (75 MHz, CDCl3, ppm): δ = 
110.7 (C-9b), 118.5 (C-9), 119.1 (C-5a), 126.2 (C-7), 128.4 (2 
C, arom. CH), 128.6 (2 C, arom. CH), 128.7 (2 C, arom. CH), 129.1 (C-1”), 
129.3 (arom. CH), 130.0 (C-9a), 130.5 (C-3’, C-4’ and C-5’), 132.4 (C-6), 134.8 
(C-8), 137.2 (C-1’), 145.8 (C-2), 151.1 (C-3a), 161.7 (C=O). LRMS (70 eV, 
ES+): m/z = 339 (M + H+). Mp (°C): 256.7-257.3. Pale pink crystals. Rf 
(PE/EA 70:30) = 0.39. 
 
2-(4-Nitrophenyl)-1H-isochromeno[3,4-d]imidazol-5-one 19l 
 
IR (KBr, cm-1): νmax = 3568, 1732 (C=O), 1615, 1509, 
1330, 1016, 853, 766, 704. 1H NMR (300 MHz, CDCl3, 
ppm): δ = 6.60 (1 H, dd, J = 7.4, 1.4 Hz, H-9), 7.38 (1 H, 
td, J = 7.4, 1.4 Hz, H-7), 7.44 (1 H, td, J = 7.4, 1.7 Hz, 
H-8), 7.51-7.56 (2 H, m, H-2’ and H-6’), 7.62 (2 H, dm, J 
= 9.1 Hz, H-2” and H-6”), 7.66-7.78 (3 H, m, H-3’, H-4’ 
and H-5’), 8.09 (2 H, dm, J = 9.1 Hz, H-3” and H-5”), 8.41 (1 H, dd, J = 7.7, 
1.7 Hz, H-6). 13C NMR (75 MHz, CDCl3, ppm): δ = 112.1 (C-9b), 118.8 (C-9), 
119.6 (C-5a), 123.7 (C-3” and C-5”), 127.0 (C-7), 128.3 (C-2’ and C-6’), 129.0 
(C-2” and C-6”), 129.4 (C-9a), 131.0 (C-3’ and C-5’), 131.2 (C-4’), 132.6 (C-6), 
135.0 (C-8 and C-1”), 136.7 (C-1’), 142.9 (C-2), 147.6 (C-4”), 151.1 (C-3a), 
161.3 (C=O). LRMS (70 eV, ES+): m/z = 384 (M + H+). Mp (°C): 254.3-
254.7. Yellow crystals. Rf (PE/EA 70:30) = 0.30. 
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2-Isopropyl-1-phenyl-1H-isochromeno[3,4-d]imidazol-5-one 19m 
 
IR (KBr, cm-1): νmax = 3573, 3435, 2973, 2920, 1726 (C=O), 
1618, 1497, 1406, 1369, 1271, 1215, 1167, 1087, 1065, 1030, 
1016, 785, 764, 710, 683, 572. 1H NMR (300 MHz, CDCl3, 
ppm): δ = 1.29 (6 H, d, J = 6.9 Hz, CH(CH3)2), 2.85 (1 H, 
septet, J = 6.9 Hz, CH(CH3)2), 6.45 (1 H, d, J = 8.0 Hz, H-9), 
7.26 (1 H, td, J = 7.7, 1.1 Hz, H-7), 7.36 (1 H, td, J = 7.7, 1.4 
Hz, H-8), 7.43-7.46 (2 H, m, H-2’ and H-6’), 7.62-7.68 (3 H, m, H-3’, H-4’ 
and H-5’), 8.34 (1 H, dd, J = 8.0, 0.8 Hz, H-6). 13C NMR (75 MHz, CDCl3, 
ppm): δ = 21.9 (2 C, CH(CH3)2), 26.3 (CH(CH3)2), 108.7 (C-9b), 118.0 (C-9), 
118.7 (C-5a),  125.7 (C-7), 128.2 (C-2’ and C-6’), 130.3 (C-9a), 130.4 (C-3’, C-
4’ and C-5’), 132.2 (C-6), 134.7 (C-8), 136.2 (C-1’), 150.7 (C-3a), 153.9 (C-2), 
161.9 (C=O). LRMS (70 eV, ES+): m/z = 305 (M + H+). Mp (°C): 225.7-
225.9. White crystals. Rf (PE/EA 70:30) = 0.37. 
 
2-Cyclohexyl-1-phenyl-1H-isochromeno[3,4-d]imidazol-5-one 19n 
 
IR (KBr, cm-1): νmax = 3573, 3414, 2931, 2851, 1714 (C=O), 
1619, 1551, 1497, 1477, 1449, 1403, 1369, 1319, 1294, 1271, 
1211, 1066, 1019, 761, 703, 682, 653, 574. 1H NMR (300 
MHz, CDCl3, ppm): δ = 1.05-1.34 (2 H, m, cHexyl), 1.62-
1.79 (8 H, m, cHexyl), 2.40-2.50 (1 H, m, cHexyl), 6.43 (1 H, 
d, J = 8.0 Hz, H-9), 7.26 (1 H, t, J = 7.7 Hz, H-7), 7.35 (1 H, 
td, J = 7.6, 0.8 Hz, H-8), 7.41-7.45 (2 H, m, H-2’ and H-6’), 7.62-7.71 (3 H, m, 
H-3’, H-4’ and H-5’), 8.33 (1 H, d, J = 8.0 Hz, H-6). 13C NMR (75 MHz, 
CDCl3, ppm): δ = 25.6 (C-4”), 26.0 (C-3” and C-5”), 32.0 (C-2” and C-6”), 
35.8 (C-1”), 108.6 (C-9b), 118.0 (C-9), 118.6 (C-5a), 125.6 (C-7), 128.1 (C-2’ 
and C-6’), 130.3 (C-9a), 130.4 (C-3’, C-4’ and C-5’), 132.2 (C-6), 134.7 (C-8), 
136.1 (C-1’), 150.7 (C-3a), 153.2 (C-2), 161.9 (C=O). LRMS (70 eV, ES+): 
m/z = 345 (M + H+). Mp (°C): 217.4-217.8. Pale yellow crystals. Rf (PE/EA 
70:30) = 0.42. 
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Ethyl N-(1-oxo-4-phenylamino-1H-isochromen-3-yl)acetimidate 136i 
 
Purification of the intermediate 136i occurred by crystallisation in diethyl 
ether without heating the solvent, because heating resulted in formation of 
the end product 19i. 
 
IR (KBr, cm-1): νmax = 3324 (NH), 1721, 1706 (C=O and 
C=N), 1639, 1599, 1559, 1495, 1478, 1368, 1283, 1255, 1226, 
1161, 1052, 1025, 905, 839, 753, 693. 1H NMR (300 MHz, 
CDCl3, ppm): δ = 1.24 (3 H, t, J = 7.2 Hz,  OCH2CH3), 2.07 
(3 H, s, CH3), 4.14 (2 H, q, J = 7.2 Hz,  OCH2CH3), 4.98 (1 
H, br s, NH), 6.62 (2 H, dd, J = 8.4, 1.0 Hz, H-2” and H-6”), 
6.79 (1 H, t, J = 7.4 Hz, H-4”), 7.15 (2 H, dd, J = 8.5, 7.4 Hz, H-3” and H-5”), 
7.40 (1 H, td, J = 7.4, 1.1 Hz, H-7’), 7.51-7.54 (1 H, m, H-5’), 7.63 (1 H, td, J 
= 7.6, 1.1 Hz, H-6’), 8.27 (1 H, dd, J = 8.0, 0.8 Hz, H-8’). 13C NMR (75 MHz, 
CDCl3, ppm): δ = 14.0 (OCH2CH3), 19.2 (CH3), 63.3 (OCH2CH3), 106.8 (C-
4’), 114.4 (C-2” and C-6”), 118.8 (C-8’a), 119.1 (C-4”), 122.7 (C-5’), 126.5 (C-
7’), 129.3 (C-3” and C-5”), 130.1 (C-8’), 135.0 (C-6’), 139.2 (C-4’a), 146.9 (C-
1”), 150.7 (C-3’), 161.8 (C=O), 167.5 (C=N). LRMS (70 eV, ES+): m/z = 323 
(M + H+), 277 (M + H+ – EtOH). Mp (°C): 110.9-111.5. Yellow crystals. Rf 
(PE/EA 70:30) = 0.48. 
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Chapter 5 - Summary and 
Perspectives 
 
Microreactor technology is a rather new type of technology which has gained 
a high interest during the last 2 decennia. A closer look into the literature 
reports learns that especially since 1997 a lot of literature has appeared on 
microreactors. Organic synthesis in microreactors is only a very small part of 
it, which means the technology is used in a much broader concept than 
organic synthesis alone. 
 
Microreactors, as part of the wide group of microsystems, were generally 
defined as ‘miniaturised reaction systems fabricated by using, at least partially, 
methods of microtechnology and precision engineering’. Nowadays the 
broader definition also contains down-scaled designs of existing reactors and 
modern reactor concepts such as falling-film reactors, packed-bed reactors 
and structured catalysts e.g. foams. 
 
From an economical point of view, studies are made which state that more or 
less 50 % of today’s chemical reactions could benefit from continuous 
processes which are mainly based on microreaction technology. Generally, a 
lot of advantages for organic synthesis are suggested by developers and 
manufacturers of microreactor systems of which a better mass and heat 
transfer, a safer handling of reactions, a higher selectivity and an easier scale 
up are the most important. Several experiments were performed as a proof-
of-concept for this technology. Most of these studies however were 
performed on easy, well known reactions. 
 
The goal of this thesis was to evaluate the use of a microreactor system for 
some selected multicomponent reactions. In this study, a commercial 
available microreactor system was used: the CYTOS® College System 
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containing generally two piston pumps, a microreactor unit and a residence 
time unit for handling longer reactions (Figure 3.1).  
 
As a first example, the Baylis-Hillman reaction (Scheme 5.1), a carbon-carbon 
bond forming reaction between e.g. an aldehyde i and an activated alkene ii 
with the aid of tertiary amines, such as DABCO iii, or phosphines was 
evaluated. The reaction appears to be very slow in batch conditions. Out of 
the wide variety of possible reagents in the Baylis-Hillman reaction, the 
reaction between 4-nitrobenzaldehyde and methyl acrylate with DABCO as a 
catalyst was chosen to be optimised. 
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Scheme 5.1: Baylis-Hillman and aza-Baylis-Hillman reaction. 
 
The optimisation consisted of several steps including the selection of the 
appropriate mixing of the reagents, the solvent and the temperature. The 
mixing of the reagents had to be chosen carefully, to avoid side reactions such 
as the formation of a stable betaine. Therefore, preliminary mixing of methyl 
acrylate and DABCO was avoided. As a solvent system, a 1:1 (v/v) mixture of 
water and 1,4-dioxane proved to be the best choice. Other solvents, such as 
dichloromethane or sulfolane, did not result in better conversions. Moreover, 
in the case of sulfolane, clogging problems occurred. To obtain the highest 
possible concentration in the microreactor, the aldehyde and the catalyst were 
dissolved in a 3:7 (v/v) water/1,4-dioxane mixture, while the activated alkene 
was dissolved in a 7:3 (v/v) water/1,4-dioxane mixture. This gave the desired 
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1:1 (v/v) mixture in the microreactor. Concerning the reaction temperature, 
room temperature proved to be the best option. Higher temperatures resulted 
in lower conversions, while lower temperatures were not possible using the 
above solvent system. In summary, a mixture of 0.4 M of 4-
nitrobenzaldehyde and 1 equivalent of DABCO in a 3:7 (v/v) water/1,4-
dioxane mixture was reacted with 3 equivalents of methyl acrylate in a 7:3 
(v/v) water/1,4-dioxane mixture at room temperature. After 2 h of reaction, a 
conversion of 93 % was achieved. A comparison with the batch reaction 
showed that there was approximately 30 % decrease in reaction time for this 
specific example. However, due to this rather small acceleration of the Baylis-
Hillman reaction, it was not possible to investigate very slow Baylis-Hillman 
reactions. 
 
Several aldehydes and alkenes were tested using these optimised conditions. 
This resulted in a conversion between 52 and 100 %. To obtain complete 
conversion in the uncompleted reactions, the stopped-flow technique was 
used: by alternative pumping and pausing the flow, the residence time in the 
system was increased. This gave somewhat higher conversions, and some 
reactions were driven to completion. However, applying these conditions in 
an industrial scale will not be economical feasible due to the long start up 
procedure and the lower yield of the experiments. 
 
In a next part of the Baylis-Hillman research, the influence of the residence 
time unit was investigated. It was observed that including the residence time 
unit gave better results at the same residence time. A clear explanation of this 
phenomenon was not found, but probably the difference in flow rates 
between the experiments plays an important role. After introducing some 
modifications in the procedure, a comparison of the Baylis-Hillman reaction 
was made in 2 different microreactors and the conventional batch procedure. 
This showed a better performance in the batch procedure, but no explanation 
was found.   
 
In a final part of this study, the aza-Baylis-Hillman was investigated (Scheme 
5.1), whereby the aldehyde i is replaced by an imine v. To avoid competition 
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with the Baylis-Hillman reaction, it was necessary to form the imine in 
advance. Unfortunately, in that case only a maximal conversion of 49 % was 
obtained. 
 
A second evaluated reaction was the production of imidazoles via a four-
component reaction (Scheme 5.2), based on a microwave-assisted optimised 
literature procedure. However, because of the problems of the scalability of 
microwave technology, a study of this reaction using microreactor technology 
seemed interesting. Imidazoles are considered as important heterocyclic 
structures from biological and synthetical point of view. 
 
The reaction itself was a modified Radziszewski reaction, in which an α-
diketone vii, a primary amine viii, an aldehyde i and ammonium acetate ix 
reacted towards tetrasubstituted imidazoles x (in the case the primary amine 
was absent, trisubstituted imidazoles xi were formed).  
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Scheme 5.2: Imidazole 4-CR. 
 
The reaction of benzil, benzylamine, isobutyraldehyde and ammonium acetate 
under acidic conditions was used to optimise this four-component 
condensation in the microreactor environment. Two main problems occurred 
during the optimisation. One was the search for an appropriate solvent, since 
no solvent was found that dissolves all reagents. Finally, an appropriate 
solvent mixture was developed. The α-diketone and the aldehyde were 
dissolved in DMF or NMP (depending on the selected reaction temperature) 
and the amine and ammonium acetate were dissolved in a primary (high 
boiling) alcohol. The second problem was the low selectivity towards the 
tetrasubstituted imidazole, because part of the starting material reacted 
towards the trisubstituted imidazole. When performing the reaction in pure 
acetic acid at 50 °C, a selective formation of the tetrasubstituted compound 
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was noticed. Therefore, the amount of acetic acid was increased from 2 
equivalents to 10 equivalents. Finally, in the optimised procedure a mixture of 
0.5 M α-diketone, 1 equivalent of aldehyde and 5 equivalents of acetic acid in 
NMP was reacted in the microreactor with a mixture of 1 equivalent of 
ammonium acetate, 1.2 equivalents of amine and 5 equivalents of acetic acid 
in n-pentanol. The temperature was adjusted to 120 °C and the residence time 
was 118 min. A study towards the general applicability of this reaction under 
microreactor conditions using different α-diketones, amines and aldehydes 
yielded between 18 and 78 % of the imidazoles. 
 
Since the type of microreactor used in this doctoral study is specially designed 
for the production of larger quantities of products, it was also interesting to 
test the production of chemical compounds on a larger scale. Therefore, as a 
third investigated reaction, the multicomponent reaction producing α-
aminophosphonates was thoroughly studied. α-Aminophosphonates xiii are 
considered as important compounds, with several biological activities due to 
their structural analogy with the corresponding α-amino acids. Starting from a 
preformed aldimine v and dialkyl phosphite xii, a batch procedure was 
modified to be suitable for the microreactor setup (Scheme 5.3). 
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Scheme 5.3: α-Aminophosphonate formation. 
 
A first modification consisted of the temperature adjustment. While the batch 
procedure proceeded at the reflux temperature of methanol, working at that 
temperature was not possible in the microreactor due to vapour formation 
and a corresponding broad residence time distribution. Secondly, it was 
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investigated to be able to work with less than 2 equivalents of dialkyl 
phosphite. However, no complete conversion was observed anymore. To 
further increase the output, the input concentrations of the reagents was 
increased to an optimal concentration in the microreactor of 40 mass% for 
the imine. Higher concentrations resulted again in a decrease of the 
conversion. A final optimisation consisted of a residence time decrease. To 
preserve a complete conversion, a shift towards higher boiling solvents was 
necessary. Although the conversion was still complete, this route was 
abandoned since the use of other alcohols resulted in side-product formation 
due to interesterification. Thus, in the optimised procedure, 20 mass% of the 
aldimine in methanol was mixed in the microreactor with 2 equivalents of the 
dialkyl phosphite in methanol, at 50 °C and a residence time of 78 min. Using 
this procedure, it was possible to obtain a variety of α-aminophosphonates 
with a throughput of 195 to 250 g/day. 
 
Switching to the three-component reaction between the aldehyde i, the amine 
viii and the dialkyl phosphite xii resulted in a competition between the 
formation of the α-aminophosphonates xiii and the α-hydroxy-
methylphosphonates xiv. Using orthoesters to promote the imine formation 
partially avoided this competition, which resulted in somewhat higher 
conversions. Unfortunately, complete conversion to the α-aminophosphonate 
using the 3-CR was never obtained and formation of the side-product would 
result in an extra purification step. Therefore, this route was abandoned. 
 
A final interest in this doctoral thesis was the ability to work with toxic 
reagents in a safe way. For this study, the multicomponent reaction to 
produce 3-amino-4-(arylamino)-1H-isochromen-1-ones xvii was chosen as an 
interesting example. To produce this compound, in situ generation of 
hydrogen cyanide is necessary.  In this reaction, 2-formyl benzoic acid xv 
reacts with an amine viii in the presence of potassium cyanide xvi and acetic 
acid (Scheme 5.4). 
 
The optimisation study was started from a literature procedure with some 
minor modifications. The reaction temperature was changed from the 
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methanol reflux temperature to 50 °C in order to obtain well defined 
residence times. Importantly, to obtain safe conditions, the acetic acid and 
potassium cyanide, necessary to generate hydrogen cyanide, were added 
separately to the microreactor. During the optimisation study, problems with 
crystallisation of the end product occurred. It was possible to solve this in 
two different ways.  
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Scheme 5.4: Formation of 3-amino-4-(arylamino)-1H-isochromen-1-ones. 
 
The first way consisted of a decrease in residence time, a decrease in 
concentration or a combination. Optimisation of both residence time and 
concentration of the starting products resulted in the following optimised 
procedure: 0.30 M of 2-formyl benzoic acid and 2 equivalents of acetic acid in 
methanol were added separately from a mixture of 1.2 equivalents of 
potassium cyanide and 2 equivalents amine in methanol to the microreactor 
system. The reaction was run at a temperature of 50 °C with a residence time 
of 39 min. A generalisation of this first procedure using different aromatic 
amines made it possible to produce between 33 and 63 g/day of the end 
product. In the case of an aliphatic amine, the Strecker product xviii was the 
main product formed, together with a small amount of the non-tautomerised 
end product xix. 
 
The other way required a change in the setup. Between the microreactor and 
the residence time unit, an extra input was connected. Via that input, the inert 
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solvent Fluorinert® FC-70 was added to the system. Using this setup, reaction 
bubbles were formed separated from each other by the inert solvent. As a 
result, no crystallisation occurred in the system and it was possible to work at 
the highest possible concentrations of the starting product, i.e. 0.4 M 2-formyl 
benzoic acid. Moreover, due to the insolubility of the added solvent, it was 
possible to easily recuperate the solvent. 
 
It was further explored if the microreactor setup was safer in handling toxic 
reaction conditions, compared to batch reactions. Therefore, the release of 
HCN to the environment was studied qualitatively and quantitatively. Using a 
colour formation procedure, it was already qualitatively visible that the HCN 
formation was slower in the microreactor procedure. By modifying an 
existing, U.S. Environmental Protection Agency approved, measurement 
method of hydrogen cyanide in water, it was possible to measure the amount 
of hydrogen cyanide released. Using the microreactor, the toxic reagent 
release was decreased approximately by two orders of magnitude.  
 
This 3-amino-4-(arylamino)-1H-isochromen-1-one compound was then 
further ring closed using the vicinal amino groups in order to attach an 
imidazole core to the molecule. As an end product, 1H-isochromeno[3,4-
d]imidazol-5-ones xxi were obtained (Scheme 5.5). After selection of an 
appropriate ring closing method, based on some batch experiments, 
optimisation studies in the microreactor were performed. 
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Scheme 5.5: Formation of 1H-isochromeno[3,4-d]imidazol-5-ones. 
 
Optimisation included the search for the appropriate temperature, the 
number of equivalents of the orthoester xx and the catalytic amount of acid. 
Summary and Perspectives 
- 178 - 
It was possible to obtain complete conversion at the end of the system, i.e. 
the microreactor and the residence time unit. However, the reaction was too 
slow to obtain complete conversion at the end of the microreactor. Even 
using the stopped-flow technique did not result in complete conversion at the 
end of the microreactor. The optimised conditions consisted in the reaction 
of 0.2 M of the 3-amino-4-(arylamino)-1H-isochromen-1-one in dimethyl 
formamide and a mixture of 5 equivalents of the orthoester with 0.1 
equivalents of p-toluenesulfonic acid in dimethyl formamide at room 
temperature and a residence time of 30 min. During the generality study, 
complete conversion was not always observed when using these conditions. 
By switching to the maximal residence time of 118 min or by changing the 
acid catalyst to trifluoro acetic acid instead of p-toluenesulfonic acid, mostly 
complete conversion was obtained. In the cases of complete conversion, it 
was possible to produce between 9 and 53 g/day of the 1H-isochromeno[3,4-
d]imidazol-5-ones. 
 
In summary, different types of multicomponent reactions were successfully 
optimised towards a continuous microreactor system. The optimised reaction 
conditions of the studied reactions are summarised in Table 5.1. From the 
results achieved in this doctoral thesis, some remarks and further perspectives 
towards the use of microreactor technology as an industrial tool have to be 
made. 
 
The type of microreactor setup used in this research suits very well for large 
scale production of chemicals. Once the appropriate reaction conditions are 
developed, large amount of a compound are produced in a short time. 
However, in my opinion some modifications are necessary when using this 
setup for the initial screening of these suitable reaction conditions. A switch 
to pumps which are accurate at lower flow rates (e.g. syringe pumps) is 
necessary, together with a low volume residence time unit. In this way, a large 
waste of starting material and solvents is avoided during the screening period.  
 
Specifically towards the application for MCRs, it is observed that using 
microreactor technology is only possible under certain conditions. In contrast 
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to a batch procedure, a prerequisite to perform MCRs in the microreactor is a 
suitable solvent or solvent system wherein all reagents dissolve. Otherwise, 
fouling of the microchannels occurs and a periodical flushing of the system is 
necessary which eliminates the advantage of continuous processing. 
Especially in the case of long reaction times this would be a major drawback 
due to the long start up period to reach steady state conditions.  
 
Furthermore, it is demonstrated that it is not possible to just apply known 
batch conditions in a microreactor procedure. Depending on the studied 
reaction, small or large modifications are necessary. Therefore, different types 
of solutions are possible such as the stopped-flow technique or the use of an 
inert solvent to avoid crystallisation. However, the use of the stopped-flow 
technique is limited because of the decreased throughputs per time unit.  
 
Finally, it is proven that the use of microreactor technology is suitable to 
considerably diminish the hazards using toxic reagents in a procedure. The 
performance of hazardous reactions in microreactor systems is definitely 
advantageous. 
 
Generally, it is believed that developing one microreactor which can handle 
all reaction types is not possible. Depending on the type of chemical reaction, 
specific adjustments of the microreactor are necessary. Therefore, I am 
convinced that one should strive towards the development of a modular 
microreactor system. In the future, the use of microreactor technology in 
industry will certainly increase, however not fully replace the existing methods 
in industrial applications. In my view, the main field wherein microreactor 
technology will play an important role is the medium to large scale production 
of easy accessible organic compounds using dangerous (exothermic, toxic) 
reaction procedures. Especially if there is an issue of selectivity, microreactor 
technology is a solution. 
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Table 5.1: Optimised reaction procedures.a 
Inlet Mixtures Solvent τ (min)
Temperature 
(°C) 
Throughput 
(g/day) 
Baylis-Hillman reaction 
A 0.4 M of aldehyde, 1 equiv of DABCO 3:7 (v/v) 
water/1,4-dioxane 118 22 1.7-22.4 
B 3 equiv of alkene 7:3 (v/v) 
water/1,4-dioxane
Imidazole formation 
A 0.5 M of α-diketone, 1 equiv of aldehyde, 5 equiv of 
acetic acid
NMP 
118 120 5.5-39.5 
B 1 equiv of NH4OAc, 1.2 equiv of amine, 5 equiv of 
acetic acid
n-pentanol 
α-Aminophosphonates 
A 40 mass% of aldimine MeOH 
78 50 196.8-256.8 
B 2 equiv dialkyl phosphite MeOH 
Formation of 3-amino-4-(arylamino)-1H-isochromen-1-ones 
A 0.30 M of 2-formyl benzoic acid, 2 equiv of acetic acid MeOH 
39 50 33.8-62.6 
B 1.2 equiv of KCN, 2 equiv of amine MeOH 
Formation of 1H-isochromeno[3,4-d]imidazol-5-ones 
A 0.2 M of 3-amino-4-(arylamino)-1H-isochromen-1-one DMF 
30 22 9.4-53.0 
B 5 equiv of orthoester, 0.1 equiv of p-TsOH DMF 
a Concentrations before mixing in the microreactor.
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Chapter 6 - Samenvatting en 
Perspectieven 
 
Microreactor technologie is een recent ontwikkelde technologie, die vooral de 
laatste 2 decennia aan interesse heeft gewonnen. Vooral sinds 1997 is er 
hieromtrent veel literatuur verschenen. De organische synthese is hierin 
slechts een beperkt onderdeel, waaruit blijkt dat deze technologie in een veel 
bredere context bestudeerd wordt.  
 
Een algemene definitie van microreactoren, als onderdeel van het brede 
gamma aan microsystemen, bestaat uit ‘geminiaturiseerde systemen die, op 
zijn minst gedeeltelijk, geproduceerd worden met behulp van 
microtechnologie en precisie engineering’. Vandaag de dag worden 
kleinschalige ontwerpen van bestaande reactoren en moderne 
reactorconcepten zoals vallende film reactoren, gepakte bed reactoren en 
gestructureerde katalysatoren (vb. met schuimstructuur) ook tot de 
verzameling van microreactoren gerekend. 
 
Uit onderzoek vanuit economisch invalshoek werd besloten dat ongeveer 
50 % van de huidige chemische reacties voordeel zou kunnen hebben bij het 
gebruik van continue processen die grotendeels gebaseerd zijn op 
microreactor technologie. Algemeen wordt door de ontwikkelaars en 
producenten van microreactor systemen een verscheidenheid aan voordelen 
voor de organische synthese toegeschreven waarvan de belangrijkste een 
betere massa- en warmtetransfer, veiligere reactieomstandigheden, een hogere 
selectiviteit en een eenvoudigere opschaling zijn. Verschillende reacties 
werden al bestudeerd om de werkzaamheid van dit concept te bewijzen. De 
meeste studies gebruikten echter eenvoudige, goed gekende reacties. 
 
Het doel van dit proefschrift was het evalueren van een microreactor systeem 
voor multicomponent reacties. In dit onderzoek werd gebruik gemaakt van 
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een commercieel microreactor systeem: het CYTOS® College System dat 
algemeen bestaat uit 2 pistonpompen, een microreactor eenheid en een 
verblijftijdseenheid om langere reacties te bestuderen (Figuur 3.1).  
 
In de eerste plaats werd de Baylis-Hillman reactie bestudeerd (Schema 6.1). 
Dit is een koolstof-koolstof binding vormende reactie tussen vb. een aldehyde 
i en een geactiveerd alkeen ii met behulp van tertiaire amines, zoals DABCO 
iii, of fosfines. De reactie verloopt algemeen vrij traag onder batch 
omstandigheden. Voor de optimalisatie van de Baylis-Hillman reactie werd 
gekozen voor de reactie tussen 4-nitrobenzaldehyde, methylacrylaat en 
DABCO als katalysator.  
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Schema 6.1: Baylis-Hillman en aza-Baylis-Hillman reactie. 
 
De optimalisatie bestond uit verschillende stappen waaronder de juiste keuze 
van mengen van de reagentia, de solventkeuze en de temperatuur. De keuze 
van mengen van de reagentia bleek belangrijk om nevenproducten, zoals de 
vorming van een stabiel betaine, te voorkomen. Daarom werd methylacrylaat 
en DABCO niet op voorhand gemengd. Een mengsel van water en 1,4-
dioxaan in een 1:1 (v/v) verhouding was de beste keuze voor het solvent-
systeem. Andere solventen, zoals dichloromethaan en sulfolaan, gaven lagere 
omzettingen. Bovendien trad er verstopping op in het geval van sulfolaan als 
solvent. Om de concentratie van eindproducten te maximaliseren in de 
microreactor, werden het aldehyde en de katalysator opgelost in een 3:7 (v/v) 
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mengsel van water en 1,4-dioxaan. Het geactiveerde alkeen daarentegen werd 
opgelost in een 7:3 (v/v) mengsel van water en 1,4-dioxaan. Zo werd de 
gewenste 1:1 (v/v) solventverhouding in de microreactor verkregen. De 
optimale reactietemperatuur bleek kamertemperatuur te zijn. Bij hogere 
temperaturen werden lagere omzettingen verkregen, terwijl het niet mogelijk 
was om bij lagere temperaturen te werken met het gebruikte solventsysteem. 
Samenvattend werd een mengsel van 0.4 M 4-nitrobenzaldehyde en 1 
equivalent DABCO in 3:7 (v/v) water/1,4-dioxaan bij kamertemperatuur 
gereageerd met 3 equivalenten methylacrylaat in 7:3 (v/v) water/1,4-dioxaan. 
Na 2 uur reactie werd 93 % omzetting bereikt. Uit een vergelijking met de 
conventionele batch reactie bleek dat er een daling van 30 % in reactietijd 
verkregen werd voor dit specifieke voorbeeld. Ondanks deze beperkte 
toename in reactiesnelheid, werden geen tragere Baylis-Hillman reacties 
bestudeerd. 
 
Vervolgens werden verschillende aldehyden en alkenen getest, gebruik 
makende van deze geoptimaliseerde omstandigheden. Er werden omzettingen 
tussen 52 en 100 % verkregen. Om volledige omzetting te krijgen in alle 
reacties, werd de ‘stopped-flow’ techniek geïntroduceerd. Daarbij werd de 
verblijftijd in het systeem verhoogd door de pompen alternerend te laten 
pompen en te pauzeren. Dit leverde hogere conversies op met soms complete 
omzetting. Het gebruik van deze techniek is echter economisch niet haalbaar 
wegens de verlengde opstartprocedure en de lagere productiehoeveelheid per 
tijdseenheid in vergelijking met de normale procedure. 
 
In een volgende deel van het onderzoek naar de Baylis-Hillman reactie, werd 
de invloed van de verblijftijdseenheid bestudeerd. Er werd waargenomen dat, 
bij een zelfde verblijftijd, betere resultaten verkregen werden als de 
verblijftijdseenheid werd gebruikt. Een duidelijke verklaring voor dit 
fenomeen werd echter niet gevonden. Waarschijnlijk speelt het verschil in 
vloeisnelheid tussen de experimenten hierbij een belangrijke rol. Nadat een 
aantal modificaties in de procedure werden doorgevoerd, werd de Baylis-
Hillman reactie vergeleken in 2 verschillende microreactoren en de 
Samenvatting en Perspectieven 
- 184 - 
conventionele batch procedure. De batch procedure gaf de beste resultaten, 
maar een passende verklaring werd niet gevonden.  
 
In een laatste deel van deze studie, werd de aza-Baylis-Hillman reactie 
onderzocht (Schema 6.1). Hierbij wordt het aldehyde i in de reactie vervangen 
door een imine v. Om competitie met de Baylis-Hillman reactie te vermijden, 
was het noodzakelijk om het imine vooraf te vormen. Er werd slechts een 
maximale omzetting van 49 % naar het aza-Baylis-Hillman adduct verkregen. 
 
Een tweede reactie die geëvalueerd werd was de productie van imidazolen via 
een viercomponentsreactie (Schema 6.2). Hiervoor werd gestart van een in de 
literatuur geoptimaliseerde procedure die gebruik maakt van microgolven. 
Door het gebrek aan opschaling van microgolfreactoren leek onderzoek van 
deze reactie in microreactoren interessant. Imidazolen zijn bovendien 
belangrijke heterocyclische structuren vanuit biologisch en synthetisch 
standpunt.  
 
De bestudeerde reactie bestond uit een gemodificeerde Radziszewski reactie, 
waarbij een α-diketon vii, een primair amine viii, een aldehyde i en 
ammoniumacetaat ix reageren met vorming van tetragesubstitueerde 
imidazolen x (als het primair amine afwezig is, worden trigesubstitueerde 
imidazolen xi gevormd). 
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Schema 6.2: Imidazool 4-CR. 
 
De reactie tussen benzil, benzylamine, isobutyraldehyde en ammoniumacetaat 
onder zure omstandigheden werd gebruikt om deze viercomponents-
condensatie te optimaliseren onder microreactor omstandigheden. Gedurende 
de optimalisatie traden 2 belangrijke problemen op. Enerzijds was er de 
zoektocht naar een geschikt solvent, aangezien er geen enkel solvent 
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gevonden werd waarin alle reagentia oplosten. Uiteindelijk werd geopteerd 
voor een solventmengsel. Het α-diketon en het aldehyde werden opgelost in 
DMF of NMP (afhankelijk van de geselecteerde reactietemperatuur) en het 
amine en ammoniumacetaat werden opgelost in een primair (hoogkokend) 
alcohol. Anderzijds werd een lage selectiviteit vastgesteld naar het tetra-
gesubstitueerde imidazool, omdat een deel van de startproducten werd 
omgezet naar het trigesubstitueerde imidazool. Wanneer de reactie echter 
werd uitgevoerd in azijnzuur bij 50 °C, werd een selectieve omzetting naar de 
tetragesubstitueerde component vastgesteld. Daarom werd de hoeveelheid 
azijnzuur verhoogd van 2 naar 10 equivalenten. Uiteindelijk bestond de 
geoptimaliseerde procedure uit de reactie in de microreactor van een mengsel 
van 0.5 M α-diketon, 1 equivalent aldehyde en 5 equivalenten azijnzuur in 
NMP met een mengsel van 1 equivalent ammoniumacetaat, 1.2 equivalenten 
amine en 5 equivalenten azijnzuur in n-pentanol. De temperatuur werd 
ingesteld op 120 °C en de verblijftijd bedroeg 118 min. Algemene toepassing 
van deze procedure, waarbij verschillende α-diketonen, amines en aldehydes 
gebruikt werden, leverde een opbrengst tussen 18 en 78 % op. 
 
Omdat het type microreactor in deze studie speciaal ontworpen werd om 
grotere hoeveelheden van componenten te produceren, leek het ook 
interessant om de productie van chemische componenten op een grotere 
schaal te onderzoeken. Daarom werd de productie van α-aminofosfonaten 
xiii via een derde multicomponentsreactie intensief onderzocht. α-
Aminofosfonaten worden bovendien als belangrijke componenten 
beschouwd, met verscheidene biologische activiteiten door hun structurele 
analogie met de overeenkomstige α-aminozuren. Vertrekkende vanuit een op 
voorhand geproduceerd aldimine v en dialkylfosfiet xii, werd een bestaande 
batch procedure gemodificeerd naar de microreactor setup (Schema 6.3).  
 
Een eerste modificatie bestond uit de temperatuursaanpassing. Terwijl de 
batch procedure bij de refluxtemperatuur van methanol verliep, was dit niet 
mogelijk in de microreactor omdat er vorming van gasbellen optrad met een 
brede verblijftijdverdeling tot gevolg. Vervolgens werd de mogelijkheid 
onderzocht om te werken zonder overmaat aan dialkylfosfiet. Daarbij werd 
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echter een onvolledige omzetting vastgesteld. Daarna werden de concentraties 
van de reagentia geoptimaliseerd naar 20 massa% imine om de productie te 
verhogen. Bij hogere concentraties werd een daling van de omzetting 
waargenomen. Een laatste optimalisatiestap bestond uit de vermindering van 
de verblijftijd. Om de volledige omzetting te bewaren, werd hiervoor 
overgeschakeld op het gebruik van hoogkokende solventen. Hoewel nog 
steeds een volledige omzetting optrad, werd deze route niet verder uitgediept 
daar er nevenproducten gevormd werden via interveresteringsreacties. Dus, in 
de geoptimaliseerde procedure werd 40 massa% aldimine in methanol 
gemengd in de microreactor met 2 equivalenten dialkylfosfiet, bij 50 °C en 
een reactietijd van 78 min. Gebruik makende van deze procedure, was het 
mogelijk om verschillende α-aminofosfonaten te produceren aan een snelheid 
van 195 tot 250 g/dag. 
 
xii xiii
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v
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R2 R2
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Schema 6.3: Vorming van α-aminofosfonaten. 
 
Wanneer omgeschakeld werd naar de driecomponentsreactie tussen het 
aldehyde i, het amine viii en het dialkylfosfiet xii, trad er een competitie op 
tussen de vorming van de α-aminofosfonaten xiii en de α-hydroxy-
methylfosfonaten xiv. Door gebruik te maken van orthoesters om de 
iminering te bevorderen werd deze competitie gedeeltelijk vermeden. Een 
complete omzetting naar de α-aminofosfonaten werd echter nooit verkregen. 
Omdat de vorming van een nevenproduct een extra opzuiveringsstap vereist, 
werd deze route verlaten. 
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Een laatste interessegebied in dit onderzoek was de mogelijkheid nagaan om 
op een veilige manier te werken met toxische producten. Als voorbeeldreactie 
bij deze studie werd gekozen voor de multicomponentsreactie voor productie 
van 3-amino-4-(arylamino)-1H-isochromen-1-onen xvii. Om deze 
component te vormen, is in situ productie van waterstofcyanide noodzakelijk. 
Tijdens de reactie reageert 2-formyl benzoëzuur xv met een amine viii in de 
aanwezigheid van kaliumcyanide xvi en azijnzuur (Schema 6.4). 
 
Voor de optimalisatie werd er gestart vanuit een gemodificeerde literatuur 
procedure. Hierbij werd de reactietemperatuur verlaagd van de reflux-
temperatuur van methanol tot 50 °C om een wel gedefinieerde verblijftijd te 
garanderen. Om veilig te werken, werd het azijnzuur en kaliumcyanide via 
afzonderlijke kanalen toegevoegd aan de microreactor. Gedurende de 
optimalisatie traden problemen op van vroegtijdige kristallisatie van het 
eindproduct in de microreactor. Dit kon op 2 manieren opgelost worden. 
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R
+ RNH2
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xvi
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O
NH
xix
R
xviii
N R
N
O
+
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Schema 6.4: Vorming van 3-amino-4-(arylamino)-1H-isochromen-1-onen. 
 
Een eerste oplossing bestond erin om de verblijftijd te verminderen, de 
concentratie te verlagen of deze 2 te combineren. Optimalisatie van zowel de 
verblijftijd als de concentratie van de startproducten resulteerde in volgende 
geoptimaliseerde procedure: 0.30 M 2-formylbenzoëzuur en 2 equivalenten 
azijnzuur in methanol werd afzonderlijk aan een mengsel van 1.2 equivalenten 
kaliumcyanide en 2 equivalenten amine in methanol aan de microreactor 
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toegevoegd. De reactie verliep gedurende 39 min bij een temperatuur van 
50 °C. Deze procedure was algemeen toepasbaar op een verscheidenheid aan 
aromatische amines met een productie van 33 tot 63 g/dag van het 
eindproduct. Als een alifatisch amine gebruikt werd, werd het Strecker 
product xviii verkregen, samen met een kleine hoeveelheid van het niet-
getautomeriseerde eindproduct xix. 
 
Voor de andere oplossing was een verandering van de opstelling vereist. 
Hierbij werd er tussen de microreactor en de verblijftijdseenheid een extra 
ingang toegevoegd. Via deze invoer werd het inerte solvent Fluorinert® FC-
70 toegevoegd aan het systeem. Deze opstelling maakte het mogelijk om 
afzonderlijke reactiebellen te produceren die van elkaar gescheiden werden 
door het inerte solvent. Daardoor werd kristallisatie in het systeem vermeden 
en was het eveneens mogelijk om bij hogere concentraties van het 
startproduct (0.4 M 2-formylbenzoëzuur) te werken. Bovendien kon het 
inerte solvent, door zijn onoplosbaarheid, gemakkelijk gerecycleerd worden. 
 
Vervolgens werd een vergelijkende studie tussen de batch procedure en de 
microreactor opstelling naar de veiligheid van deze toxische reactie uitgevoerd. 
Dit gebeurde door de vrijstelling van HCN in de omgeving kwalitatief en 
kwantitatief te meten. Gebruik makende van een kleurreactie werd er 
kwalitatief vastgesteld dat de HCN vorming trager was in de batch procedure. 
Door modificatie van een bestaande, door de U.S. Environmental Protection 
Agency goedgekeurde kwantificatiemethode van HCN in water, was het 
mogelijk om de hoeveelheid vrijgesteld HCN te meten. Deze vrijstelling was 
ongeveer 2 grootteordes lager in het geval van de microreactor procedure.  
 
Dit 3-amino-4-(arylamino)-1H-isochromen-1-on werd vervolgens verder 
ringgesloten ter hoogte van de vicinale aminogroepen om een imidazoolkern 
te incorporeren in de molecule. Als eindproduct werd dan het 1H-
isochromeno[3,4-d]imidazol-5-on xxi verkregen (Schema 6.5). Na de selectie 
van een geschikte ringsluitingsreactie op basis van een aantal batch 
experimenten, werd een optimalisatiestudie in de microreactor uitgevoerd. 
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De optimalisatie bestond uit de zoektocht naar een geschikte 
reactietemperatuur, het aantal equivalenten orthoester xx en de katalytische 
hoeveelheid zuur. Een complete omzetting op het einde van het systeem (na 
de verblijftijdseenheid) was mogelijk. De reactie was echter te traag om een 
volledige omzetting na de microreactor te verkrijgen, zelfs na het gebruik van 
de ‘stopped-flow’ techniek. De geoptimaliseerde procedure bestond erin om 
0.2 M 3-amino-4-(arylamino)-1H-isochromen-1-on in DMF bij kamer-
temperatuur te laten reageren in de microreactor met een mengsel van 5 
equivalenten orthoester en 0.1 equivalenten p-tolueensulfonzuur in DMF 
gedurende 30 min. Wanneer deze geoptimaliseerde procedure werd getest 
voor andere startproducten, werd niet altijd een volledige omzetting 
verkregen. Een aanpassing naar de maximale verblijftijd van 118 min of het 
gebruik van trifluorazijnzuur als zure katalysator gaf meestal een volledige 
omzetting. Verschillende 1H-isochromeno[3,4-d]imidazol-5-onen, aan een 
productiesnelheid van 9 tot 53 g/dag, werden verkregen. 
 
O
NH
NH2
O
O
O
N
N
R2
xvii xxi
R2C(OR3)3
xx
R1R1
+
8 voorbeelden  
Schema 6.5: Vorming van 1H-isochromeno[3,4-d]imidazol-5-onen. 
 
Samenvattend werden verschillende types van multicomponent reacties 
succesvol geoptimaliseerd naar een continu systeem, gebruik makend van een 
microreactor. De geoptimaliseerde reactieomstandigheden van de bestudeerde 
reacties worden samengevat in Tabel 6.1. Vanuit de resultaten behaald in dit 
werk, kunnen een aantal opmerkingen en perspectieven geformuleerd worden 
over het gebruik van microreactor technologie in industriële toepassingen. 
 
Het type microreactor set-up in dit onderzoek is zeer geschikt voor de 
productie van chemische componenten op grote schaal. Een grote 
hoeveelheid van een product kan op korte tijd geproduceerd worden eenmaal 
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de geschikte reactieomstandigheden zijn ontwikkeld. Volgens mij zijn er 
echter een aantal aanpassingen nodig wanneer deze set-up gebruikt wordt 
voor het screenen naar de geschikte omstandigheden. Een omschakeling naar 
pompen die accuraat zijn bij lagere vloeisnelheden (vb. plunjerpompen) en 
een verblijftijdseenheid met een klein volume zijn hierbij nodig. Zo wordt een 
groot verlies aan startmateriaal en solvent vermeden gedurende de screening 
fase. 
 
Uit dit onderzoek blijkt verder dat het gebruik van microreactor technologie 
voor MCRs enkel onder bepaalde voorwaarden mogelijk is. In tegenstelling 
tot een batchprocedure is het vinden van een solvent of solventsysteem 
waarin alle reagentia oplosbaar zijn vereist. Anders treedt er verstopping van 
de microkanalen op waardoor periodiek spoelen noodzakelijk wordt. 
Daardoor wordt echter het voordeel van continue processing tenietgedaan. 
Dit zou vooral bij lange reactietijden een enorm nadeel zijn door de lange 
opstartprocedure die dan nodig is om de evenwichtstoestand te bereiken. 
 
Daarnaast werd er aangetoond dat het niet mogelijk is om zomaar de batch 
procedure te implementeren naar een microreactor procedure. Afhankelijk 
van de bestudeerde reactie is het daarom noodzakelijk om kleine of grote 
wijzigingen door te voeren en mogelijke oplossingen zijn vb. het gebruik van 
de ‘stopped-flow’ techniek of het gebruik van een inert solvent om 
kristallisatie te vermijden. Het gebruik van de ‘stopped-flow’ techniek is 
gelimiteerd door de verlaagde productiehoeveelheid per tijdseenheid. 
 
Ten slotte werd ook bewezen dat het gebruik van een microreactor systeem 
de mogelijkheid biedt om toxische gevaren te verminderen. De toepassing 
van gevaarlijke reacties in microreactoren is zeer zeker voordelig. 
 
Algemeen kan gesteld worden dat het niet mogelijk is om een microreactor te 
ontwikkelen dat alle types reacties kan uitvoeren. Afhankelijk van het type 
chemische reactie, moeten er specifieke aanpassingen gebeuren aan de 
microreactor. Daarom denk ik dat er moet gezocht worden naar een modulair 
microreactor systeem. In de toekomst zal het gebruik van de microreactor 
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technologie in de industrie zeker toenemen, maar ze zal de bestaande 
methoden in de industriële toepassingen niet volledig gaan vervangen. Naar 
mijn mening wordt het belangrijkste toepassingsgebied voor de microreactor 
technologie de productie van gemakkelijk toegankelijke organische 
componenten op medium tot grote schaal, waarbij gebruik wordt gemaakt 
van gevaarlijke (exotherme, toxische) reacties. Vooral als de selectiviteit een 
belangrijke rol speelt, is het gebruik van microreactor technologie een 
oplossing. 
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Tabel 6.1: Geoptimaliseerde reactieprocedures.a 
Invoer Mengsels Solvent τ (min)
Temperatuur 
(°C) 
Productie 
(g/dag) 
Baylis-Hillman reactie 
A 0.4 M aldehyde, 1 equiv DABCO 
3:7 (v/v) 
water/1,4-dioxaan
118 22 1.7-22.4 
B 3 equiv alkeen 
7:3 (v/v) 
water/1,4-dioxaan
Imidazoolvorming 
A 0.5 M α-diketon, 1 equiv aldehyde, 5 equiv azijnzuur NMP 
118 120 5.5-39.5 
B 1 equiv NH4OAc, 1.2 equiv amine, 5 equiv azijnzuur n-pentanol 
α-Aminophosphonaten 
A 40 massa% aldimine MeOH 
78 50 196.8-256.8 
B 2 equiv dialkylfosfiet MeOH 
Vorming van 3-amino-4-(arylamino)-1H-isochromen-1-onen 
A 0.30 M 2-formylbenzoëzuur, 2 equiv azijnzuur MeOH 
39 50 33.8-62.6 
B 1.2 equiv KCN, 2 equiv amine MeOH 
Vorming van 1H-isochromeno[3,4-d]imidazol-5-onen 
A 0.2 M 3-amino-4-(arylamino)-1H-isochromen-1-on DMF 
30 22 9.4-53.0 
B 5 equiv orthoester, 0.1 equiv p-TsOH DMF 
a Concentraties vóór menging in de microreactor.
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